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The antigenic determinants of the protein subunit of tobacco mosaic 
virus CTMV) have been studied by inhibition of complement .fixation, 
inhibition of micro-precipitin and direct binding experiments. 
The viral subunit has been found to possess six antigenic determi-
nants. Two of these, situated in try pt i c peptide I (residues 1-41 ), 
were found to be a cryptotope (i.e. an antigenic determinant absent 
from the outer surface of the assembled viral capsid) and a viral 
antigenic determinant. Tryptic peptides 4 (residues 62-68) and 8 
(residues 93-112) also contained cryptotopes which were situated in 
the region of residues 63-65 and 108-112 respectively. Tryptic pep-
~ide 12 (residues 142-15$) contained both a cryptotope and a neoto-
pe (i.e. an antigenic determinant which is only expressed on the 
outer surface of the viral caps id), which are situated in the C-ter-
minal region of the polypeptide chain of the TMV protein, residue 
156 being associated with the cryptotope and residue 158 with the 
neotope. No antigenic activity could be demonstrated in tryptiG pe-
ptide I I (residues 135-14 I ) • 
When the resul_ts are analyzed in terms of the three-dimensio.nal 
structure of the viral subunit, it appears that al I the antigenic 
reactive regions occupy highly accessible locations on the surface 
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PART I. REVIEW OF LITERATURE AND INTRODUCTION 
I .I PERSPECTIVE 
From the outset of the pioneering work that established the complete 
antigenic structure of the protein myoglobin, Atassi did not belleve 
that any single chemical approach would be c;idequate to the task, as 
each approach had its own limitations and shortcomings. Accordingly 
a strategy of five approaches, designed to minimize the drawbacks of 
·any single approach, was evolved: (a) determination of the confor .. 
mational influence on the immunochemical properties; (b) immunochem-
lstry of specific derivatives of the intact protein; (c) preparation 
and immunochemistry of a large number of peptides with a variety of 
overlaps; (d) immunochemistry of specific derivatives of immunocheml-
cal ly reactive peptides; and (e) having narrowed down the reactive 
regions to a conveniently smal I size by the foregoing approaches, 
final delineation is achieved by studying the immunochemistry of 
synthetic peptides representing various parts of each region. 
The sequential application of these approaches al lows the information 
obtained to be assembled in such a way that the findings from any one 
approach can be confirmed or corrected by the results of the next 
approach in the strategy. Thus the application of a multi frontal 
attack minimizes labour and increases effectiveness in the solutrqn 
of a compl·ex and time-consuming problem.(Atassi, 1975; 1977 a; 1977 b.) 
In contrast to the concerted labour that the immunochemistry of myq-
globin and lysozyme received, the efforts to elucidate the antigenic 
structure of tobacco mosaic virus CTMV) and its protein subunit have 
continued sporadically for two decades (Harris and Knight, 1955; 
2 
van Regenmortel and Lelarge, 1973) with several independant groups 
each contributing a limited number of approaches out of the context 
of a guiding strategy. This, as can be expected, has led to mis-
interpretation of specific features and confusion over the operation 
of the system as a whole. 
For this reason it is proposed that the literature as wel I as the 
present work be organised into the framework of Atassi 's strategy 
for the sake of clarity, even if the historical perspective is lost. 
1.2 CONFORMATION AND ITS INFLUENCE Of\! IMMUNOCHEMICAL PROPERTIES 
I. 2. I RATIONALE 
The role played by the tertiary conformation in the immunochemistry 
of a protein antigen must be assessed before comparison between the 
activity of modified protein derivatives and the native protein can 
'·' 
be considered valid. l·n.! this way it can be ascertained whether 
any change in immunochemical activity is directly due to the modified 
resldue(s) or to a conformational change associated with the modifl~ 
cat! on. (Atass i, 1977 b.) 
Over and above this important consideration, the matter becomes more 
complicated when dealing with antigens which have a quaternary pro-
teln strudure. This is because two new kinds of antigenic sites, 
in addition to those sites which remain unaltered in the transition 
from the individual subunits to the quarternary complex, become 
possible. The first of these new antigenic sites has been cal led 
a cryptotope (Jerne, 1960; van Regenmortel, 1966) and is defined as 
an antigenic determinant of the subunit which is no longer present 





A schematic representation of a TMV protein monomer 
and the corresponding polymer, showing the outside 
surfaces available for antibody binding. In a 
helical polymer like TMV, surfaces B, C, D, E and F 
would be hidden and could harbour cryptotopes. 
Surface A could also possess cryptotopes if it 
differed from surface A' because of conformational 
change in the polypeptide chain (adapted from van 
Regenmortel and Lelarge, 1973). 
3 
in the quaternary complex. This may be due to corformational change 
induced in the subunit during the formation of the quaternary complex 
or merely due to the fact that portions of the subunit's surface area 
are hidden in the quaternary complex (fig. I. I). Similarly, the 
second kind of new antigenic site, cal led a neotope (van Regenmortel, 
1966), Is defined as an antigenic determinant which exists only in the 
quaternary complex, and may be due to the unique conformation of the 
quaternary complex or to the juxtapositioning of amino acid residues 
from neighbouring subunits (van Regenmortel. and Lelarge, 1973). 
As al I three kinds of antigenic sites are possible in TMV· and its pro-
tein subunits, it is necessary to devote attention to the structural 
and conformational features of the virus and protein subunit before 
an understanding of its immunochemistry is possible. 
1.2.2 THE STRUCTURE AND CONFORMATION OF TMV AND ITS PROTEIN SUBUNIT 
The TMV virion is a rod-like particle with the dimensions 300xl8 nm 
. 6 
and a molecular weight of 40xl0 daltons. Each particle is a pro-
0 
tein helix with a pitch of 23 A and 130 turns, and each turn contains 
161/3 protein subunits (there are 49 subunits in every three turns -
the repeat unit). 
0 
diameter of 20 A. 
At the centre of the helix there is a hole with a 
The total number of protein subunits per virion 
is 2130 and each subunit has a molecular weight of 17500 daltons (fig. 
I • 2) . The RNA content of each vi rion is 5% and three nucleotides are 
bound to each protein subunit, probably by hydrophobic interactions 
between the bases and aliphatic amino.acids as wel I as by ionic inter-
actions between the phosphate groups of the RNA and three arginine 







2ol Radius of hole 
~ 75l -.j Mean radius 
r Particle axis 
A schematic representation of a short length of a 
virion of TMV showing the helical structure. The 
lower portion of the virion is cut in half to show 
the dimensions of the helix, the central
0
hole and 
the location of the strand of RNA at 40 A. 
(Adapted from Rappa po rt, 1965) . 
5 
In addition to these two components, each virion also contains a 
26500 dalton protein of host origin, the H-protein, which is not 
associated with a specific site in the virion, but may be inter-
calated between the protein subunits, or more probably, lodged in 
the central hole of the virion <Asselin anq Zaitlin, 1978). 
The primary structure of the TMV protein subunit was initially 
determined by two groups working separately, but simultaneously, 
by the use of classical sequencing methods (Anderer et~., 1960; 
Tsugita et~., 1960). Minor disagreements about parts of the 
sequence (particularly the I-peptide, r~sidues I - 41 - so named 
by Gish (Ramachandran and Gish, 1959) because of its insolubi I ity 
at pH4,5) and the placement of amide groups were resolved (Anderer 
and Handschuh, 1962; Funatsu et~., 1964) into the sequence pre-
sented in figure 1.3. 
The TMV protein is a single chain of 158 amino acids containing one 
cysteine <residue 27), but not cystine, nor methionine or histidine. 
The advantage conferred by this lack is not readily apparent except 
in as far as the virus would make an inadequate diet for most micro-
organisms. In fact the HR strain which has both histidine and 
methionine is more susceptible to bacterial spoi I age than the other 
strains. <Fraenkel-Conrat, 1962.) 
The C-terminal threonine is readily released by carboxypeptidase, even 
from the intact virus, while no further amino acids are split off by 
enzyme action (Harris and Knight, 1952). This is due to the location 
of prol ine third from the end of the chain, which prevents the enzyma-
tic release of alanine. The protective role that praline plays 
6 
Peptide 1 
5 10 15 
Acetyl-Ser-Tyr-Ser-1 le-Thr~Thr-Pro-Ser-Gln-Phe-Val-Phe-Leu-Ser-Ser-
20 25 30 
Ala-Trp-Ala-Asp-Pro-1 le-Glu-Leu-1 le-Asn-Leu-Cys-Thr-Asn-Ala-
2 
35 40 I 45 
Leu-Gly-Asn-Gln-Phe-Gln-Thr-Gln-Gln-Ala-Arg Thr-Val-Gln-Val-
3 . 
I 50 55 60 Arg Gln-Phe~Ser-Gln-Val-Trp-Lys-Pro-Ser-Pro-Gln-Val-Thr-Val-
4 5 6 
I 65 I 70 I 75 Arg Phe-Pro-Asp-Ser-Asp-Phe-Lys Val-Tyr-Arg Tyr-Asn-Ala-Val-
80 85 90 
Leu-Asp-Pro-Leu-Val-Thr-Ala-Leu-Leu-Gly-Ala-Phe-Asp-Thr-Arg-
7 8 
I I 95 100 105 Asn-Arg lie-I le-Glu-V9l-Glu-Asa-Gln-Ala-Asn-Pro-Thr-Thr-Ala-
9 
110 I 115 120 
Glu-Thr-Leu-Asp-Ala-Thr-Arg Arg-Val-Asp-Asp-Ala-Thr-Val-Ala-
10 11 
I 125 130 1135 I le-Arg Ser-Ala-I le-Asn-Asn-Leu-1 le-Val-Glu-Leu-1 le-Arg Gly-
12 




fig. 1.3 The primary structure of the protein of the common strain 
of TMV. Tryptic cleavage sites are indicated with a 
bar Cl) and the peptide number is written to the right of 
it. 
7 
against exopept i dases Is i I I ustrated by the p rope rt i es of certain 
mutants of TMV where the proline in position 156 is replaced by 
leucine: in contrast to TMV vulgare, these mutants are extensively 
degraded by carboxypeptidase CTsugita and Fraenkel-Conrat, 1962). 
Similarly the N-terminal serine is acetylated (Narita, 1958) or re-
placed by proli.ne in some strains (Wittmann, 1965) and this, with the 
proline near the C-terminus, appears to represent an evolutionary ad-
vantage in giving the protein additional stabi I ity against exopepti-
dases CFraenkel-Conrat, 1969). Protection of the viral rod against 
endopeptidases,which degrade the isolated protein, would be afforded 
by the tight packing of the subunits in the helix CFraenkel-Conrat, 
1962). 
The elucidation of the secondary and tertiary structure of the TMV 
pro'tein subunit proved to be more problematic than the solution of the 
primary structure, because TMV protein presents a difficult problem 
for X-ray crystallographic structure determination. It can be cryst-
al Ii zed as disks consisting of two layers of rings (each 17 subunits in 
circumference) without RNA, but the asymmetric unit is very large 
(600 000 da I tons) and this posed a form i dab I e tech n i ca I prob I em (Durham 
and Butler, 1975; Champness et El_., 1976). This encouraged structural 
predictions based on sequence data, low resolution X-ray crystallography 
and the avai labi I ity of specific residues for enzymic, immunological or 
chemical reaction (Schiffer and Edmundson, 1967; Fraenkel-Conrat, 1968; 
Leberman, 1971; Durham and Butler, 1975). 
Leberman (1971) modified the rules formulated by Kotelchuck and Scheraga 
(1969) and using these, roughly predicted three of the a-helices in the 
8 
protein subunit, while Durham and Butler (1975), utilizing the Chou 
and Fasman rules for predicting protein conformation (Chou and Fasman, 
1974 a, b) suggested a wedge-shaped molecule with the N- and C-terminal 
residues on the surface of the virion and a secondary structure of a-
helices ands-pleated sheets. Although they anticipated a-helical 
0 
structure below the 40 A radius, they suggested that the backbone of 
0 
the prote)n, above the 40 A radius was B-structure. This has been 
shown to be unlikely by Holmes et~· (1975) who were able to produce 
0 
an electron density map of the protein at a resolution of 6,7 A by 
analysis of the X-ray diffraction pattern given by orientated gels of 
the virus. They concluded that, apart from very short sequences, the 
0 
only ptace where a B-sheet could be accommodated was above the 70 A 
radius (Holmes et~., 1975). 
Champness et~· (1976) used the method of isomorphous replacement 
to solve the structure of TMV protein In crystals of the disk to a 
0 
resolution of 5 A. They used only two heavy atom derivatives (Hg, 
Au), but these nevertheless gave good phases using the 17-fold rota-
tlonal symmetry of the disk which gave rise to redundant information 
in the X-ray data that could be exploited in phase determination. 
With consideration for sequence .data relating to the locations of the 
heavy atom label led residues, the accessibility of certain residues to 
reactants and regions of conserved sequence in the strains and mutants, 
0 
the polypeptide chain could be traced for the 5 A model (Champness et 
~., 1976) with I ittle ambiguity. The main structural feature of this 
model was a super-secondary structure (Rao and Rossman, 1973), which 




approximately radial "rods" of a-helix between the 40 A and 70 A 
rad i i ( f i g. I . 4) . If the course of the polypeptide chain is viewed 
in plan, the upper two helices were cal led the left and right slewed 
rods (LS and RS respectively) while the lower helices were cal led 
the left and right radial rods (LR and RR). The order of these 
helices from the N-terminus to the C-terminus on the polypeptide 
chain is LS, RS, RR and LR. 
The spatial similarity of this arrangement of a-helices in TMV pro-
tein to one of the three domains in tyrosyl-tRNA synthetase has led 
to the speculation that this structure is associated with the 
functional property of RNA binding and is conserved during evolution 
for this reason (Argos et~., 1977). 
0 
The 5 A map is,howeveG deficient in two respects. Firstly, the lack 
0 
of density below the 40 A radius, where it is expected as judged from 
0 
the 6,7 A map of the protein in the viral helix (Holmes et~., 1975), 
suggests that this region is very disordered in the disk (Champness 
et~., 1976). Secondly, at this low resolution the chain tracing 
0 
is ambiguous at the level of the 70 A radius and the direction of the 
sequence through the "loop" from the RS helix to the RR helix was 
chosen as the best fit for the electron density map (Champness et~., 
1976). 
0 
The extension of the map to a resolution of 2,8 A by the same group of 
workers provided more detai I of the conformation and interactions of 
the subunits in the disk (Bloomer et~., 1978). The higher resolu-
tion of the electron density map confirmed that al I the subunits in 
the disk are practically identical in conformation. 
It also showed that the wrong alternative for the connectivity of 
0 
the polypeptide chain at the 70 A radius had been chosen (Bloomer 
et ~. , I 9 78) . Thi.s did not affect the sequence of the four a-
helices, but it did mean that the course of the polypeptide chain 
0 
above the 70 A radius had to be rearranged in the form depicted 
i n f i g u re I . 4. · 
This revealed that the pair of slewed helices was tied to the 
lower pair of radial helices by four strands of anti-para I lei 
S-sheet at the distal ends, and perpendicular to the axis of the 
he Ii ces. Beyond this a group of aromatic residues (tryptophan 
17, tyrosine 70, tyrosine 139, phenylalanine 12 and phenylalanine 
144) together with proline 56 and praline 63 formed a hydrophobic 
0 
cluster in the neighbourhood of the 75 A radius. A further hydro-
phobic cluster on both sides of the molecular interface (phenylala-
nine 67 and proline 20 with phenylalanine 10 and prol ine 7 on the 
adjacent subunit) and several aliphatic side chains at the same 
radius make up a continuous belt of hydrophobic interactions which 
circles the disk from subunit to subunit. Distal to this are the 
residues that make up the surface of the virion - the projecting N-
and C-terminal amino acids. <Bloomer et~., 1978.) 
0 
The higher resolution of the 2,8 A map did not clarify the path of 
0 
the polypeptide chain below the 40 A radius, instead it emphasized 
the disorder in this region (BI oome r et ~. , 19 7 8) . High reso-
lution proton ~uclear magnetic resonance (NMR) studies by Jardetzky 
et al. (1978) confi nned that the lack of definition in the electron 
density maps is due to thermal disorder, which indicates flexibi I ity 
11 
In 
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40 60 80 
Radius ( ~) 
A diagramatic representation of the secondary and tertiary 
structure of the TMV protein in the 20 S disk. The four 
approximately para I lel helices are represented as cylinders 
(based on Bloomer et al., 1978; Argos et al., 1977). 
Residues I and 158-are-located at the surface of the subunit 
which is exposed at the outer periphery of the capsid. 
Residues 90-114 are hidden inside the assembled caps id. 
(A) The molecule viewed in plan. (8) The molecule viewed 
from a side elevation. 
13 
in the region rather than Irregular packing of this segment of the 
polypeptide chain in the crystal. 
0 
The 4 A electron density map of Stubbs et~· (1977), which was 
obtained from X-ray fibre diffraction patterns of orientated gels 
of the virus, shows a vertical a-helix (the V-hel ix) extending 
0 
from residues 103-112 at the 20 A radius (fig. 1.5). This he I ix, 
which constitutes the major difference between the conformation of 
the virus and the disk, is also present in reconstituted TMV pro-
tein subunits as judged by the radial electron density distribution 
(Frankl in, 1956). This suggests that the conformational change 
that gives rise to this helix is more directly caused by protein-
protein interactions rather than by protein-RNA interactions when 
the helix is formed. Other differences between the two mode Is con-
cern the exact location of, and the residues comprising the main a-
helices (Bloomer et~·, 1978). 
0 
The 4 A electron density map is deficient in that it yields very 
little information about the outer region of the protein subunit in 
the virion (Stubbs et~., 1977). The resolution fal Is off rapidly 
0 0 0 
above the 65 A radius and is as low as 5,5 A at the 80 A radius. As 
a result of this, the authors did not attempt a detailed fit for their 
0 
model above the 60 A radius (Stubbs et .9...!_., 1977). This deficiency 
leaves the question of the similarity between the conformation of the 
surface residues in the viral helix and the disk unanswered. Graham 
and Butler ( 1978), however, compared the locations of label led cysteine 
27 and tyrosine 139 in the disk and the viral helix by X-ray crystal lo-
graphy. They concluded that, during the transformation from the dis.k 











A diagramatic representation of the secondary and tertiary 
structure of the TMV protein in the viral helix. The five 
helices are represented as cylinders (based on Stubbs et al., 
I 9 77; Argos et a I . , I 9 77) . - -
Residues I an(i""""l58 are located at the surface of the subunit 
which is exposed at the outer periphery of the capsid. The 
helix consis.ting of residues 103-112 is hidden inside the 
assembled capsid. The location of the RNA relative to the 
protein subunits is shown in side elevation. 
-· .:1 
to the helix, the subunit undergoes a rigid body downward ti It of 
at least 10°, but that there is I ittle distortion of the conforma-
l 0 
tion of the subunit during this process, at least between the 60 A 
0 . 
and 75 A radii (Graham and But I er, 1978). This being so, the 
surface conformation of the subunit in the disk and the viral helix 
would be practically identical. 
Less is known about the conformation of the TMV protein monomer 
which exists only in conditions of low temperature, low ionic strength 
and high pH. In mi Ider conditions it is found in the form of the 
15 
A-protein, a smal I aggregate of three or more subunits with a sediment-
ation coefficient of 4S, but, as conditions become more favourable for 
aggregation, a series of larger discrete aggregates with sedimentation 
coefficients of 7-8S, 18-22S (the disk), 28-33S and larger, appear 
as is i I lustrated in fig. 1.6 (Klug and Durham, 1971). This tendency 
to aggregate can readily be understood in terms of the alternating 
patches of hydrophobic residues and salt interactions on the inter-
surfaces between the subunits in the disk (Bloomer et .9..!_., 1978). 
Circular dichroism (CO) studies of the transition of the A-protein to 
the disk indicate that the gross conformation is the same for both of 
these species, and that the structural change which occurs is local-
ized (Vogel, 1973). Considering that the greatest dichroic absorp-' 
tion change occurs between 250 nm and 295 nm and that tyrosine 139, 
which is near the C-terminus, participates in the fomiation of the 
~ '·" 
disk (Ohno et .9..!_., 1972), it is I ikely that the C-terminal end of the 
TMV protein is involved in the conformational changB leading to the 
formation of the disk (Vogel and Jaenicke, 1974). This is confirmed 
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5.0 6.0 7.0 8.0 9.0 
pH 
A diagram showing the ranges over which the different 
modes of aggregation of TMV protein predominate in the 
equl librium. The conditions were a concentration of 
5mg/ml at 20° C. (A) pH-dependant aggregation to disks 
(thick arrows) and helices (thin arrows) at constant 
ionic strength .. (8) Ionic strength-dependant aggrega-
tion to disks (thick arrows) and stacked disks (thin 
arrows) at constant pH. (Adapted from Klug and Durham, 
1971; Vogel and Jaenicke, 1974.) 
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in the mutant Ni. 1927 causes comparable dichroic absorption changes 
(Vogel and Jaenicke, 1974). 
The chief conformational difference between the surface residues of 
the subunit in the viral helix and those same residues in the A-
protein is therefore expected to be the configuration of the C-term-
inal amino acids. 
1.2.3 IMMUNOLOGICAL CROSS-REACTIONS BETWEEN TMV AND THE AGGREGATES 
OF ITS PROTEIN MONOMER 
The manner in which TMV protein changes its state of aggregation 
with differing physical conditions (Klug and Durham, 1971) and the 
evidence that the various aggregates express different conformational 
features of the protein subunit (Vogel, 1973; Vogel and Jaenicke, 
1974) means that immunization with a single immunogen is practically 
impossible. Injected virus,which has partially dissociated into 
protein monomers or A-protein in the animal,wi 11 give rise to a heter-
ogenous population of antibodies which wi I I be specific for the con-
formations of the subunit in the virion as wel I as in the free protein 
(van Regenmortel and Lelarge, 1973). Similarly, injected A-protein 
can aggregate to give rise to antibodies which wi I I recognize the viral 
subunit conformation (Loar, 1967; van Regenmortel and Le large, 1973). 
This serological multispeci ti city can be I imited by the use of cross-
absorbed sera, but sti I I the results of cross-reaction experiments may 
be arnb i guous. 
RNA-free reaggregated protein rods have been shown to be serologically 




TMV sera containing only antibodies specific for the virus (van Regen-
mortel and Lelarge, 1973). This is consistent with the crystal lo-
graphic data (Graham and Butler, 1978) that the surface residues of 
the subunits in the virus and in the aggregates, 20S and larger, are 
practically identical in conformation. They would be expected to 
share common.antigenic determinants. The rest of the subunit is 
increasingly hidden in the larger aggregates and would be unavailable 
to react with antibody except at the extremities of the rods. In 
the disk these "rod extremities" would account for the reaction with 
the antibodies remaining in anti-TMV sera absorbed with formalinized 
TMV (van Regenmortel and Lelarge, 1973), but they would not be 
numerically significant in the case of the larger aggregates and 
would so escape detection. 
Although the A-protein and the virus are known to show a weak cross-
reaction indicative of related antigenic determinants (van Regenmortel 
and Lelarge, 1973), they possess several distinct antigenic determi-
nants as we I I . Fol lowing absorption of anti-TMV serum with A-protein, 
antibodies specific for the virus sti 11 remain (Star Ii nger, 1955; 
Takahashi and Gold, 1960; van Regenmortel, 1967). Similarly absorp-
tion of ahti-protein serum with virus does not remove al I the anti-
bodies that react with the A-protien (Aach, 1959; van Regenmortel, 1967; 
van Regenmortel and Lelarge, 1973). This phenomenon has been explain-
ed in two ways. Firstly, Rappaport et~· (1965) proposed that the 
TMV protein subunit had a single antigenic determinant which assumed a 
variety of slightly altered configurations as the result of polymeriza-
tion, so giving rise to an antibody population of heterogenous specifi-
city. This explanation is no longer tenable in view of the monomer's 
calculated antigenic valence of 5-6 in the precipitin reaction (van 
Regenmortel and Lelarge, 1973). The alternative multideterminant 
model (van Regenmortel, 1967) proposes that the virus specific anti-
bodies remaining after A-protein absorption, are directed against 
neotopes and that the protein specific antibodies remaining after 
virus absorption are directed against cryptotopes. 
The phenomena described in the preceding paragraph have not been 
universally observed. Kleczkowski (1961) found that no detectable 
anti-virus activity remained when a considerable excess of A-protein 
(50 mg/ml) was used to absorb the anti-TMV serum. However, the use 
of such concentrated A-protien preparations could have resulted in 
considerable aggregation with the concomitant production of neotopes 
(van Regenmortel, 1966). Du Plessis and van Regenmortel (1977) com-
pletely inhibited the protein-anti-protein reaction in a modified 
phage assay with an approximately ten fold excess of intact virus. 
This would seem to contradict the presence of cryptotopes on the pro-
tein subunit, but the explanation may I ie in the possible partial 
dissociation of the virus or in the presence of sufficient crypto-
topes on the extremities of the virus rods. 
TMV and its protein can therefore be expected to express al I three 
types of antigenic determinants: neotopes, cryptotopes and determi-
nants common to both the virus and the dissociated. protein subunit. 
1.3 IMMUNOCHEMISTRY OF SPECIFIC DERIVATIVES 
I .3. I EFFECTIVENESS OF THE APPROACH 
lmmunochemical studies which compare the reactivities of a protein 
I~ 
antigen and its derivatives which,have specifically modified residues, 
are able to indicate the rough locations of antigenic determinants as 
wel I as yielding information about the particular residues that make 
20 
up the determinant. For this approach to be truly effective, however, 
the specificity of the modification and the homogeneity of the deri-
vative are important. The modification reaction should be chosen to 
be specific for a single, or a limited number of amino acid side 
chains, and the particular derivative must be rigorously purified to 
homogeneity. Only results obtained with a single molecular species 
can be mean i ngfu I. Another consideration is whether conformatfona I 
change is induced by a particular modification. The resulting 
change in the immunochemical reactivity of the derivative could wel I 
be independant of the specific residue that was modified and could 
lead to invalid conclusions in respect of the locations of antigenic 
determinants. Only derivatives that have suffered no conformational 
change can yield meaningful results. On the other hand, the absence 
of a change in immunochemical reactivity after a particular modifica-
tion does not exclude the possibility of that residue being part of 
an antigenic determinant. The nature of the modification may be 
chemically or sterical ly insufficient to affect the role played by the 
side chain in the antigenic activity of the molecule. This prob I em 
can be overcome by modifying each amino acid side chain in more ways 
than one before assessing its role in the immunochemistry of the pro-
tein. The number of avai I able modification reactions and the steric 
avai labi I ity of the side chain to the reagent does constitute a limit-
ation. (Atass i, 1977 b.) 
Apart from the possible chemical derivatives of TMV and its protein, 
there also exists a set of wel I characterized strains and mutants 
(Hennig and Wittmann, 1972), which may be regarded as derivatives for 
the purposes of this approach. Here modifications of the viral RNA 
are expressed as a limited number of amino acid exchanges in the 
sequence of the coat protein. The I imitati.on is imposed by the 
necessity for the conservation of certain amino acid residues and 
sequences which are essential for biological function. A Iteration 
of these latter amino acids results in the inactivation of the virus 
molecule. 
Virus variants that are isolated from the field are distinguished as 
strains, whereas variants arising under experimental conditions are 
termed mutants. The spontaneous mutation rate is relatively high 
('V I x I o-2) (Sehga I and Krause, 1968), and can st i I I be enhanced up 
to 30 times (Mundry and Gierer, 1958) by the use of chemical or 
physical means. Nitrous acid (HN02 > which deaminates the nucleotide 
bases without the RNA chain breaking, is the most effective tool for 
inducing mutations and has been used almost exclusively to produce 
large amounts of mutants (Hennig and Wittmann, 1972). Other reagents 
which have a mutagenic effect are hydroxylamine, alkylating agents 
such as dimethyl suplhate (OMS), N-methyl-N'-nitro-N-nitrosoguanidine 
(MNNG) and substances which cause the halogenation of the nucleotide 
bases such as N-bromosuccinimide (NBSI ). The physical induction of 
mutants can be accomplished by X- or U.V. irradiation or by increased 
temperature. (Hennig and Wittmann, 1972.) 
More than 300 spontaneous and chemically induced mutants of TMV have 
been examined for their amino acid composition and it was found that 
more than two-thirds of these have only one amino acid replacement 
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each, and that the rest have two or, quite seldomly, three exchanges 
each (Hennig and Wittmann, 1972). This makes them ideal for use in 
immunochemical comparisons with the common strain since their viabi-
lity attests to the retention of biological function, and hence, to 
a larger extent, the natural conformation of the wi Id type protein 
subunits. The only remaining consideration is whether a particular 
amino acid exchange is sufficient to affect the immunochemical role 
played by a specific residue occupying an identical position in the 
sequence of the wi Id type protein. 
The same criteria apply to the strains, although they usually have 
more amino acid exchanges, probably due to a number of single muta-
tion steps that have accumulated with time (Hennig and Wittmann, 
1972). 
1.3.2 SEROLOGICAL STUDIES WITH CHEMICAL DERIVATIVES AND POINT 
MUTANTS OF TMV 
Specific derivatives of TMV have been obtained in two ways. Some 
workers have chemically modified the side chains of certain amino 
acids of the proteins of the virus (Malkiel, 1952; Price, 1954; 
Anderer and Handschuh, 1963; and Staab and Anderer, 1976), or re-
leased amino acids from the C-termini of the protein in the viral 
helix (Harris and Knight, 1952 and 1955; van Sengbusch and Wittmann, 
1965). Others have exploited the usefulness of the mutants of TMV 
as a probe for the quaTernary and antigenic structure of the pro-
tein subunit in the intact virus (von Sengbusch and Wittmann, 1965; 
von Sengbusch, 1965; and van Regenmortel, 1967). 
The interpretation of the results of the serological studies with 
22 
chemically derivatized TMV requires that three criteria be consid-
ered: the number of different residues in the TMV protein modified 
simultaneously, the extent of the modification reaction in as far 
as the number of protein subunits modified per virus particle is 
concerned and the effect of a particular modification on the native 
conformation of the protein subunit in i-he virus. For examp I e, 
Malkiel (1952) concluded that derivatives with phenol groups modi-
fied by the attachment of an azo-arsani I ic group, exhibited serolo-
gical behaviour identical to the untreated TMV, while Price (1954) 
found that the diiodo-tyrosine derivative of TMV had undergone a 
significant change in serological specificity. In view of the 
finding that none of the tyrosine or lysine residues of the intact 
virus could be substi·tuted by dinitrophenyl groups (Anderer and 
Handschuh, 1963), it was suggested (von Sengbusch, 1965; van Regen-
mortel, 1966) that tyr9sine residues near the surface of the subunit 
in the viral helix could be avai I able to the smal I iodine molecule, 
but not to the larger dinitrophenyl group or the azo-arsani I ic group. 
A more simple explanation would be that the modification reaction at 
56°C to produce the di iodo-tyrosine derivative (Price, 1954) caused 
a certain amount of denaturation and conformational change which made 
normally hidden residues avai I able and caused the change in serologi-
cal specificity. The modification reaction of Malkiel (1952) may 
not have affected sufficient tyrosine residues per virus particle to 
change serological behaviour. 
Simi larly,Staab and Anderer (1976) found that when dimethyl sulphate 
was used to methylate the residues: cysteine 27; tyrosine 2,70 (?), 
72, 139; lysine 68; and the surface carboxyl groups of TMV, it sti 11 
showed a strong cross-reaction with untreated TMV so long as the 
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degree of methylation did not affect the conformation of the protein 
subunits. It is not clear whether this modification was inadequate 
to affect the immunochemical role played by any of the above mention-
ed residues, or whether an insufficient number of residues of the 
intact virus were modified before conformational change caused the 
disintegration of the virus particles. 
There are fewer variables to consider in the serological studies 
with point mutants of TMV. Each mutant has a I imited number of 
characterized amino acid exchanges and each exchange is expressed 
in every subunit of the virus. Nevertheless, the possibi I ity of 
localized conformational modulations due to the presence of the new 
amino acids can not be ruled out (von Sengbusch, 1965). 
Von Sengbusch ( 1965) compared the serological reactivity of twenty-
four mutants of TMV with known amino acid exchanges (Wittmann, 1962 
and 1964; von Sengbusch, 1965) with that of TMV. He used the 
technique of cross-absorption of anti-mutant and anti-TMV sera in 
conjugation with quantitative precipitin assays. This work was ex-
tended by van Regenmortel (1967), who used the intragel cross-absorp-
tion technique to compare a further sixteen chemically induced mu-
tants (Funatsu and Fraenkel-Conrat, 1964) with TMV vulgare. Some 
of these mutants had the same amino acid exchanges as those used by 
von Sengbusch (1965) while others had different amino acid exchanges 
in the same position or amino acid exchanges in different positions 
on the polypeptide chain. With the exception of the mutant 171 
(praline in position 156 replaced by leucine), van Regenmortel (1967) 
found that, while a serum against the U2 strain was able to differ-
entiate between some of the mutants and TMV, a TMV antiserum and a 
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ti g. I . 7 The polypeptide chain of TMV protein. Amino acid 
exchanges studied by von Sengbusch (1965) and van 
Regenmortel (1967) are indicated by circles and 
squares respectively. Chemically altered residues 
in derivatives studied by Price (1954), Harris and 
Knight (1955) and Anderer and Handschuh (1963) are 
indicated by triangles. Serologically distinguish-
able derivatives are indicated by solid line symbols, 
while those derivatives that are serologically 
indistinguishable are indicated by dashed symbols. 
(Adapted from van Regenmortel, 1967.) 
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number of anti-mutant sera could not. Mutants that could not be 
differentiated from TMV by the U2 antiserum were regarded as being 
serologically identical to TMV vulgare. 
The significant results and conclusions from the serological compar-
ison of both chemical derivatives and point mutants with TMV vulgare 
are summarized in fig. 1.7 and table I.I. Serologically indistin-
guishable modifications or amino acid exchanges are associated with 
those residues which are unlikely to be involved in antigenic deter-
minants. Modifications or amino acid exchanges that are serologi-
cally distinguishable indicate residues that are, either directly 
involved in, or, have a conformational modulating affect on an anti-
genic determinant. 
The antigenic role of the N-terminal amino acids, which are on the 
surface of the TMV protein subunit in the viral helix, cannot be 
assessed in this approach due to the lack of chemical derivatives 
and amino acid exchanges in mutants in this region. However, nei-
ther the replacement of praline in position 20 by leucine (von-Seng-
busch, 1965; van Regenmortel, 1967) or threonine (van Regenmortel, · 
1967),nor the replacement of isoleucine in position 21 by threonine 
or valine (van Regenmortel, 1967), is serologically distinguishable 
as would be expected from the location of these amino acids at the 
beginning of the LS a-helix which I ies approximately radially to the 
axis of the viral rod and is thus hidden between adjacent protein 
subunits (Champness et~., 1976; Stubbs et .9_]_., 1977; Bloomer et 
.9_]_., 1978). The replacement of asparagine in position 25 by serine 
(van Regenmortel, 1967) and the chemical modification of cysteine in 





Surface of the viral capsid 
A diagramatic representation of three protein subunits 
in the TMV helix viewed in plan. The five a-helices 
are represented as cylinders and the N- and C-terminal 
residues are located at the surface of the subunits 
(Stubbs et al., 1977; Argos et al., 1977; and Bloomer 
et~·, T978T. The nomenclatureof the helices (right 
hand side) is that of Champness et al. (1976) and 
Stubbs et al. ( 1977). - --
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iodine in potassium iodide at pH 7,0 (Price, 1954), or carbamido-
methylation (Anderer and Handschuh, 1963), or reaction with mercuri-
benzoate (Anderer and Handschuh, 1963), are also serologically 
indistinguishable due to their location in the LS a-helix (Champness 
et .9.!_., 1976; Bloomer et .9.!_., 1978). 
Mutants with the amino acid exchanges, serine in place of asparagine 
in position 33, and lysine or glycine in place of arginine in position 
46,were also found to be serologically indistinguishable from TMV 
vulgare (van Regenmortel, 1967). These residues are located near 
0 
the 50 A radius in the protein subunit (Bloomer et .9.!_., 1978) and 
would be hidden in the viral helix. 
The amino acids between residues 59 and 66 form part of an extended 
chain across the surface of the protein subunit in the viral helix 
CBloomer et~., 1978; Stubbs et~., 1977) and so are available to 
antibodies. Of these amino acids, the replacements of threonine in 
position 59 by isoleucine, and pro I ine in position 63 by serine, are 
not serologically distinguishable (von Sengbusch, 1965), while the 
replacements of both serine in position 65 (van Sengbusch, 1965; van 
Regenmortel, 1967) and aspartic acid in position 66 (von Sengbusch, 
1965) by glycine, are serologically distinguishable. In view of 
their surface locations, these latter two residues are I ikely ~o be 
part of an antigenic determinant. 
After residue 66 the polypeptide chain continues to turn away from the 
viral surface, inwards towards the centre of the viral helix and deve-
lops into the RR a-helix (Stubbs et .9.!_., 1977; Bloomer et .9.!_., 1978). 
The replacement of a residue in this a-helix, threonine in position 81; 
by alanine, is not serologically distinguishable (van Regenmortel, 
1967). 
The next two amino acid replacements, glycine for glutamic acid in 
position 97 (von Sengbusch, 1965; van Regenmortel, 1967) and argi-
nine for glutamine in position 99 (van Regenmortel, 1967), are found 
0 
near the central hole in the virus rod at approximately 25 A radius 
(Stubbs et.~,L.,, 1977), and they too are serologically indistinguish-
abie. 
A short length of a-helix, from approximately residue 103-112, Is 
found parallel to the viral axis and lining the central hole of the 
virus rod (Stubbs et~·, 1977). Surprisingly, an amino acid ex-
change in this Va-helix, that of methionine for threonine in posi-
ti on 107, is serologically distinguishable (von Sengbusch, 1965). 
As this residue is too deeply hidden to be part of any viral antige-
nic determinant, the amino acid exchange at position 107 must be 
assumed to cause a conformational change in the protein subunit that 
affects those residues on the surface of the viral rod. 
Subsequent to the Va-helix, as the polypeptide chain changes direct-
ion back to the viral surface (Stubbs et~·· 1977), two amino acid 
replacements, serine for asparagine in position 126 (van Regenmortei, 
1967) and valine for isoleucine in position 129 Cvon Sengbusch, 1965; 
van Regenmortel, 1967), were found to be serologically indistinguish-
able. 
The polypeptide chain continues along the LR a-helix, which extends 
from residues 114-134, and emerges on the viral surface (Stubbs et~., 
29 
1977; Bloomer et~., 1978). Three amino acid replacements in this 
region have been found to be serologically distinguishable. They 
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are the replacement of threonine by isoleucine in position 136 Cvon 
Sengbusch, 1965), the replacement of serine by phenylalanine in posi-
tion 138 (von Sengbusch, 1965; van Regenmortel, 1967) and the replace-
ment of asparagine by lysine in position 140 Cvon Sengbusch, 1965). 
In view of their closeness to the viral surface, these residues are 
likely to be part of an antigenic determinant in this region. How-
ever, the alternate possibility, that they exert their influence by 
modulating the conformation of the projecting C-terminus, cannot be 
excluded. 
The same arguments can be used in the case of the serologically dis-
tinguishable amino acid exchange at position 148, where serine is re-
placed by threonine (van Regenmortel, 1967). This residue is on the 
viral surface, but may exert its influence by altering the conforma-
tion of the C-terminal amino acids. 
Von Sengbusch (1965) found that two mutants, Ni 1927 and Ni 1688, 
which share a common amino acid exchange in position 156, where a pro-
1 ine residue is replaced by leucine, sti I I reacted with absorbed TMV 
antisera after al I the TMV specific antibodies had been removed. The 
mutant Ni 1927 also formed more precipitate with TMV antisera in quan-
titative precipitin tests than TMV vulgare itself did. Similar phe-
nomena were noted by van Regenmortel (1967) with the mutant 171 which 
also has the prol ine residue in position 156 replaced by ·leucine. 
The C-terminal threonine of the TMV protein is readily released, even 
from the intact virus, by the action of carboxypeptidase A (Harris and 
Knight, 1952), but no further amino acids are liberated by the enzyme 
due to the location of a proline residue in position 156. The symp-
toms and infectivity of the carboxypeptidase treated virus CC T virus) 
in Turkish tobacco are unaltered (Harris and Knight, 1955). Antisera 
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raised in rabbits to CT virus and to untreated TMV showed strong mu-
tual cross-reactions in precipitin tests, but if the anti-TMV sera 
were absorbed with Cr virus, they were sti I I able to precipitate TMV 
although the heterologous reaction was prevented. Similarly CT virus 
antisera absorbed with TMV were able to precipitate CT virus, but not 
TMV. (Harris and Knight, 1955.) This change in specificity, that 
occured when the threonine was removed, implicated the C-terminal resi-
due .of the subunit in the virus as part of an antigenic determinant. 
When this residue was removed, antibodies specific for this determi-
nant could no longer recognise it. 
The treatment of intact virus of the TMV mutant Ni 1927, which has pra-
line in position 156 replaced by leucine, with carboxypeptidase A re-
sults in the release of al I three C-terminal amino acid residues (Leu-
Ala-Thr) from each subunit of the virus (von Sengbusch and Wittmann, 
1965). Similar to the change in specificity between CT virus and 
TMV, Ni 1927 antiserum absorbed with Ni 1927 virus sti I I reacted with 
the carboxypeptidase treated Ni 1927 virus derivative (von Sengbusch 
and Wittmann, 1965). More suprisingly, this derivative reacted more 
strongly with TMV antiserum than either Ni 1927 virus, TMV or CT virus 
did (von Sengbusch, 1965). Also, a TMV antiserum absorbed with Ni 
1927 virus sti I I reacted with the carboxypeptldase treated NI 1927 
virus derivative (von Sengbusch and Wittmann, 1965). 
It is arguable whether the removal of a single amino acid residue from 
the C-terminus of the TMV protein would cause a drastic conformation-
al change in the whole subunit as the biological properties of the 
CT virus are the same as those of TMV (Harris and Knight, 1955), but 
a localized conformational change affecting only the viral subunit 
surface cannot be excluded. However, when the observation that un-
treated Ni 1927 virus could sti 11 react with TMV antiserum after 
absorption with.TMV (von Sengbusch and Wittmann, 1965) is taken into 
account, these results point to the existence of heterospecific anti-
. bodies in TMV antisera <van Regenmortel, 1978). 
Van Regenmortel (1966, 1967) has proposed that in addition to the 
antigenic detenninant at the C-terminus, there exists an immunogenic 
determinant that cannot react with its specific antibody because of 
steric hindrance by the proline residue in position 156. If this 
proline were replaced by the less rigid leucine, or if al I three of 
the C-tenninal amino acids were removed, the "non-reactive" antigenic 
determinant would become exposed and so be able to react with its 
antibody (von Sengbusch and Wittmann, 1965). 
Loor (1971 ), however, suggested that the heterospecific antibodies 
in TMV antisera have affinities for the immunogen that are too low 
to measure, but, by chance, have higher affinities for cross-reacting 
anti gens.· 
A third explanation can be fonnulated in terms of the antibody compo-
sition of the antisera as wel I as the structure of the viral subunit. 
It is wel I known that antisera obtained after intramuscular injection 
of TMV (or other relatively unstable viruses) contain both antibodies 
specific for cryptotopes of free protein subunit~ which have arisen . 
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by breakdown of the virus, as well as antibodies specific for viral anti-
genic determinants (van Regenmortel, 1966; van Regenmortel and Lelarge, 
1973; von Wechmar and van Regenmortel, 1968). It is also known that free 
TMV protein can exist in two conformational forms with different C-ter-
minal configurations Nogel, 1973; Vogel and Jaenicke, 1974) and that one 
of these configurations is very similar to the C-terminal configuration 
of the 20S disk (Vogel, 1973), and hence the protein subunit in the virus 
(Graham and Butler, 1978). The virus-like C-terminal configuration ot the 
free protein is likely to have the same antigenic dEitermina_nt as the C-ter-
minal region of the polypeptide chain in the intact virus and it is prob-
ably located at the C-terminus of each viral subunit (Harris and Knight, 
1955; van Regenmortel, 1966). If the other C-terminal configurational 
form of the free protein had a cryptotope further from the C-terminus, 
say in the region of residues 150-155 or even overlapping the viral deter-
minant at position 156, TMV protein antibodies (in TMV antisera) specific 
for this cryptotope would not be able to react properly with it on the 
intact virus, because of the steric hindrance of the C-terminal amino 
acids and especially the proline in position 156. These antibodies could, 
therefore, not be removed from the antiserum by absorption with intact 
TMV. Although low affinity antibodies specific for such a cryptotope 
could react with mutant viruses which have the proline in position 156 
replaced by a more flexible amino acid, absorption with these mutants may 
sti I I not accomplish the complete removal of the high affinity antibodies. 
Only derivatives lacking the C-terminal amino acids (such as carboxypep-
tidase A treated Ni 1927 virus) could react fully Cvon Sengbusch and Witt-
mann, 1965) with all the antibodies specific for such a cryptotope. This 
argument, based on the existence of two conformational forms of the sub-
unit, wi II be further developed in the Discussion (3.2). 
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Table 1.11 DERIVATIVES OF TMV : RESULTS AND CONCLUSIONS 
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1.3.3 A SEROLOGICAL STUDY WITH THE PROTEINS OF TMV MUTANTS AND 
ANTISERA AGAINST TMV PROTEIN 
Use of the sensitive modified phage technique developed by Haimovich , 
et~· (1970), was made by Du Plessis and van Regenmortel (1977),who 
attempted to inhibit the •inactivation of TMV protein - T4 phage con-
jugates by TMV protein antiserum with protein derived from the muta-
nts 371 (serine in positions 138 and 148 replaced by phenylalanine) 
and CP 415 (asparagine in position 140 replaced by lysine). They 
found no significant differences in the degree of inhibition caused 
by the mutants and TMV vulgare protein. 
If the discriminating powers of the modified phage assay are compar-
able to those of precipitin tests, residues 138, 140, and 148 are 
unlikely to form part of any antigenic determinant of the free pro-
tein,as the same residues were shown to be serologically distinguish-
able in the intact virus (von Sengbusch, 1965; van Regenmortel, 1967). 
It must be borne in mind, however, that each virion consists of 2130 
p~tein subunits, and this may cause an amp I ificatio~ of any change in 
serological specificity in the intact virus that may go undetected in 
the free protein. 
I .3.4 VALIDITY OF THE RESULTS OF THIS APPROACH 
Just as the absence of a change in the immunochemical behaviour of a 
derivative is not conclusive of the non-participation of the modified 
residue in an antigenic determinant, neither is a change in immuno-
chemical reactivity proof positive of the involvement of that residue 
unless it is possible to completely exclude the change of a minor con-
formational change due to the modification (Atassi, 1977 b). Not al I 
of the amino acid residues imp I icated to be in antigenic determina.nts 
of the virus by this approach are likely to lie directly on the 
02 
approximately 700 A surface of the subunit in the viral helix Cvon 
0 
Sengbusch, 1965). Indeed, in the 4,0 A model (Stubbs et 2.l_., 1977), 
shown in figure I .5, residue 107, which is serologically distinguish-
able when threonine is replaced by methionine Cvon Sengbusch, 1965), 
I ies buried near the core of the viral rod. It is possible that 
some of the modifications or exchanges of particular residues affect 
the immunochemical behaviour of the derivative indirectly by a subtle 
modulation of the conformation of the whole molecule 01- its surface 
region (von Sengbusch, 1965). It is necessary to confirm or correct 
the findings of this approach with the results from the other approach-
es. 
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In any event, it is not possible to derive the complete antigenic struc-
ture of a protein from this approach alone, as not al I the amino acids 
can be suitably modified. Al I that can be achieved is a broad type of 
delineation deduced from the involvement or otherwise of certain resi-
dues in antigenic determinants. (Atassi, 1977b.) 
I .4 IMMUNOCHEMISTRY OF PEPTIDES 
1.4. I THE VALUE OF THE APPROACH 
This approach is based on the likely ability of an antigenic region to 
react ~Ith the antibody specific for it when it is isolated free from 
the intact antigen (Atassi, 1977 b). Atassi and Sap I in (1968) have 
suggested that a peptide in solution wi I I exist in a number of unfold-
ed conformational states and that very few of these conformational 
states wi I I approach the mode of folding of that region in the native 
protein. Thus the need for the large molar exesses of peptide in 
immunochemical reactions was explained. 
Circular dichroism (C D) and optical rotatory dispersion (ORD) 
studies on the conformation of peptides derived from Sperm Whale 
myoglobin by cleavage at the praline (Singhal and Atassi, 1970) 
and arginine residues (Atassi and Singhal, 1970) showed that, al-
though these peptides contain a considerable helical content, it 
is much less than is expected for that region in the native pro-
tein. The addition of methanol to the solutions increased the 
helical content of the peptides, but it stil.1 remained only a fra-
ction of the he(ical content of the equivalent region of the native 
protein. Peptides that were I arge enough to make I ong range inter-
actions. feasible were found to have the most stabi I ized helical str-
ucture. They also found that an increase of folded structure was 
accompanied by a decrease in the molar excess of peptide required 
for maximum immunochemical reactivity. Thus the greatest limita-
tion of this approach I ies in the unrelatedness of peptide struc-
ture to the structure of the same region in the native protein 
(Atassi ,1977 b)and in the necessity for the native mode of folding 
for the proper reaction of an antigenic determinant with antibody 
raised to that determinant in the intact protein antigen (Atassi, 
1967; Atassi and Sap I in, 1968; Habeeb and Atassi, 1971 ). On the 
other hand, the antibody may be able to induce a peptide,which con-
tains an antigenic determinant,to assume the correct mode of folding 
necessary to fit the antibody combining site (Atassi, 1975). 
The other I imitations of this approach may be minimized with suitable 
precautions. 
The use of a variety of c I eavage procedures, which w i I I produce a range 
of overlapping peptides, and reference to the results of the preceding 
37 
38 
approach which uti I ized derivatives of the whole antigen, can reduce 
the possibi I ity of scission of an antigenic determinant during the 
fragmentation of the protein CAtassi,1975,1977 a, 1977 b. Informa-
tion gained by indiscriminate cleavage at multiple locations wi I I be 
limited, confusing, and possibly erroneous (Atassi, 1977b). Unfortu-
nately, In the case of TMV and its protein subunit, peptide studies 
(Anderer, 1963 b; Benjamini et 2J..., 1964) preceded the serological 
studies with the mutants Cvon Sengbusch, 1965; van Regenmortel, 1967). 
A variety of overlapping peptides wi I I also minimise the chance of 
bulky amino acid side chains on residues adjacent to an antigenic 
determinant sterical ly obstructing antibody binding (Atassi, 1977 b). 
This phenomenon has only been observed with synthetic peptides CKok-
etsu and Atassi 1 1974 a, b; Atassi and Pai, 1975), but the princi-
ple applies to any cleavage site. 
Care must be exercised in chemical cleavage operations that may be 
accompanied by other modifications, or cleavage side reactions, so 
that the resulting peptides are not internally modified (Atassi, 
1977 b). Also, al I peptides uti Ii zed in immunochemical work must be 
rigourously purified, as trace impurities that are immunological IY 
active, wi I I become significant in the large molar excesses of pep-
tides used (Atassi, 1977 a, 1977 b). 
From the foregoing, it can be appreciated that, although this app-
roach can yield valuable information about the locations of anti-
genic determinants, the results with unreactive peptides must be con-
firmed by the other approaches before it can be certain that they do 
not contain antigenic regions (Atassi, 1977 b). 
Unless the limitations of this approach are taken into account in 
both the design and analysis of experiments, and unless the results 
obtained are substantiated by other independant approaches, the 
conclusions that can be reached wl I I be incomplete and less valua-
ble to the understanding of the immunochemistry of the antigen as 
a whole. (Atassi, 1977 b.) 
1.4.2 THE IMMUNOCHEMICAL RELATIONSHIP OF PEPTIDES OF TMV PROTEIN 
TO THE INTACT VIRUS 
Anderer (1963 b) prepared twenty peptides of tryptic, chymotryptlc 
and peptic origin (fig. I .9) which accounted for the whole sequence 
of protein of TMV vulgare. The regions corresponding to the seque-
nces 1-46, I 13-122, 123-134 ahd 142-158 were covered by overlapping 
peptides. Al I the peptides were tested for their ab! I ity to inhibit 
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the precipltln reaction between TMV and its antiserum in the equiv-
alence zone close to the zone of antigen excess. He found that the 
inhibition of precipitation caused by a particular peptide was depen-
dent on the concentration of the peptide and that a considerable molar J 
excess of the peptide was required to achieve a significant inhibition 
effect. 
Of the twenty peptides, nine failed to cause any inhibition and four 
peptides, residues 47-61, 69-71, 91-92 and I 14-122 caused a slight 
inhibition effect (maximum 5-10%> which approximated the standard de-
viation of the experiment and was thought to result from temporary, 
non-specific reaction with the antibody CAnderer, 1963 b). Seven 
peptides, representing 15-25 % of the sequence of the TMV protein, 
caused a significant degree of inhibition of the TMV-anti-TMV reaction. 
These peptides corresponded to the fol lowing regions of the primary · 
Residues: I - 10 C,P. 93 - 112 TB. 
- 41 TI. 113 - 122 T9. 
17 - 23 P. 114 - 122 T. 
18 - 23 c. 123 - 134 TIO. 
42 - 46 T2. 123 - 128 P. 
47 - 61 T3. 129 - 131 P. 
62 - 68 T4. 135 - 141 Tll. 
69 - 71 T5. 142 - 158 Tl2. 
72 - 90 T6. 151 - 158 C,P. 
91 - 92 T7. 153 - 158 c. 
Fig. I .9: The twenty peptides used by Anderer (1963 b) in precipita-
tion inhibition tests. Each peptide is identified by the 
corresponding sequence in TMV protein. The origin of the 
peptides is indicated as fol lows: P - obtained by hydro-
lysis with pepsin, C - obtained by hydrolysis with chymo-
trypsin and T - obtained by hydrolysis with trypsin. The 
tryptic peptides are numbered according to their position 
from the N-terminus of the protein. 
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sequence of TMV protein: residues 18-23, 62-68, 123-134, 129-131 , 
142-158, 151-158 and 153-158 (Anderer, 1963 b). Al I the possible 
two- and three-component mixtures of the reactive peptides were also 
tested. None of these mixtures caused inhibition equal to the sum 
of the inhibitions caused by the individual peptide components <And-
erer, 1963 b). A selection of these results are presented in fig. 
1.10. It was also found that some of the peptides formed aggregates 
as their concentration increased and this was suggested as the reason 
for the tai loff in inhibition caused by certain peptides (residues 
142-158, 151-158 and 153-158) above an optimal concentration <Anderer, 
1963 b). 
The greatest inhibition of the reaction between TMV and its antiserum 
was caused by the peptide corresponding to the sequence 18-23 (just 
over I I µmoles of the peptide caused approximately 40% inhibition),but 
two other peptides (residues 1-41 and 17-23) which overlap this region 
were found to be inactive (Anderer, 1963 b). Anderer (1963 b) sugges-
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ted that aggregation of these latter peptides prevented their detection. 
On the basis of Braunitzer's findings that hot trichloroacetic acid and 
hydroxyl amine preferentially split the aspartic acid-prol ine peptide 
bond between residues 19 and 20 (Schramm and Braunitzer, 1953; Braun-
itzer, 1955; Braunitzer, 1956; Ramachandran and Narita, 1958), 
Anderer (1963 b) argued that the region comprising residues 18-23 was 
on the surface of the viral subunit and thus avai I able for reaction 
0 
with antivirus antibodies. In actuality this region Is almost 20 A 
from the projecting C-terminus and forms the bend at the beginning of 
the LS ~-helix <Bloomer et EJ..., 1978). 
The mutants Ni I 18 (Wittmann, 1962) and 218 and 430 (funatsu and Fraen-







fig. I. 10 
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PEPTIDE CONCENTRATION (,(I-mole hapten/ml} 
Hapten inhibition of the precipitin reaction of TMV and 
iTs antiserum by peptides derived from the TMV protein. 
0,1 ml of a 1/64 dilution of TMV antiserum was added to 
I ml of peptide solution and incubated at 37°c for 2 hours 
before 0,1 ml of a TMV solution (I ,5 mg/ml) was added. 
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This was incubated at 37°c for an hour and then for 4 days 
at 4°C with intermittent shaking. After low speed centri-
fugation the precipitates were washed and quantitated by 
the Fol in reaction. The amount of precipitate formed in 
the absence of inhibitor was compared to the amount of pre-
cipitate formed with increasing concentrations of each pep-
tide. Peptides corresponding to the fol lowing regions in 
the protein were found to be immunologically active: 
residues 18-23(e); 62-68(0); 123-134(.); 129-131 (A.); 
and 142-158(0). Mixtures of the active peptides did not 
cause inhibition equal to the sum of the individual peptides: 
residues 18-23 + 142-.158(.6.). (Anderer, 1963 b.) 
by leucine or threonine and the mutant 415 (Funatsu and Fraenkel-
Conrat, 1964) which has the isoleucine residue in position 21 re-
placed by valine, were not serologically distinguishable from TMV 
vulgare either <von Sengbusch, 1965; van Regenmortel, 1967). 
These considerations diminish the I ikel ihood of this region con-
taining part of, or a whole antigenic determinant of the intact 
virus. 
The Inhibition of the TMV-anti-TMV reaction caused by the peptides 
corresponding to the sequences 123-134 and 129-131 (Anderer, 1963 b) 
is also in doubt as these residues make up part of the LR a-helix, 
which is not exposed on the surface of the viral subunit (Bloomer et 
~·, 1978). Neither were the mutants 378 <Funatsu and Fraenkel-
Conrat, 1964), which has the asparagine residue in position 126 re-
placed by serine, and Ni 458, Ni 470, Ni 1045, Ni 1196, Ni 1234 
(Wittmann, 1962), A 14 (Melchers unpublished data - von Sengbusch, 
1965) and 369 (Funatsu and Fraenkel-Conrat, 1964), which have the 
isoleucine residue in position 129 replaced by threonine or valine, 
serologically distinguishable from TMV vulgare (von Sengbusch, 1965; 
van Regenmortel, 1967). The discrepancies between the results of 
the derivative approach and the peptide approach concerning the imm-
unological activity of the regions containing the residues 18-23 and 
123-134 have led van Regenmortel (1967) to suggest that some of And-
erer's effects (1963 b) were not specific. 
The findings, that the mutants FU 243 (Wittmann, 1964) and 414 (Fun-
atsu and Fraenkel-Conrat, 1964), which have the serine residue in 
position 65 replaced by glycine, and Ni 102 and Ni 116 (Wittmann, 
1962), which have the aspartic acid residue in position 66 replaced 
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by glycine, are serologically distinguishable from TMV vulgare (von 
Sengbusch, 1965; van Regenmortel, 1967), confirmed that the inhibition 
of the TMV-anti-TMV reactionp that Anderer (1963 b) found with the 
peptide corresponding to the sequence 62-68, was I ikely to be specific. 
This region of the TMV protein sequence is also exposed on the surface 
0 
of the viral subunit in the 2,8 A model of Bloomer et 2l_. (1978). In 
view of von Sengbusch's (1965) demonstration of the inabi I ity of the 
replacement of the praline residue .in position 63 by serine, to affect 
the serological behaviour of the mutants Ni 1045, Ni 1196 and Ni 1234 
(Wittmann, 1962) compared to TMV vulgare, it is likely that the residues 
comprising part of, or a whole antigenic determinant are accommodated In 
the latter half of the peptide. 
The practically identical inhibition curves caused by the three peptides 
corresponding to the sequences 142-158, 151-158 and 153-158 (Anderer, 
1963 b) encourage the conclusion that the entire immunological activity 
of these peptides in the TMV-anti-TMV system is expressed in the region 
containing the residues 153-158. This is supported by the change in 
serological behaviour resulting from the removal of the C-terminal re-
sidues as demonstrated by Harris and Knight (1955) and von Sengbusch 
and Wittmann (1965), and the replacement of the prol ine residue in pos-
ition 156 by leucine in the mutants Ni 1688, Ni 1927 (Wittmann, 1964) 
and 171 (funatsu and Fraenke I -Con rat, 1964) as shown by von Sengbusch 
(1965) and van Regenmortel (1967). 
The antigenic determinant in the region 153-158 was investigated further 
by the immunization of rabbits with the N-(p-aminobenzoyl) derivatives 
0f various ~-t8rminal peptides of TMV protein coupled to cross-linked 
bovine serum albumin <BSA) by diazotization (Anderer, 1963 a; Andere·r 
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and Schlumberger, 1965). Antibodies specific for the C-terminal hexa-, 
penta-, tetra- and tripeptides were able to precipitate and neutralize 
the infectivity of both TMV vulgare and dahlemense, which differs from 
vulgare in the C-terminal hexapeptide in that the glycine residue in 
position 155 is replaced by serine (Anderer and Schlumberger, 1965). 
Antisera prepared to threonine and serine (the C-terminal residues of 
TMV vulgare and dahlemense respectively) were only able to precipitate 
the virus with the homologous C-terminal amino acid in large amounts, 
but either antiserum readily and specifically neutral I zed the infecti-
vity of both strains (Anderer and Schlumberger, 1966 a, b). 
The C-terminal residues of the TMV protein project from the surf.ace of 
the viral subunit (Bloomer et~., 1978) and, judging by its serologi-
cal reactivity, the C-terminal threonine is exposed and probably kept 
in a favourable orientation by the praline residue at position 156 
(van Regenmortel, 1978). 
Although antibodies specific for the C-terminal hexapeptide of the TMV 
protein cross-react strongly with the intact virus (Anderer and Schlum-
berger, 1965), so few antibodies specific for the sequence of the six 
C-terminal residues exist in TMV antisera,that they cannot be detected 
by precipitin tests CAnderer, 1963 a; Anderer and Schlumberger, 1965; 
Anderer et~., 1971 ), but only by the more sensitive indirect haema-
gglutination test CAnderer and StrBbel, 1972). The projecting C-term-
inal residues are much more immunogenic in the surface conformation of 
the viral subunit than they are when coupled to a carrier protein 
CAnderer and StrBbel, 1972). 
These findings; that the antigenic determinant at the C-terminus of the 
polypeptide chain in the virus is dependant on the configuration of 
the terminal residues and hence is by definition a neotope (van Regen-
mortel, 1966) as the configuration of these residues differs in the 
free protein at pH 8,0 (Vogel, 1973; Vogel and Jaenicke, 1974), can 
be used to argue in support of the hypothesis (section I .3.2 ) that 
the C-terminal region contains two antigenic determinants, one for 
the virus and the other for the protein. The antibodies that sti I I 
react with the mutants, which have the praline in position 156 repla-
ced by leucine, after absorption of the serum with TMV, were detected 
by precipitation (von Sengbusch and Wittmann, 1965; von Sengbusch, 
1965; and van Regenmortel, 1967) and are uni ikely to be specific for 
the sequence of the C-:-termi nus as Anderer and co-workers (Anderer, 
1963 a; Anderer and Schlumberger, 1965; and Anderer et~., 1971) 
found that sequence specific antibodies to this region were too scarce 
to be detected by precipitation tests. It is more likely that these 
non-absorbable antibodies recognize another part of the C-terminal re-
gion such as a cryptotope which is hidden by the surface conformation 
of the TMV subunit and exposed in the mutants. 
I .4.3 THE IMMUNOCHEMICAL RELATIONSHIP OF THE TRYPTIC PEPTIDES OF TMV 
PROTEIN TO THE PROTEIN SUBUNIT 
A tryptic digest of TMV protein, from which the I-peptide (residues 
1-41) had been removed, was chromatographed on Sephadex G50 and the 
fractions containing material with a molecular weight of less than 
10000 daltons (G50 s2) were pooled and dialysed against cold disti I led 
water. Some of the material, thought to be partially digested frag-
ments of TMV protein and those peptides that aggregate on standing, 
precipitated and was lyophi I ized as fraction o1. The dialysable pep-
tides were lyophi lized as fraction 02. These two fractions and whole 
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TMV protein, dissolved in phosphate buffered saline (PBS) containing 
Evans blue, were used to cha I lenge guinea pigs which had been intra-
dermal ly injected with TMV protein antiserum three hours previously. 
TMV protein and fraction o1 caused cutaneous anaphylaxis, but frac-
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tion D2 did not. Furthermore, when fraction o2 was mixed with TMV pro-
tein antiserum prior to the initial injection, it completely inhibited 
the cutaneous ahaphylaxis reaction resulting from the cha I lenge with 
an excess of TMV protein. Fraction o1 was able to significantly re-
duce the cutaneous anaphylaxis reaction when it was prnmixed with the 
TMV protein antiserum. (Young et~., 1963.) 
The G50 s2 fraction, which was incapable of fixing complement on its 
own, was able to specifically and completely inhibit the fixation of 
complement by TMV protein and different TMV protein antisera raised 
in three rabbits. The I-peptide (residues 1-41) was also tested for 
its abi I ity to either fix complement with TMV protein antisera, or to 
inhibit complement fixation by TMV protein-anti TMV protein complexes. 
It was found to be immunologically inactive by these criteria. <Ben-
jami ni et El_., 1964.) 
In an effort to locate the haptenic activity in the G50 s2 fraction, it 
was subjected to ion exchange chromatography with Dowex l-X2 resin and 
the isolated peptide fractions were tested for their abi I ity to inhibit 
complement fixation by TMV protein and anti-TMV protein antibodies. 
Only the fraction containing tryptic peptides 4 (residues 62-68) and 8 
(residues 93-112) and the fraction eluting immediately prior to it, were 
inhibitory, although the latter fraction was much less active than the 
former. When peptides 4 and 8 were separated by the isoelectric preci-
pitation of peptide 8 at pH 3,8, and individually tested, only peptide 
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8 had activity. The less active fraction eluting prior to peptides 
4 and 8 was found to contain trace amounts of peptide 8 which accounted 
for its activity. Results with two other antisera confirmed the immu-
nological activity of peptide 8. (Benjamini et~., 1964.) 
As peptide 8 was found to inhibit the complement fixation by TMV pro-
tein and indivi°dual antisera completely, and as this inhibition was 
specific for anti-TMV protein antibodies, it was concluded that this 
peptide was I ikely to contain the major part of, or a whole antigenic 
determinant of the protein <Benjamini et~., 1964)'. The possibility 
of other antigenic determinants on the protein was not excluded, but 
the total number of determinants was expected to be low (Benjamin!, 
1977). 
1.5 THE NARROWING DOWN OF THE POSSIBLE LOCATIONS OF ANTIGENIC 
DETERMINANTS ON PEPTIDES 
1.5. I EVALUATION OF THE APPROACHES 
The results obtained with immunochemical ly reactive overlapping peptides 
can be useful in deducing the locations of antigenic determinants on 
these peptides as long as the conclusions reached are not in conflict 
with the findings of any of the foregoing approaches (Atassi, 1975, 
1977 b). An example of this process is the location of the antigenic 
determinant of the intact virus in the region 142-158 of the TMV protein. 
The similar reactivities of the peptides corresponding to the residues 
142-158, 151-158 and 153-158 of the protein point to the C-terminal re-
sidues of these peptides being the immunochemical ly reactive region 
(Anderer, 1963 b). The results obtained with derivatives of the virus 
(Harris and Knight, 1955) and mutants with amino acid exchanges in this 
region (von Sengbusch and Wittmann, 1965; von Sengbusch, 1965; and-
van Regenmortel, 1967) support this conclusion. 
However, in some cases immunochemical ly reactive peptides which do 
not have overlaps, or where the degree of overlap is too great to be 
useful, wi 11 occur. In order to accurately locate the antigenic 
determinant in such peptides, additional approaches are required 
(Atassi, 1977 ·b). 
The immunochemical reactivity of shortened peptides, corresponding 
to the regions of the reactive peptide, can be stu'died, but al I the 
limitations that apply to peptide cleavage (discussed in section 
I .4. I ) are relevant to this approach. The antigenic determinant 
may be disrupted, or the results obtained with the shortened peptides 
may be misleading (Atassi and Sap I in, 1968) as the mode of folding 
required for anti body binding of the peptide may be destroyed by the 
removal of an unrelated.segment of the peptide (Atassi, 1977 b). An-
other limitation is the avai labi I ity of cleavage reactions to give the 
desired shortened peptides (Atassi, 1977 b). 
The approach of choice (Atassi, 1968, 1975 and 1977 b) for the location 
of antigenic determinants in immunochemical ly reactive peptides is 
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the modification of specific amino acid side chains to form derivatives 
of the reactive peptide. This way the antigenic determinant cannot be 
disrupted and the conformation of the peptide derivative is more likely 
to resemble the unaltered peptide than is the case with shortened pep-
tides (Atassi, 1968). The homogeneity and purity of the peptide deri-
vatives wi I I be of tantamount importance to the success of this approach 
(Atassi, 1977 b). 
Once again, the mutants and strains of TMV are of potential use as 
a source of peptides with single amino acid exchanges which would 
serve as peptide derivatives of immunochemical ly active peptides 
in both the anti-virus and anti-TMV protein systems. 
1.5.2 THE ROUGH DELINEATION OF THE ANTIGENIC DETERMINANT IN TRYPTIC 
PEPTIDE 8 (RESIDUES 93-112) OF TMV PROTEIN 
The immunochemical activity of tryptic peptide 8 (residues 93-112) 
of TMV protein was confirmed by the direct binding of a N-< 14cl 
acetyl derivative of the peptide with TMV protein antibodies (Ben-
jamini et~., 1965) in a Farr assay <Farr, 1958). The marked 
difference between the binding of the peptide derivative by acetyl-
cholinesterase antibodies and TMV protein antibodies, as wel I as 
the absence of binding with a TMV protein antiserum absorbed with 
TMV protein, proved the reaction to be specific (Benjamini et~., 
1965). The equivalent inhibition of complement fixation, by TMV 
protein and its antiserum, by the N-( 14clacetyl derivative of peptide 
8 and the native peptide (Young et~., 1966) excluded the I ikel !hood 
of thelsoteucine residue in position 93 participating in an antigenic 
determinant. 
In order to locate the antigenic region in tryptic peptide 8, degra-
dation products of the peptide were prepared by digestion with pepsin, 
subti Ii sin and carboxypeptidases A and·~ as wel I as by the stepwise 
degradation of the peptide from the N-terminal end using the phenyl 
isothiocyanate method (Crestfield et~., 1963), and tested for their 
abi I ity to inhibit the complement fixation of TMV protein and its 
antiserum or the direct binding of N-< 14cl acetyl peptide 8 by TMV 
14 protein antibodies (Young et~., 1966). N-( Clacetyl derivatives 
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of some of the degradation products of peptide 8 were also tested 
for direct binding with TMV protein antibodies (Young et~., 1966). 
Shortened peptides, lacking either the five N-terminal residues or 
the two C-terminal residues, were immunochemical ly active (although 
the direct binding of their N-( 14c>acetyl derivatives was somewhat 
lower than that of N-( 14c>acetyl peptide 8) while the peptic and 
subti lisin digests were inactive. From this, Young and co-workers 
(1966) concluded that the sequence 98-110 was responsible for much 
of the antigenicity of tryptic peptide 8 in the TMV protein-anti 
TMV protein system. 
1.6 THE ACCURATE DEL1NEATION OF ANTIGENIC DETERMINANTS 
1.6. I THE VALUE OF IMMUNOCHEMICAL STUDIES WITH SYNTHETIC PEPTIDES 
Once the foregoing approaches have yielded the locations and rough 
delineations of the antigenic determinants of a protein antigen, a 
point is reached where further definition would require the modifi-
cation of unreactive non-polar or hydrophobic amino acid side chains 
(Atassi, 1977 b), or, In the case of virus antigens, the isolation of 
mutants with amino acid exchanges which would affect their viabi I ity. 
This impasse was broken by the pioneering work of the Berkely group 
who applied the technique of sol id-phase peptide synthesis (Merri-
field and Stewart, 1965) to the manufacture of a peptide correspond-
ing to an antigenic region of the TMV protein (Stewart et~., 1966). 
By careful consideration of the results of the foregoing approaches, 
which narrow down the antigenic regions, it is possible to deduce and 
synthesize a limited number of peptides corresponding to the various 
parts of each antigenic region. lmmunochemical studies with these 
peptides can give the final definition of the antigenic determina·nts 
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and shed light on the roles played by the individual amino acids, 
which comprise each determinant, in antibody binding <Atassi, 1975, 
1977 b; Benjamini et~., 1968 a,b, 1969; Young et .9._!_., 1967, 1968). 
Care must however be exercised with regard to the purity and homoge-
neity of the synthetic peptides, as a drawback of the sol id phase 
technique is product heterogeneity (especially with longer peptide 
sequences) and impure peptides can give misleading and erroneous re-
sults (Atassi, 1977 b). This necessitates the use of purification 
and monitoring procedures of high resolving power. 
A special case is presented by proteins which have the amino acids 
comprising an antigenic determinant grouped in a cluster on the pro-
tein surface rather than sequentially on the polypeptide chain. An 
example of this phenomenon is the protein lysozyme which has each of 
its three antigenic determinants grouped around a disulphide bridge 
(Atassi and Habeeb, 1977). This problem has been solved by the 
development of the concept of the surface-simulation sy~thetic pep-
tide (Atassi et~., 1976; Atassi and Habeeb, 1977; Atassi, 1978), 
which is constructed to duplicate the three dimensional surface stru-
cture of a region of the protein by having the active amino acids 
se:i~arati::d by glycine soacer residues. This requires a detailed know-
ledge of the three dimensional structure of the protein in question. 
1.6.2 THE DEFINITION AND DESCRIPTION OF THE CRYPTOTOPE CORRESPONDING 
TO RESIDUES 108-112 OF THE TMV PROTEIN. 
Having shown that the sequence 98-110 of the TMV protein was import-
ant for the antigenic reactivity of tryptic peptide 8 (residues 93-
112) with antibodies to the whole protein (Young et~., 1966) Stewart 
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and co-workers (1966) tested the immunochemical activity of a syn-
thetic decapeptide corresponding to residues 103-112, which was 
prepared by the method of Merrifield and Stewart (1965). After 
ion exchange chromatography on Dowex l-X2 resin, the purity of the 
decapeptide was evaluated by electrophoresis and amino acid analysis 
14 before it was used to inhibit the direct binding of the N-( C)acetyl 
derivative of peptide 8 by TMV protein antibodies. The decapeptide was 
found to bind approximately 10 times less efficiently to TMV protein 
antibodies than peptide 8 did (Stewart et~., 1966). The binding of 
the N-< 14c>acetyl derivative of the decapeptide to TMV protein anti-
bodies was specific as no binding with comparable amounts of acetyl-
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cholinesterase antibodies could be demonstrated <Stewart et~., 1966). 
As a consequence of these findings, shorter N-c 14c>acetyl peptides 
corresponding to the C-terminal region of peptide 8 were synthesized 
and their direct binding with TMV protein antibodies was determined. 
The shortest peptide able to be bound by TMV protein specific anti-
bodies (but not acetylcholinesterase antibodies) was the pentapeptide 
corresponding to the sequence Leu-Asp-Ala-Thr-Arg (residues 108-112), 
but the results indicated that the quantity of peptide bound by a 
given amount of antibodies increased with peptide length. (Young et 
El·, 1967.) 
The finding, that a N-< 14c>acetyl-(Ala) -pentapeptide conjugate was 
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more efficiently bound by TMV protein antibodies than the pentapep-
tide, indicated that the increase in peptide size contributed in a 
non-specific manner to the binding of the pentapeptide. That this 
non-specific enhancement of binding was hydrophobic in origin, was 
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demonstrated by the specific binding of a N-( C)acetyl-octanoyl-
tetrapeptide (residues 109-112) to TMV protein antibodies with an 
average association constant higher than that of the N-< 14c>acetyl 
pentapeptide, N-c 14c>acetyl-CA1a) 5-pentapeptide conjugate or the 
N-c 14c>acetyl decapeptide. The shortest octanoyl-peptide able to 
be specifically bound by the TMV protein antibodies was the C-termi-
nal tripeptid~, Ala-Thr-Arg (residues 110-112). CBenjamini et 2-!_., 
1968 b.) 
It was also found (Benjamini et 2-!_., 1968 a) that, although al I 
animals (rabbits, guinea pigs, rats and mice), immunized with TMV 
protein, produced antibodies which bound N-c 14c> acetyl peptide 8, 
in only one out of four rabbits could this binding be inhibited by 
the decapeptide corresponding to residues 103-112. However, al I 
the rabbit antisera were able to bind the N-c 14c>acetyl decapeptide 
and the binding of two of these antisera could be inhibited by the 
C-terminal pentapeptide or a (Ala> 5-pentapeptide conjugate. Some 
rabbits produced antibodies which bound the N-C 14c>acetyl pentapep-
tide, but others required the hexa- or heptapeptide for demonstrable 
binding. This suggested that the antibodies produced by different' 
rabbits do not necessarily bind to the same region or regions of try-
ptic peptide 8, but, as al I the rabbits do produce antibodies to pep-
tides containing the C-terminal pentapeptide sequence, it was postula-
ted that this sequence, or part of it, constitutes a portion of, or a 
region which is antigenic to al I the rabbits tested (Benjamini et~., 
1968 a). This was confirmed by the specific binding of octanoyl-
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Ala-Thr-Arg by the antibodies of al I rabbits tested, even though two 
of these rabbits produced antibodies which did not bind the N-< 14c>ace-
tyl pentapeptide significantly (Benjamini et 2-!_., 1969). This binding 
was in excess of that with the N-< 14c>acetyl decapeptide in al I cases. 
These results suggest that the tripeptide Ala-Thr-Arg dictates the 
antigenic specificity of the region, although, by itself, it has no 
capacity to bind with antibodies <Benjamini et~., 1968 a; Benjamini, 
1977). The differences in binding between various antibody popula-
tions from different animals probably I ie in the location of comple-
mentary hydrophobic areas in juxtaposition to the antibody combining 
site for Ala-Thr-Arg (Benjamini et~., 1969; Benjamini, 1977). 
Thus the antibody populations with inadequate or incorrectly located 
hydrophobic regions would not have a sufficiently high affinity to 
bind the pentapeptide irreversibly enough for measurement. 
The roles of the amino acids which comprise the antigenic determinant 
in tryptic peptide 8 were studied by the use of synthetic homologues 
of the C-terminal pentapeptide <Young et~·· 1968). Every one of 
the eleven peptide homologues,which differed from the pentapeptide 
by a single amino acid exchange, bound less strongly to the TMV pro-
tein antibodies than the pentapeptide, and, in general, the homologues 
with amino acid replacements similar to the original residue in the 
pentapeptide retained some immunochemical reactivity. 
the reverse sequence of the pentapeptide was inactive. 
A peptide with 
When the N-terminal leucine of the pentapeptide was replaced by a 
hydrophobic amino acid such as D-leucine, isoleucine or tyrosine, the 
resultant peptide was sti I I bound by TMV protein antibodies to a sig-
nificant extent, but alanine in this position caused the peptide to 
retain only a marginal activity (Young et~., 1968). The substitu-
tion of this leucine residue by octanoic acid resulted in an octanoy-
lated tetrapeptide which was more extensively bound by TMV protein 
antibodies than the pentapeptide <Benjamini et~., 1968 b). The 
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shape of this residue is therefore considered to be less important 
for antibody binding than its hydrophobic character (Young et~., 
1968). 
The shape of the aspartic acid residue corresponding to residue 109 
of the TMV protein, is, on the other hand, more important than its 
negative charge, as the reactivity of the peptide is retained when 
aspartic acid is replaced by asparagine, and is lost when glutamic 
acid is substituted for it (Young et~., 1968). 
Peptides in which the alanine (corresponding to position I 10) was 
replaced by leucine or glycine, exhibited only marginal activity 
(Young et~., 1968), but an octanoylated tripeptide containing the 
a-aminobutyryl group instead of alanine was bound to asimilar or 
greater extent than octanoyl-Ala-Thr-Arg by three out of four rabbit 
antisera, while the fourth antiserum barely recognized it <Benjamini 
et 2..!_., 1969). This latter observation was thought to reflect a 
structural difference in the antibody combining sites of different 
rabbits rather than a requirement of the particular amino acid resi-
due, as leucine in this position of the octanoylated tripeptide did 
not exhibit a high association of ~ignificant specificity with any of 
the antisera <Benjamini et~., 1969). 
Serine replacing threonine (corresponding to position I I I) results in 
an active peptide, while glycine does not (Young et~., 1968). This 
points to the need of a hydroxyl group on the side chain of the amino 
acid in this position for antibody recognition, as octanoylated tri-
peptides with leucine or the a-aminobutyryl group replacing threonine 
exhibited low binding specificities (Benjamlni et.£..!_., 1969). 
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Removal of the C-terminal arginine of the pentapeptide results in a 
loss of immunochemical activity even when a N-terminal threonine is 
added to maintain the size of the peptide. This shows that the argi-
nine corresponding to position I 12 is critical for binding by some 
antisera (Young et~., 1968), although it may be less important for 
others,as Young et~· (1966) have shown that the desarginated peptide 
8 was sti I I active. The addition of another arginine residue to the 
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C-terminus of the pentapeptide and the removal of the N-terminal leu-
cine to maintain peptide size, did not affect binding relative to the 
reference pentapeptide, while retention of the N-terminal leucine to 
form a hexapeptide, Leu-Asp-Ala-Thr-Arg-Arg, caused the binding almost 
to be doubled <Young et~., 1968). Another hexapeptide which had an 
N-terminal threonine and only one arginine was not bound significantly 
better than the pentapeptide (Young et~., 1968). Whether two popu-
lations of antibodies exist in a particular antiserum, one which recog-
nizes the pentapeptide and another which is directed against an area 
of the protein composed of the C-terminal region of peptide 8 and the 
N-terminal region of peptide 9, or whether the arginine residue corres-
ponding to position I 13 merely enhances the binding of the pentapeptide 
by the antibodies specific for it, is not yet clear (Young et~., 1968). 
The location of the antigenic determinant, Leu-Asp-Ala-Thr-Arg (residues 
108-112), near the core of the virus rod (Champness et~., 1976; Stubbs 
et~~' 1977; Bloomer et~., 1978) means that it would only be avail-
ab le to antibodies after the virus had dissociated and would be a cryp-
totope in terms of the definitions of Jerne (1960) and van Regenmortel 
(1966). 
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1.7 THE NEED FOR FURTHER INVESTIGATION OF THE ANTIGENICITY OF TMV 
AND ITS PROTEIN SUBUNIT. 
Relevant aspects of the research to identify and delineate the anti-
genie detenninants of TMV and its protein subunit have been described 
in the foregoing review. From this it is clear that discrepancies 
between th·e resu I ts of the various approaches exist, and that the 
overal I picture is far from complete. 
The results of two approaches, one uti Ii zing specific derivatives and 
the other overlapping peptides, which have supplied the bulk of the 
information about the antigenic regions of the whole virus, are not 
completely in agreement. Amino acid exchanges in positions 20, 21, 
63, 126 and 129, which are included in the active peptides correspo-
nding to residues 18-23, 62-68 and 123-134 (Anderer, 1963 b) were 
not found to be serologically distinguishable (von Sengbusch, 1965; 
van Regenmortel, 1967) while amino acid exchanges in positions 107, 
136, 138 and 140, which were serologically distinguishable (von Seng-
busch, 1965; van Regenmortel, 1967) were part of peptides which 
were immunologically inactive (Anderer, 1963 b). 
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In the 2,8 A res-
olution model of the TMV protein subunit (Bloomer et EJ_., 1978) the 
peptides corresponding to residues 18-23 and 123-134 are not readily 
accessible from the viral surface, but neither is residue 107 where 
an amino acid exchange is serologically detectable. These conf Ii cts 
can be rationalized in terms of the disruption of antigenic detenni-
nants during enzymatic hydrolysis and subtle conformational modulation 
effects, but no clear explanation is available. 
In the system consisting of TMV protein and its antisera only one 
cryptotopic antigenic detenninant, located in tryptic peptide 8 
(residues 93-112),could be found (Benjamini et E.!_., 1964). In view 
of the wel I known serological cross-reaction between whole TMV and TMV 
A-protein and the finding of van Regenmortel and Le large ( 1973) that 
the valence of the TMV protein subunit is at least 3, it is obvious 
that other antigenic determinants beside that one studied by Benjam-
ini and co-workers must exist. Some of these regions wi I I be identi-
fied in the present work. 
Five tryptic peptides of TMV protein have been chosen on the basis of 
their positions in the conformation of the subunit and the results of 
earlier investigations. They are peptides I (residues 1-41), 4 (re-
sidues 62-68), 8 (residues 93-112),· !!(residues 13.5-141) and 12 (resi-
dues 142-158). As it is now realised that TMV particles often spon-
taneously release protein subunits, and that TMV protein preparations, 
in addition to containing protein monomers, also contain disk aggre-
gates which are antigenical ly similar to the whole virus (van Regen-
mortel and Lelarge, 1973), immunochemical studies with these peptides 
in which the state of aggregation of the antigen is control led, should 
go some way to resolving the discrepancies of earlier investigations. 
In the present work, the contribution of virus-specific and protein-
specific antibodies to the overal I reactivity of the antisera was al-
so tested. Some of the results here included have already been pub-
1 i shed (Mi I ton et ~·, 1977; Mi I ton and van Regenmorte I, 1979). 
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PART 2. RESULTS 
2. I THE PREPARATION OF ANTIGENS AND PEPTIDES 
2.1. I EXTRACTION OF VIRUS FROM INFECTED LEAVES 
TMV viruses were extracted from the leaves of infected Nicotiana 
tabacum cultivar soulouk plants by the method of von Wechmar and van 
Regenmortel (1970), followed by differential centrifugation unti I a 
clear pellet of virus was obtained (4.1.2). 
In this method the virus is released from the leaf eel Is by homogeni-
zation and the particulate plant material is removed from the solution 
by filtration through cheese cloth and low speed centrifugation. The 
bulk of the dissolved plant material is removed by filtration through 
activated charcoal suspended in a matrix of eel ite. The virus, sus-
pended in a large volume of filtrate, is then concentrated by an exclu-
sion and salting out process when the ti ltrate is made 4% (w/v) with 
respect to both polyethylene glycol and NaCl, which causes the virus to 
precipitate so that it can be pelleted by low speed centrifugation. 
The virus, resuspended in 0,05M phosphate buffer pH 7,5, can either be 
further purified by a second polyethylene glycol/NaCl precipitation, or 
0 differential centrifugation, or both, and stored at +4 C. 
60 
The approximate concentration of the virus solutions was determined by 
the use of an extinction coefficient of E~66%nm = 3,22 (Takahashi, 1951), 
and yields of 2-3 g of virus per kg infected leaves were regularly obtal-
ned with this method. The purity of a virus preparation was judged by 
the profile of its ultraviolet absorbance spectrum in the wavelength 
range from 240-320 nm. Criteria of purity were the ratios of the exti-
nctions at 250 nm and 260 nm as wel I as at 260 nm and 280 nm. 
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2.1.2 THE PREPARATION OF TMV PROTEIN 
The proteins of TMV and the mutants were prepared from the virus by 
either the cold acetic acid method (4.1 .3.1) of Fraenkel-Conrat (1957) 
or according to the ethanolamine-DEAE method (4. 1.3.2) of Durham (1972). 
In the cold acetic acid method, the virus is dissociated to protein 
and RNA in the non-polar environment of a solution of 66% (v/v) glacial 
acetic acid in water, which also causes the RNA to precipitate so that 
it can be removed by low speed centrifugation. The protein-containing 
supernatant is then dialysed against water unti I the pH is sufficiently 
high to al low the protein to precipitate at its isoelectric point. 
Centrifugation and resuspension in water effectively concentrates the 
protein and removes the remaining acetic acid from the protein solution. 
In contrast, the method developed by Durham exploits the observation 
that the equilibrium between helices, disks and free protein subunits 
favours the dissociated protein at high pH. The virus dissociates in 
the O,IM ethanol amine - HCI buffer pH I I ,0, and th~ RNA is retained 
when the solution is passed through an anion exchanger such as DEAE-
cel lulose. If the dissociated virus is chromatographed through DEAE-
cel lulose a characteristic elution profile is obtained (fig. 2.1 ). The 
first peak consists of undissociated or reassociated virus and the first 
half of the second peak is pure protein. As the second peak tai Is off, 
however, the eluted protein is increasingly contaminated with RNA. 
Of these two methods, the latter was found to be more advantageous in 
that the protein was generally more easily soluble and judicious pooling 
of the eluant from the DEAE-cel lulose column could minimize the RNA con-









Fig. 2. I 
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FRACTION (8.0ml) 
DEAE-cel lulose chromatography of TMV disrupted in 
O,IM ethanolamine -HCI buffer pH 11,0. The first 
peak consists of short rods of 'intact virus, while 
in the second peak pure TMV protein is initially 
eluted. From fraction 40 onwards RNA contamina-
tion may be encountered. 
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proteins (414, Ni 568 and Ni 1688) which were difficult to dissolve 
after i soe I ectri c p rec i pi tat ion, were more eas i ly prepared by substi-
tuting O,IM NaOH for the ethanolamine buffer when disrupting the virus, 
and then, after the removal of the RNA, the protein was kept at a pH 
above its isoelectric point. 
The concentration's of protein so I ut ions were determined spectrophoto-
metri ca I ly using an extinction coefficient of E~a~%nm= I ,27 (Fraenkel-
Conrat, 1957). Both methods described gave yields greater than 90% 
of the virus present in the initial extract (2.1.1 and 4.1.2). 
2. I .3 THE GENERATION AND PURIFICATION OF THE TRYPTIC PEPTIDES OF TMV 
PROTEIN 
The proteins of TMV and the mutants were digested with trypsl n 
(4.1.4.1) by the method utilized by Benjamini et~· (1964), except 
in as far as l,OM ammonia solution, instead of 0,2M NaOH, was used to 
maintain the digest at pH 8,0. It was thought that this would dee-
rease the sa It content of the digest after I yoph i I i zat ion. 
The I-peptide (residues 1-41) was separated from the digest by iso-
electric precipitation at pH 4,5, and purified by three further iso-
electric precipitations fol lowed by prolonged dialysis against frequent 
changes of water (4.1.4.2). Dialysis in cellophane tubing, boiled to 
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reduce the pore size so that the I-peptide was retained while the smal I-
er peptides were not, gave a greater yield of pure peptide than an in-
creased number of isoelectric precipitations would have done. 
The differing electrophoretic mobi I ities of the eleven remaining pH 4,5 
soluble tryptlc peptides were exploited in an attempt to separate and . 
purify them by anion-exchange chromatography with the resin AGl-X2. 
Depending on the shape of the pH gradient used, characteristic elution 
profiles are obtained with each peak or shoulder representing one or 
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two of the peptides (Funatsu, 1964; Fraenkel-Conrat, 1965; Wittmann, 
1965). Two different pH gradients were used (4.1.4.3.1), one recommend-
ed by Funatsu (1964) - depicted in fig. 2.2 and the other by Wittmann 
(1965) - depicted in fig. 2.3. In both cases the pooled peaks contain-
ed a number of components as judged by peptide mapping (4.2.1). It has 
been suggested that a few fractions under each peak contain a pure pep-
tide· and the contamination found in pooled peaks is due to "overlap" or 
"tai loft" of the adjacent peaks (Fraenkel-Conrat, 1965). In any case, 
for preparative purposes, the pooled eluant from any peak must be further 
purified by an additional procedure, such as chromatography or electro-
phoresis (Fu nats u, 1964; Fraenke I -Con rat, 1965). 
In view of the requirement of this study for only four of the pH 4,5 
soluble tryptic peptides, viz. peptide 4 (residues 62-68), peptide 8 
(residues 93-112), peptide II (residues 135-141) and peptide 12 (resi-
dues 142-158), it was logical to omit the ion-exchange chromatography 
and to develop a preparative electrophoresis system that adequately 
separated these peptides. Increasing the time of the electrophoretic 
step of peptide mapping and applying 25 mg of the pH 4,5 soluble portion 
of the tryptic digest across the centre of the paper proved to be a good 
compromise (4. 1.4.3.2). Yields of the individual peptides, from the 
paper, varied between 60-80% after a single electrophoretic run and in 
most cases amino acid analysis (4.2.2) proved the peptides to be suffi-
ciently pure (table 2.2). An additional advantage of this system is 
that the individual peptides precipitate out of solution after a few 
weeks, and preparative electrophoresis al lows a fresh supply to be made 












7 3 12 2 5 
8 
100 200 300 400 
FRACTION (3.3ml) 
Ion-exchange chromatography on Dowex l-X2 (150x0,9 cm column) 
of the pH 4,5 soluble tryptic peptides of TMV protein. The 
peptides were eluted by the fol lowing gradient (volume percen-
tages): (I) 1% pyridine, 1% collidine and acetic acid pH 8,2 
(250 ml) (2) 1% pyridine, 1% collidine and acetic acid pH 7,3 
(360 ml) (3) 0,02M acetic acid (240 ml) (4) 0,2M acetic acid 
(120 ml) (5) 0,35M acetic acid (120 ml) (6) 0,5M acetic acid 
(120 ml) (7) 0,65M acetic acid (240 ml) (8) l,7M acetic acid 
(120 ml) (9) 5,0M acetic acid (120 ml) (Funatsu, 1964). 
The flow rate was maintained at 40 ml/hr and the temperature 
at 37°C. The Fol in-Lowry colour obtained with 0,1 ml of each 
3,3 ml fraction was measured as the optical density at 700 nm. 
Tubes containing peptide 8 and peptide 10 showed a precipitate. 
The bars <I> indicate the manner in which the fractions were 
pooled and the numbers refer to the tryptic peptide eluted 









7 8 6 
2,3 
11,12 
100 200 300 400 500 600 
FRACTION (4.0ml) 
Ion-exchange chromatography on Oowex l-X2 (150x0,9 cm column) 
of the pH 4,5 soluble tryptic peptides of TMV proteins. The 
peptides were eluted by the fol lowing gradient (volume percen-
tages): (I) 1% pyridine, 1% col Ii dine and acetic acid pH 8,4 
(125 ml) (2) 2% pyridine, 1% collidine and acetic acid pH 
7,5 (125 ml) (3) 1% pyridine, 1% picoline, 1% lutidine and 
acetic acid pH 7,2 (600 ml) (4) 1% pyridine, 1% picoline, 
1% lutidine and acetic acid pH 6,0 (600 ml) (5) 2% pyridine, 
2% picoline, 2% lutidine and acetic acid pH 5,0 (600 ml) 
(6) 3% pyridine, 3% lutidine and acetic acid pH 4,0 (600 ml) 
(7) 2,0M acetic acid (150 ml) (Wittmann, 1965). 
The flow rate was maintained at 40ml/hr and the temperature 
at 37°C. The optical density at 570 nm was read after alka-
1 ine hydrolysis and the reaction with ninhydrin of 0,2 ml of 
each 4,0 ml fraction. The bars <I> Indicate the manner in 
which the fractions were pooled and the numbers refer to the 
tryptic peptides. 
2. 1.4 THE REMOVAL OF THREONINE FROM TRYPTIC PEPTIDE 12 (RESIDUES 
142-158) BY CARBOXYPEPTIDASE A 
67 
TMV protein has a proline residue at position 156, third from the C-
terminus (Anderer et~., 1960; Tsugita et~., 1960). The C-termi-
nal threonine is therefore readily released by carboxypeptidase A, 
while no further amino acids are split off by the action of the enzyme 
(Harris and Knlght, 1952). This was tested by subjecting trypt!c pep-
tide 12 (residues 142-158) to carboxypeptldase A digestion by a modifi-
cation of a method described by Ambler (1972) and detailed in section 
4. I .4.3.3. 
The whole digest was chromatographed on a column of Sephadex G50 fine, 
equi I ibrated and run with disti I led water (in which psptide 12 is sol-
uble), and the elution profile shown in fig. 2.4 was obtained by plot-
ting the absorbance at 280 nm and 210 nm against the fraction number. 
20 µI of every second fraction was spotted onto Whatman 3 Chroma paper, 
dried and tested for colour development with 0,2% (w/v) ninhydrin in 
ethanol containing 5% (v/v) col I idine. As only fractions 44-65 showed 
a blue colour, it was concluded that the first major peak consisted of 
undigested peptide 12, which does not stain with ninhydrin (2.2. I. I). 
This was confirmed by amino acid analysis of portions of each pool of 
the fractions under the final three peaks. The first major peak con-
sisted of peptide 12, the second peak of peptide 12 minus threonine and 
the third peak of threonine. The yield of the carboxypeptidase A pro-
duct (peptide 12 minus threonine) was only about 10% as judged by amino 
acid analysis (4.2.2). 
The chromatographic separation of the undigested peptide 12 and peptide 
















Gel exclusion chromatography of a carboxypeptldase A digest 
68 
of peptide 12 (residues 142-158) on a 65xl,6 cm column of 
Sephadex G50 fine equilibrated and run with disti I led water. 
2,6 mg of digest, dissolved in N-ethylmorphollne buffer pH 
8,1, was applied to the column at room temperature while the 
flow rate was maintained at 30 ml/hr. The absorbance at 280 
nm (broad trace) and 210 nm (narrow trace) was plotted against 
the fraction ( 1,5 ml) number. The broad bracket indicates 
the fractions that were ninhydrin positive in a spot test on 
paper. The bars (I) indicate the manner in which the frac-
tions were pooled. 
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ation range of Sephadex G50, nevertheless the amino acid analysis (table 
2.2) of the pooled peaks must be believed. It is possible that peptide 
12 exists in solution in the form of smal I polymers (dimers or trimers), 
which cause it to be eluted from the column earlier. 
2./.5 THE GENERATION OF FORMIC ACID PEPTIDES FROM TMV PROTEIN 
The TMV protein has two aspartyl-proline peptide I inkages in its seq-
uence that can be selectively cleaved by high concentrations of certain 
organic acids (Anderer, 1963 a; Baltz and van Regenmortel, 1974). The 
formic acid method of Miki and Knight (1965) was used to degrade TMV 
protein and the I-peptide (residues 1-41) in an effort to prepare pep-
tides corresponding to the first nineteen residues and the ensuing 
twenty-two residues of the protein's sequence (4. 1.5. I). 
TMV protein was incubated in a solution of 66,6% (v/v) formic acid in 
0 water for 20 hrs at 37 C and .evaporated to dryness. On resuspension 
in water a precipitate was formed and this was separated from the sup-
ernatant by centrifugation. The supernatant was tested by the ninhy-
drin reaction after alkaline hydrolysis (Benson and Patterson, 1971) 
and found to contain proteinaceous material. 
In an effort to discover the distribution of protein or peptides in the 
precipitate and supernatant, samples of both of these, as wel I as the 
whole digest, were submitted to SDS-polyacrylamide gel electrophoresis 
(4. 1.5.3). Three proteins, viz. TMV protein (17500 daltons), lysozyme 
(14000daltons) and insulin (6000 daltons), were used as markers. The 
whole digest was found to contain three components, the largest of which 
had a molecular weight just greater than that of insulin and was probably 
the peptide corresponding to the sequence 78-158. The other two 
components had molecular weights similar to, and just greater than 
insulin and were probably the peptides corresponding to the sequences 
20-77 and 1-19 respectively. The precipitate contained the largest 
and smallest of these peptides, while the supernatant contained the 
water soluble peptide corresponding to the sequence 20-77. 
An attempt was made to separate the three formic acid peptides by 
exclusion chromatography with Sephadex G50 equi I ibrated and run with 
a solution of 50% (v/v) glacial acetic acid in water (4. I .5.2). An 
elution profile with three peaks was obtained (fig. 2.5), but SOS-
polyacrylami de gel electrophoresis of samples from each pool of frac-
tions corresponding to the individual peaks revealed that the first 
peak was composed of al I three peptides while the second and third 
peaks contained the water soluble peptide. It is thought that the 
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peaks in the elution profile correspond to different aggregation states 
of the peptides. 
The I-peptide resulting from tryptic digestion (4.1 .4. I) contains a 
single aspartyl-proline peptide bond which should also be susceptible 
to formic acid cleavage, so It too was incubated in a solution of 66,6% 
(v/v) formic acid in water and dried. Resuspension in water again 
yielded an insoluble precipitate, but the supernatant was free of pro-
teinaceous material as judged by the ninhydrin reaction (Benson and 
Patterson, 1971). 
The precipitates of the formic acid degraded TMV protein and the I-pep-
tide were found to dissolve in O,IM HCI, but when this was evaporated 
they sti I I could not be dissolved in water. It was found, for both of 













Gel exclusion chromatography of the formic acid peptides on 
a 80xl ,6 cm column of G50 fine equi I ibrated and run with 
50% Cv/v) glacial acetic acid in water. 50 mg (5.0 ml) of 
the formic acid digest of TMV protein was dissolved in 50% 
(v/v) glacial acetic acid and applied to the column at room 
temperature. The flow rate was maintained at 30-40 ml/hr 
and the absorbance at 280 nm of each 3,0 ml fraction was read 
against a 50% (v/v) glacial acetic acid blank. The bars (I) 
indicate the manner in which the fractions were pooled. 
attained in the presence of I ,0% (w/v) SOS or when an equal volume of 
formic acid, glacial acetic acid or pyridine was added to the precipi-
tates in water. 
2.2 CHARACTERIZATION OF TMV PROTEIN, THE PROTEINS OF THE TMV MUTANTS 
AND THEIR PEPTIDES 
2.2. I PEPTIDE MAPPING 
2.2. I. I PEPTIDE MAPPING OF THE pH 4.5 SOLUBLE TRYPTIC PEPTIDES OF TMV 
PROTEIN 
72 
The pH 4.5 soluble portion of the tryptic digest of TMV protein (4.1 .4. I) 
produces the characteristic pattern of peptide spots (depicted in fig. 
2.6) when the prescribed conditions (4.2. I) are maintained during high 
voltage electrophoresis in the first dimension and ascending chromato-
graphy in the second. The pH, potential difference, and current were 
as suggested by Benjamini et~· (1964), except in as far as the electro-
phoretic buffer was made 20% (v/v) with acetone prior to use. The ch ro-
matographic system was suggested by Dr. B. Wittmann-Liebold (personal 
communication). 
Using this system for peptide mapping, al I the tryptic peptides, except 
peptides 6 (residues 72-90) and 10 (residues 123-134), which remain at 
the origin during electrophoresis, could be separated and identified by 
their differing electrophoretic and chromatographic mobi I ities and their 
differing staining properties. Peptide 2 (residues 42-46), 3 (residues 
47-61), 4 (residues 62-68), 5 (residues 69-71), 8 (residues 93-112), and 
9 (residues I 13-122), as wel I as the spot consisting of peptides 6 and 
10 stained purple with ninhydrin, while peptides 7 (residues 91-92) and 
I I (residues 134-141) stained characteristically grey and yellow respec-
tively (Woody and Knight, 1959; Benjamini et~., 1964). Peptide 12 
Fig. 2.6 
f6,10 
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cm 
Peptide mapping of the tryptlc peptides of TMV protein by 
high voltage electrophoresis and ascending chromatography 
on paper. I mg of the pH 4.5 soluble portion of a tryptic 
digest of TMV protein was applied to the origin on a 35x40 
cm sheet of Whatman 3 Chroma paper, at the position marked 
x. After 2,5 hrs electrophoresis (1000 V, 45 mA) at pH 
6,4 the paper was dried and subjected to ascending chroma-
tography in pyridine, iso-amylalcohol and water (5:4:4). 
Numbers associated with the spots refer to the tryptic pep-
tides. The staining colour of peptides 2,3,4,5,8 and 9, as 
wel I as 6 and 10, was purple, peptide I I was yellow, peptide 
7 was grey and peptide 12 did not stain with ninhydrin. Pep-
tides 3 and 12 were stained with Erlichs reagent (Jepson, 
1963) and only peptides 4 and 12 did not fluoresce under UV 
light after staining with pheneanthrenequinone (Yamada and 
ltano, 1966). The electrophoretic and chromatographic mobi-
1 ities of the tryptic peptides from the TMV mutants, 414, 
CP 415, Ni 118, Ni 568, Ni 1688 and Ni 1927 did not differ 
significantly from the corresponding peptides of TMV and 
practically identical peptide maps were obtained with al I 
these mutants except for peptide I I of CP 415 which stained 
purple with ninhydrin instead of a characteristic yellow. 
(residues 142~158) did not develop colour with the ninhydrin reagent. 
The two tryptophan containing peptides, 3 and 12, developed a violet 
colour with Ehrllchs reagent (Jepson, 1963) and al I the peptides, ex-
cept peptides 4 and 12 which do not contain arginine, could be made 
to fluoresce in ultraviolet light with a wavelength of 266 nm by tre-
atment with pheneantrenequinone (Yamada and ltano, 1966) 
2.2. 1.2 PEPTIDE MAPPING OF THE pH 4,5 SOLUBLE TRYPTIC PEPTIDES OF 
THE PROTEINS OF THE TMV MUTANTS 
The pH 4,5 soluble tryptic peptides of each of the six TMV mutants 
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used in this work (viz. 414, CP 415, Ni 118, Ni 568, Ni 1688 and Ni 
1927) were prepared (4. 1.4.1) and subjected to peptide mapping (4.2. I). 
None of the peptides, which contained amino acid exchanges, was found 
to have an electrophoretic or chromatographic mobi I ity which was signi-
ficantly different from that of the corresponding peptides of the wi Id 
type virus protein. Similarly, the mutant peptides stained identically 
with ninhydrin and Erlichs reagent (Jepson, 1963) to their wi Id type ho-
mologues, except for peptide I I (residues 135-140) of CP 415 protein 
(asparagine in position 140 is replaced by lysine) which stained purple 
with ninhydrin rather than the yellow colour that is characteristic of 
the wi Id type peptide 11 (Woody and Knight, 1959; Benjamini et~., 
1964). 
2.2. 1.3 PEPTIDE MAPPING OF INDIVIDUAL pH 4,5 SOLUBLE TRYPTIC PEPTIDES 
Tryptic peptides isolated by the high voltage electrophoresis method 
(4. 1.4.3.2) have been characterized as regards their electrophoretic mo-
bi I ity and purity during the preparative process. Only peptide bands 
with characteristic electrophoretic mobi I ities, which were sufficiently 
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separated from the adjacent bands, were extracted from the paper. 
Nevertheless, representative peptide preparations were subjected to 
peptide mapping to ascertain that single spots, with the correct elec-
trophoretic and chromatographic mobi I ities and staining characteristics, 
resulted. Similarly, if the amino acid composition of an electropho-
reti ca I ly prepared peptide was doubtfu I, a peptide map was made to check 
the purity of the preparation. 
2.2.2 AMINO ACID COMPOSITION 
2.2.2. I AMINO ACID COMPOSITION OF THE PROTEINS OF THE TMV MUTANTS 
The amino acid composition after acid hydrolysis (4.2.2) of the proteins 
of the six TMV mutants used in this work is given in table 2. I. It 
can be seen that, although the general composition of the proteins is 
practically identical, the amino acid replacements characterizing each 
mutant are clearly demonstrated. 
2.2.2.2 AMINO ACID COMPOSITION OF THE TRYPTIC PEPTIDES OF TMV PROTEIN 
AND THE PROTEINS OF THE TMV MUTANTS, AS WELL AS A DERIVATIVE OF PEP-
TIDE 12 (RESIDUES 142-157) 
Typical amino acid compositions of each of the tryptic peptides from 
TMV protein, a carboxypeptidase A treated derivative of peptide 12 (resi-
dues 142-157) and the tryptic peptides of the TMV mutants, that were 
used in this work, are shown in tables 2.2 and 2.3. 
No evidence of any significant cross-contamination between the various 
pH 4,5 soluble tryptic peptides could be found even when individual pep-
tides were subjected to peptide mapping (4.2.1). The low level of con-
tamination is thought to be the result of amino acids extracted from the 
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The three tryptic I-peptides from TMV, Ni 118 and Ni 568, were submitted 
to SDS-polyacrylamide gel electrophoresis on 18% (w/v) slab gels (4.2.3) 
79 
to test for virus protein contamination (fig. 2. 7). Al I three I-peptides 
migrated as single bands with the same electrophoretic mobi I ity, and, 
even when the gels were overloaded with the peptides, no sign of a virus 
protein band was detectable. 
2.3 THE EFFECT OF CHANGES IN THE C-TERMINAL CONFIGURATION OF TMV PROTEIN 
ON THE CROSS-REACTION BETWEEN TMV AND TMV A-PROTEIN 
2.3. I CHANGES IN THE C-TERMINAL CONFIGURATION OF TMV A-PROTEIN BETWEEN pH 
7 ,O AND pH 8,0 
Near-ultraviolet circular-dichroism absorption spectra of TMV A--protein at 
20°c, pH 7,0 and pH 8,0, show a change in their 280-295 nm wavelength 
range (Vogel, 1973; Vogel and Jaenicke, 1974). This is I ikely to be 
associated with a localized structural change, as only tyrosine and tryp-
tophan overlap in this spectral range, and tryptophan, which is the only 
species absorbing above 290 nm, shows only a slight change in the intens-
ity of the 295 nm-band. This indicates that it is not likely to be 
involved in the structural change (Vogel, 1973). The involvement of the 
tyrosine in position 139, near the C-terminus, in the formation of the 
20S disk (Ohno et~., 1972), and the observation that the exchange of 
prol ine in position 156 for leucine (in the mutant Ni 1927) causes a com-
parable change in dichroic absorption (Vogel and Jaenicke, 1974), points 
to the C-terminal region of the TMV protein being involved in the local-
ized structural change which occurs between pH 7,0 and pH 8,0 (Vogel and 
Jaenicke, 1974). 
As the C-terminal residues of the TMV protein subunit in the virus are 
known to be involved In an antigenic determinant of the .virus (Harris· and 














Densitometer traces of TMV protein and the three tryptic 
I-peptides electrophoresed in one slab of 18% Cw/v) poly-
acrylamide 1% (w/v) SOS gel and the bands stained using 
Coomassie bri I Ii ant blue. The arrow indicates the direc-
tion of electrophoresis from the top of the gel on the 
left hand side to the bottom on the right. (A) 5 µI of a 
1,0 mg/ml solution of TMV protein. (B) 20 µI of a stock 
solution of TMV I-peptide. CC) 20 µI of a stock solution 
of Ni I 18 I-peptide. (0) 15 µI of a stock solution of Ni 
568 I-peptide. 
Knight, 1955; von Sengbusch and Wittmann, 1965; von Sengbusch, 1965; 
and van Regenmortel, 1967), it was decided to investigate the effect 
of the conformational change in the C-terminal region of the TMV A-
protein on the cross-reaction between the intact virus and the A-pro-
tein. To ensure the validity of the results, the problem of virus 
disaggregation and specificity of the reaction between the anti-TMV 
antibodies and the A-protein had to be solved. 
2.3.2 A MICRO-PRECIPITIN ASSAY WITH RADIOLABELLED TMV TO ENSURE THAT 
ONLY THE SPECIFIC REACTION BETWEEN TMV AND ANTl-TMV ANTIBODIES IS 
MEASURED. 
[4,6-3HJ uridine was incorporated into TMV RNA in infected plants by 
the same basic method that was used by Singer (1971) to incorporate 
radioactive amino acids into TMV protein (4.3.4. I. I). Once the radio-
label led virus had been extracted from the plants it was found that 10% 
of the <3H-)uridine had been incorporated into the virus, which had a 
6 specific activity of. 3,67 x 10 dpm/mg. The ultraviolet spectrum of 
the radioactive virus was identical to that of unlabelled TMV. 
Fig. 2.8 shows the precipitin reaction between 0,5 µg of <3H)uridine-
TMV and increasing dilutions of a TMV antiserum. After the antibody-
TMV precipitate had formed, it was removed by low speed centrifugation 
and the amount of radioactivity in I ,0 ml of the supernatant, which is 
proportional to the amount of unbound <3H>uridine-TMV, was plotted 
against the reciprocal of the antiserum dilution. The first part of 
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the curve corresponds to the zone of antibody excess where al I the <3H>-
uridine-TMV is bound by antibody and removed from the solution by preci-
pitation. The inflection point of the curve indicates equivalence pro-
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SERUM DILUTION1 
A precipitin curve of the reaction between 0,5 µg of c3H> 
uridine-TMV and increasing dilutions of a TMV antiserum. 
The amount of radioactivity in I ,0 ml of the supernatant, 
after the removal of the precipitate by centrifugation, 
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was plotted against the reciprocal of the antiserum di lu-
tion. The region of the curve between A and B corresponds 
to the zone of antibody excess, B indicates the zone of 
equivalence and the region between B and C corresponds to 
the zone of antigen excess. The region from C to 0 corres-
ponds to the zone in which soluble antibody-antigen complex-
es occur. The antibody:antigen proportions chosen for the 
precipitation-inhibition tests are indicated by the arrow. 
This point is in the zone of antigen excess, near the 
equivalence region. 
al I the (3H)uridine-TMV which starts appearing in the supernatant 
in increasing amounts. This is the zone of antigen excess. The 
proportions of (3H)uridine-TMV and antiserum, used for. inhibition 
tests, were chosen to be in the zone of antigen excess, near the 
equivalence point, so that antibodies would be divalently bound and 
thus more easily prevented from precipitating the radiolabel led an-
tigen in the presence of inhibitor. 
The advantage of this system, apart from the obvious ease of working 
with the supernatant rather than the precipitate, is that, due to the 
location of the radioactive label in the RNA, only the reaction between 
TMV and its specific antibodies is measured. Hence the reaction be-
tween anti-TMV protein antibodies and TMV protein subunits, dissociated 
from the virus, is not detectable and cannot influence the measurement 
of the TMV-anti TMV reaction. Thus the inhibition which is measured, 
is specific for the TMV-anti TMV system. Another advantage is that 
the inhibition of the specific precipitin reaction by non-haptenic 
·molecules ls possible with this system. Un label led antigens such as 
TMV protein and even intact TMV particles were found to be successful 
inhibitors of the reaction between (3H)uridine-TMV and specific anti-
TMV antibodies. 
In experiments where the TMV-anti TMV reaction was inhibited, it was 
decided to express the concentration of the inhibitor in terms of "TMV 
equivalents", where one TMV equivalent is equal to the amount of TMV, 
used per test in n-moles, multiplied by 2130 (the number of subunits in 
a TMV capsid). The rationale behind this choice is that, although for 
reasons of steric hindrance the valence of the virus is approximately 
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800 (Hardie and van Regenmortel, 1975; van Regenmortel and Hardie, 1976), 
each subunit of the virus has on its surface identical antigenic deter-
minants which are equally attractive to the antibodies specific for 
them irrespective of the particular subunit. The antigenic regions 
of the inhibitor compete with every available antigenic determinant 
on the virus and the number of available virus antigenic determinants 
increases as inhibition tends towards a maximum. 
2.3.3 THE EFFECT OF pH ON THE ABILITY OF TMV PROTEIN AND Ni 1927 
PROTEIN TO INHIBIT THE REACTION BETWEEN RADIOLABELLED TMV AND SPECIFIC 
ANTl-TMV ANTIBODIES 
The proportions of c3H>uridine-TMV and TMV specific antibodies most 
suitable for inhibition experiments were determined as described in 
sections 2.3.2 and 4.3.4.2.5 (Fig. 2.8). The precipitin reaction be-
tween 0,5 µg of c3H>uridine-TMV and 0,5 ml of a 1/16384 dilution of a 
TMV antiserum was inhibited by increasing concentrations of TMV pro-
tein and Ni 1927 protein, which were preincubated with the antiserum 
0 for 16-18 hrs at +4 C. This was done under two different pH condi-
tions for each of the inhibitors, viz. pH 6,8 and pH 8,0. A complete 
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set of maximum and minimum c3H)uridine-TMV binding controls was included 
at each pH and the percentage inhibition for each test was calculated 
from the controls carried out at the same pH as the test (4.3.4.3. I). 
Fig. 2.9 i I lustrates the effect of pH, and hence the C-terminal config-
uration of the virus proteins (2.3. I), on the cross-reaction of TMV 
protein and Ni 1927 protein with c3H)uridine-TMV. Complete inhibition 
of the reaction between c3H)uridine-TMV and TMV specific antibodies was 
obtained with TMV protein at pH 6,8 and pH 8,0 as wel I as Ni 1927 pro-
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TMV EQUIVALENTS 
The effect of pH on the cross-reaction between TMV and TMV 
protein, and TMV and Ni 1927 protein. The reaction between 
radiolabel led TMV and specific anti-TMV antibodies was inhi-
bited by increasing concentrations of TMV protein and Ni 1927 
protein in different pH conditions. The amount of inhibitor 
is expressed in TMV equivalents, where one equivalent is equal 
to the amount of radio label led TMV used per test multiplied 
by 2130 - the number of subunits in a virus particle. The 
amount of inhibition per test was calculated from controls 
carried out at the same pH as the test. ( •) TMV protein 
at pH 6,8, (Q) TMV protein at pH 8,0, <•)Ni 1927 protein 
at pH 6,8, and <Dl Ni 1927 protein at pH 8,0. 
TMV protein at pH 6,8, which is in the conformational form closest to 
the subunits of the 20S disk (Vogel, 1973; Vogel and Jaenicke, 1974) 
and hence closest to the subunits of the intact virus (Graham and 
Butler, 1978), is the best inhibitor with I I ,3 TMV equivalents (corr-
esponding to a 24080 molar excess of TMV protein over virus) causing 
50% inhibition. TMV protein at pH 8,0, which has a C-terminal con-
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figuration different from that of the subunits of the 20S disk (Vogel, 
1973; Vogel and Jaenicke, 1974) and the subunits of the intact virus 
(Graham and Butler, 1978) is less efficient as an inhibitor of the TMV-
anti-TMV reaction, for 64,0 TMV equivalents of protein (corresponding 
to a 136320 molar excess of TMV protein over virus) are required to 
achieve 50% inhibition. 
In the case of Ni 1927 protein, which has the pro I ine residue 156 rep la-
ced by leucine, the position is reversed. 21 5,3 TMV equivalents of Ni 
1927 protein at pH 8,0 (i.e. a molar excess of 458589 protein subunits 
for every TMV particle) in contrast to 861 ,I TMV equivalents of Ni 1927 
protein at pH 6,8 (i.e. a molar excess of 1834143 protein subunits for 
every TMV particle) are required for 50% inhibition of the reaction be-
tween <3H>uridine-TMV and TMV specific antibodies. 
In an effort to determine whether the specific inhibition described 
above co~ld possibly be due to the aggregation of the TMV and Ni 1927 
proteins into 20S disks or RNA free helices <which would be antigenical ly 
identical to the virus) 0,5 mg/ml and I ,0 mg/ml solutions of the proteins 
at pH 6,8 and pH 8,0 respectively, were subjected to conditions identical 
to those of the inhibition assays and submitted to an ultracentrifugal 
analysis at 40000 rpm and 56000 rpm using an AnD rotor with a standard 
12 mm single sector centrepiece in a Betkman model E analytical ultra-
centrifuge (4.2.4). The sedimentation coefficients of the TMV and 
Ni 1927 protein preparations were calculated by the method of Cher-
venka (1969) from photographs taken with the schlieren optical system 
at various intervals. No protein aggregates with sedimentation co-
efficients significantly greater than 4S could be detected in ·any of 
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the protein preparations. The highest concentration of protein inhibi-
tor used in the inhibition assay was 0,64 mg/ml, and it is therefore 
unlikely that any large aggregates were present during the tests. 
When a different TMV antiserum with a lower precipitin titre was used 
in a siml lar inhibition assay, the results obtained were not substan-
tially different from those i I lustrated in fig. 2.9, except that high-
er concentrations of the inhibitor were required to obtain equivalent 
degrees of inhibition of the radiolabel led TMV-anti-TMV system. 
2.4 IMMUNOCHEMICAL STUDIES WITH THE PROTEINS OF TMV MUTANTS 
2.4. I A MEANS OF DETERMINING THE ROLE OF SPECIFIC AMINO ACIDS IN THE 
ANTIGENICITY OF TMV PROTEIN 
Von Sengbusch (1965) concluded from serological studies with mutants of 
TMV that not al I of the amino acid exchanges, which were serologically 
distinguishable from TMV, could be in antigenic determinants, as the 
surface of each protein subunit in the viral helix was not large enough. 
Some of the amino acid exchanges would affect the immunological reactions 
of the mutant virus indirectly by causing a subtle modulation of the con-
formation of the protein subunit. This was borne out by X-ray crystal 1-
ographic studies on the virus (Holmes et~., 1975) and the 20S disk 
(Champness et~., 1976; Bloomer et~., 1978) which showed that residue 
107, which is serologically distinguishable when threonine is replaced by 
methionine (von Sengbusch, 1965), is located near the core of the viral 
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helix, far from the surface of the subunit (I .3.4). 
It was thought that asimilar situation may exist in the TMV protein 
system. In order to determine which amino acid exchanges affected the 
immunologic~! reactivity .of the TMV protein by altering its conforma-
tion, and which by directly changing anti'genic determinants, six mu-
tants of TMV, which had amino acid exchanges in one or more of the 
five tryptic peptides utilized in this work, were selected for study. 
An immunochemical comparison of the reactivity of these mutant proteins 
with TMV protein would determine which amino acid exchanges were sero-
logical I~ distinguishable in the TMV protein-anti-TMV protein system 
(2.4.3). Meanwhile, the immunochemical reactivity of mutant protein 
peptides, which contained an amino acid exchange, would be compared 
with the equivalent peptides from TMV protein using the same antisera 
<2.6.I). Serologically distinguishable amino acid exchanges which 
affect the reactivity of the mutant protein, but not the corresponding 
random coi I peptide, would be likely to exert their influence by modu-
lating the protein conformation, while those amino acid exchanges which 
affected the reactivity of both the protein and the peptide would be 
likely to form a part of an antigenic determinant. 
In this way information about the role of specific amino acids in the 
conformation and the antigenicity of TMV protein would be obtained. 
This section deals with the results of the immunochemical comparison of 
the mutant proteins with the TMV protein. 
2.4.2 A MICRO-PRECIPITIN ASSAY USING RADIOLABELLED TMV PROTEIN 
The fol lowing tritiated amino acids were incorporated into TMV protein 
in infected plants by the method of Singer (1971 ): L-[2,3-3H] alanine, 
L-[4,5(n)-3HJ isoleucine, L-[4,5-3H] leucine, L-[3-3HJ serine and 
L-[3,4(n)-3H] valine (4.3.4. 1.2). Once the virus had been extracted 
from the plants and TMV protein prepared, it was founq that_...A. 1% of 
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the radiolabel led amino acids had been incorporated into the virus pro-
tein which had a specific activity of 5,67xi06 dpm/mg. The ultraviolet 
spectrum of the radiolabel led protein was identical to that of unlabelled 
TMV protein. 
The micro-precipitin assay with the radiolabelled TMV protein was iden-
tical to the system described in section 2.3.2, except for the differ-
ent antigen and pH at which the reaction took place. pH 7,4 was main-
tained in the radiolabel led TMV protein assays compared to pH 6,8 
which was used in the <3H>uridine-TMV assays (4.3.4.2.5). Fig. 2.10 
shows the precipitin reaction between 0,5 µg of radiolabel led TMV pro-
tein and increasing di--iutions of a TMV protein antiserum. The preci-
pitate, which formed, was removed by low speed centrifugation and the 
amount of radioactivity in I ,0 ml of the supernatant was monitored and 
plotted against the reciprocal of the antiserum dilution. The first 
part of the curve, where there is relatively little radiolabel led anti-
gen in the supernatant, corresponds to the zone of antibody ex~ess. 
The region of the curve immediately before the inflection point corres-
ponds to the equivalence zone and the next part of the curve, where 
the amount of radiolabel led antigen in the supernatant increases, corr-
esponds to the zone of antigen excess. The final plateau of the curve 
where the amount of radiolabel led antigen in the supernatant is maximal, 
corresponds to the zone in which soluble antibody-antigen complexes are 
formed. Inhibition studies were performed using the proportions of anti-
body and radio label led antigen that corresponded to a point in the zone 
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SERUM DILUTION-1 
A precipitin curve of the reaction between 0,5 µg of radio-
label led TMV protein, into which tritiated amino acids were 
incorporated, and increasing dilutions of a TMV protein 
antiserum. The amount of radioactivity in I ,0 ml of the 
supernatant, after removal of the precipitate by centrifu-
gation, was plotted against the reciprocal of the antiserum 
dilution. The region of the curve between A and 8 corres-
ponds to the zone of the antibody excess, 8 indicates the 
zone of equivalence and the region between 8 and C corres-
ponds to the zone of antigen excess. The region from C to 
D corresponds to the zone in which soluble antibody-antigen 
complexes occur. The antibody:antigen proportions chosen 
for the precipitation-inhibition tests are indicated by the 
arrow. This point is near the equivalence point, in the 
zone of antigen excess. 
antibody between the inhibitor and the radiolabel led antigen would 
Increase the sensitivity of the assay. 
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Similar to the C3H)uridine-TMV micro-precipitin assay, the chief advan-
tage of this system is that only the specific binding of antibodies to 
the radiolabel led TMV protein can be measured, and therefore inhibited. 
Also the system is not I imited to hapten inhibition, so any unlabelled 
protein or peptide inhibitor can be tested for its cross-reaction with 
specific anti-TMV protein antibodies. 
The potential aggregation of the radio label led TMV protein and other 
free virus proteins to the 20S disk or protein helices can be a problem 
if the concentration of the proteins is al lowed to become too high 
(Klug and Durham, -1971). Ultracentrifugal studies on TMV protein 
(4.2.4) have shown that even a 1,0 mg/ml solution of the protein at pH 
6,8 and physiological ionic strength had a sedimentation coefficient 
not greater than 4S (2.3.3). The total virus protein concentration in 
inhibition assays was kept as low as I ,0 µg/ml at the same ionic stre-
ngth and a higher pH, so aggregation should be neg I igible in this system. 
2.4.3 A COMPARISON OF THE ABILITIES OF TMV PROTEIN AND SIX TMV MUTANT 
PROTEINS TO INHIBIT THE PRECIPITIN REACTION OF RADIOLABELLED TMV PROTEIN 
WITH SPECIFIC ANTIBODIES 
The proportions of radiolabel led TMV protein and anti-TMV protein anti-
bodies most suitable for inhibition experiments were determined as des-
cribed in sections 2.4.2 and 4.3.4.2.5 (fig. 2. 10). The precipitin 
reaction 0,5 µg of radiolabel led TMV protein and 0,5 ml of a 1/128 di lu-
tion of a TMV protein antiserum was inhibited by increasing concentra-
tions of TMV protein, or one of six TMV mutant proteins, which were 
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preincubated with the antiserum for 16-18 hrs at +4°C. The percentage 
inhibition was calculated from maximum and minimum radiolabel led TMV 
protein binding controls carried out under the same conditions as the 
inhibition assays (4.3.4.2.6). 
The results of the inhibition assays are shown in fig. 2.1 I A and B. 
The precipitin reaction between radio label led TMV protein and anti-
TMV protein antibodies was efficiently inhibited by unlabelled TMV 
protein, with 75% inhibition being caused by 0,024 µg (I ,4 p-moles) 
of the unlabelled protein. This is equivalent to a 0,047 molar ex-
cess of unlabelled over radio label led TMV protein. Complete inhibi-
tion was obtained with 1,0 µg of unlabelled TMV protein which is equi-
Valent to a 2 molar excess of unlabelled TMV protein. The inhibition 
obtained with the mutant proteins, 414 <serine replacing glycine in 
position 65) and CP 415 (lysine replacing asparagine in position 140), 
was not significantly different from that obtained with unlabelled TMV 
protein. In both cases 75% inhibition was obtained with a 0,047 mola~ 
excess of mutant protein over radio label led TMV protein. The resu I ts 
wi'th CP 415 protein concur with the finding of du Plessis and van 
Regenmortel (1977) that the exchange of lysine for asparagine in posi-
tion 140 is not serologically distinguishable in TMV protein. In the 
case of 414 protein, if a serological difference between it and TMV pro-
tein exlsts, this assay is not sufficiently sensitive to clearly detect 
it. 
The remainder of the mutant proteins are serologically distinguishable 
from TMV protein by this method; although the difference in their inhi-
bitory behaviour is not as great as expected. This is understandable 
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Fig. 2.11 
MOLAR EXCESS OF INHIBITOR OVER TMV PROTEIN 
Quantitative inhibition of the precipitin reaction of radiola-
bel led TMV protein with a TMV protein antiserum by increasing 
concentrations of unlabelled TMV protein and mutant proteins. 
The concentration of the inhibitor is expressed as the molar 
ratio of inhibitor over the amount of radio label led TMV pro-
tein present in each test. (A). TMV protein (Q); 414 
p rote i n ( 0 ) ; CP 41 5 p rote i n ( .& ) ; Ni I 18 p rote i n ( e ) ; 
and Ni 568 protein (..6.). B. TMV protein (Q); Ni 1688 
protein ( .- ) ; and Ni 1927 prote In ( •). 
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Of the six mutant proteins, four have only one amino acid exchange 
(414, CP 415, Ni 118 and Ni 1927) and the rest have two amino acid 
exchanges (Ni 568 and Ni 1688). A maximum of two out of five anti-
genic determinants in the mutant proteins could therefore be affected, 
whl le specific antibodies react unhindered with the remaining antigenic 
determinants. Shepard et~., (1974) have also suggested that se-
quence homologies are more likely to be expressed in cross-reactions of 
the depolymerized coat proteins of plant viruses than in the undissociat-
ed virus. 
l,n constrast to the 0,047 molar excess of unlabelled TMV protein required 
for 75% inhibition of the reaction of radlolabel led TMV protein and anti-
TMV protein antibodies, a 0,063 molar excess (equivalent to 0,032 µg pro-
t":iin) of Ni 1927 protein (leucine replacing proline in position 156) was 
required for the same inhibition. A 0,119 molar excess (equivalent to 
0,060 µg protein) of Ni 118 protein (leucine replacing proline in position 
20) was required for 75% inhibition, while for Ni 568 protein (isoleucine 
replacing threonine in position 5 and methionine replacing threonine in 
position 107) and Ni 1688 protein (serine replacing proline in position 
156) molar excesses of 0,250 (equivalent to 0,125 µg protein) and 0,663 
(equivalent to 0,332 µg protein) respectively, were required for the same 
i nh i b it i on . 
These results, with those of du Plessis and van Regenmortel (1977), are 
summarized in fig. 2. 12 to show the relationship between serological 
distingui~habi I ity of the mutant and the position of the amino acid ex-
change in the sequence of the TMV protein. 
A 10 15 
Acetyl-Ser-Tyr-Ser-1 le~Thr-Pro-Ser-Gln-Phe-Val-Phe-Leu-Ser-Ser-
20 25 30 
Ala-Trp-Ala-Aspel le-Glu-Leu-1 le-Asn-Leu-Cys-Thr~Asn-Ala-
35 40 45 
Leu-Gly-Asn-Gln-Phe-Gln-Thr-Gln-Gln-Ala-Alg-Thr-Val-Gln-Val-
50 55 60 
Arg-Gln-Phe-Ser-Gln-Val-Trp-Lys-Pro-Ser-Pro-Gln-Val-Thr-Val-
Arg-PheeAsp:~:~}Asp-Phe-Lys-va1-~~r-Arg-Tyr-Asn-Ala-~:1-,,,. 
80 85 90 
Leu-Asp-Pro-Leu-Val-Thr-Ala-Leu-Leu-Gly-Ala-Phe-Asp-Thr-Arg-
95 100 105 
Asn-Arg-1 le-I le-Glu-Val-Glu-Asn-Gln-Ala-Asn-Pro-Thr-Thr-Ala-
. 110 115 120 
GluE::}Leu-Asp-Ala-Thr-Arg-Arg-Val-Asp-Asp-Ala-Thr-Val-Ala-
125 130 135 
I le-Arg-Ser-Ala-1 le-Asn-Asn-Leu-1 le-Val-Glu-Leu-1 le-Arg-Gly-
140 145 150 
r· ·-. .,". r· ... 
Thr-Gly~SerlTyrfAsn~Arg-Ser-Ser-Phe-Glu-Ser-Ser~SerJGly-Leu-
• I I ~ • I 




Fig. 2.12 The primary sequence of TMV protein showing the amino acid 
exchanges studied in this work and by du Plessis and van 
Regenmortel (1977). The residues marked by circles were 
studied in this work, and those marked by squares, by du 
Plessis and van Regenmortel. Solid I ine symbols indicate 
serologically distinguisable residues while dashed symbols 
indicate those residues which were not serologically distin-
guishable from TMV protein. 
2.5 IMMUNOCHEMICAL STUDIES WITH FIVE OF THE TRYPTIC PEPTIDES OF 
TMV PROTEIN 
2.5. I STUDIES WITH PEPTIDES IN THE TMV-ANTI TMV AND THE TMV PROTEIN-
ANTI TMV PROTEIN COMPLEMENT FIXATION SYSTEMS 
2.5. I. I COMPLEMENT FIXATION AS A MEANS OF TESTING THE IMMUNOCHEMICAL 
ACTIVITY OF PEPTIDES 
Antigen binding by certain classes and subclasses of antibody exposes 
a site on the Fe region of the antibody molecule which is able to 
bind the C' I protein complex and activate the complement cascade. 
When the antibody is specific for the eel I surface antigens of sheep 
erythrocytes this process results in eel I lysis. Complement fixation 
by soluble antibody-antigen complexes, in the absence of sheep eryth-
rocytes, leads to the inactivation of the initial products in the com-
plement cascade as they are labile unless membrane bound. The prin-
ciple underlying the complement fixation assay is the competition for 
complement between the primary reaction of antibody with soluble anti-
gen (which is being studied) and the later reaction of specific anti-
bodies with the membranes of the sheep erythrocytes (the indicator 
system). 
Both lgM and lgG antibodies are able to fix complement, but uni ike lgM, 
two adjacent molecules of lgG are required to Initiate this process. 
As virtually al I the antibodies in late-course antisera are of the lgG 
type, hapten binding wi I I not result in complement fixation, but wi I I 
cause a decrease in the amount of complement fixed in the presence of 
soluble antigen. The inhibition of complement fixation by the anti-
body and the intact antigen can be used as a measure of the haptenic 
activity of fragments of the antigen. 
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A particular peptide can behave in one of three possible ways with 
respect to complement fixation: If it has a single antigenic region 
it wi I I inhibit the complement fixation caused by its antigen and spe-
cific antibody. If it contains two or more antigenic regions it wi I I 
fix complement in its own right with the antibodies specific for the 
determinants of the whole antigen. Lastly, if the peptide is immune-
chemically inadtive it wi I I not affect complement fixation at al I. 
In the studies described below, it was found that a peptide with more 
than one antigenic region was able to react with antibodies specific 
for it and to fix complement, in the presence of the whole antigen, 
so to cause an enhancement of the complement fixation resulting from 
the reaction of the antigen with its antibodies. 
2.5. 1.2 COMPLEMENT FIXATION BY TMV AND TMV PROTEIN AND THEIR ANTISERA 
Both TMV- and TMV protein-antibody complexes were found to fix comple-
ment in microcomplement fixation assays (4.3.2), based on the method 
of Levine (Wasserman and Levine, 1961; Levine and van Vunakis, 1968), 
irrespective of whether whole sera or globulin preparations from sera 
(4.3. 1.3) were used. Serum titres, defined as that dilution of the 
antiserum which gave 75% fixation at the peak of the complement fixa-
tion curve (Champion et~., 1974), differed for the two antigens. 
The titres of TMV antisera in complement fixation assays with TMV were 
invariably high. They ranged from 1/1600 - 1/500G except for a glob-
ulin preparation which had been absorbed with TMV protein (4.3. I .2.2), 
to remove al I the anti-protein activity, where the titre was reduced 
to 1/500. The range of antigen concentrations associated with maxi-
mal complement fixation was 0,125 - 0,500 µg TMV/ml. 
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The titres of TMV protein antlsera were usually much lower than their 
antl-TMV counterparts, averaging 11300. The lowest titre encountered 
was 11250 for an anti-TMV protein globulin preparation which was absor-
bed with TMV (4.3.1.2.1) to remove all the anti-virus activity. Only 
one anti-TMV protein globulin preparation was outstanding in that it 
had a titre of 1/1250. The range of antigen concentrations associated 
with maximal complement fixation in the TMV~protein-anti TMV protein 
system was 0,063 - 0,500 µg/ml when whole sera or unabsorbed globulin 
preparations were used. The antl-TMV protein globul In preparation 
which was absorbed with TMV fixed the most in the 2,0 - 8,0 µg/ml anti-
gen range. 
Fig.s 2. 13 and 2. 14 i I lustrate the effect of antiserum dilution on 
complement fixation by the TMV-anti TMV and TMV protein-anti TMV pro-
tein immune systems respectively. In both cases increasing dilution 
of the antiserum caused a related reduction in the peak height of the 
complement fixation curves. When the peak height of the complement 
fixation curve is plotted against the logarithm of the antiserum di lu-
tion, a straight line with a slope characteristic for the particular 
immune system is obtained (Champion et.£..!_., 1974). 
defined by the equation 
y = m log x + b 
The s I ope Cm) is 
where y =%complement fixed at the peak of the curve, x = antiserum 
concentration expressed as the reciprocal of its dilution and b is the 
y- intercept. The slope for the TMV-anti TMV syst~m i I lustrated in 
fig. 2. 13 is m = 231, while the slope for the TMV protein-anti TMV pro-
tein system in fig. 2. I 4 is m = I I I . 
The consistent difference of the slopes obtained with the TMV-anti TMV 
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-3.2 -3.3 -3.4 
LOG SERUM DILUTION 
(A). Complement fixation curves with different dilutions 
of TMV antiserum. <•>l/1620, (0)1/1780, (,A)l/2000 and 
(.6.)1/2200. The test antigen was TMV. (B). Dependance of 
the peak height of the curves obtained in (A) on antiserum 
concentration. A slope, m=231, was calculated from the 
equation y=m log x + b where y = % complement fixed at the 
peak, x=antiserum concentration and b is they-intercept 






























-2.2 -2.3 -2.4 
LOG SERUM DILUTION 
(A). Complement fixation curves with different dilutions 
of TMV protein antiserum. <•>1/150, <D>l/175, (A)l/200 
and (.!:::,.)1/250. The test antigen was TMV protein. CB). 
Dependance of the peak height of the curves obtained in (A) 
on antiserum concentration. A slope, m=I I I, was calculated 
from the equation y=m log x + b where y= % complement fixed 
at the peak, x= antiserum concentration and b is the y-
intercept (Champion et al., 1974). (From Milton and van 
Regenmorte I, 1979). - -
2.5. 1.3 THE EFFECT OF PEPTIDES ON COMPLEMENT FIXATION BY TMV AND ITS 
ANT ISERA 
Increasing concentrations of tryptic peptide I (residues 1-41 ), 4 
(residues 62-68), 8 (residues 93-112), II (residues 135-f41) and 12 
(residues 142-158) were incubated with three late-course antisera from 
different rabbits, prior to the addition of TMV antigen, in complement 
fixation assays (4.3.2. 1.9). None of these peptides, even when pre-
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sent in amounts corresponding to 800 TMV equivalents (2.3.2), i.e. a 
molar excess of 1704000: I of peptide over virus, was able to cause any 
significant inhibition or enhancement of the complement fixation by TMV 
and its specific antibodies. 
The possibility existed that the lack of activity by any of the peptides 
was due to their combination with anti-TMV protein antibodies present 
in the TMV antisera because of virus breakup prior to, or after, injec-
tion of the immunogen. To rule out this factor, the same peptides were 
preincubated with an anti-TMV globulin preparation (4.3. I .3), which had 
been absorbed with TMV protein to remove al I the anti-protein activity 
(4.3. 1.2.2), before the addition of TMV to the complement fixation assay. 
Again the peptides failed to affect the fixation of complement by TMV 
and anti-TMV antibodies even when 800 TMV equivalents of peptide were 
used in the assay. 
2.5. I .4 THE EFFECT OF PEPTIDES ON COMPLEMENT FIXATION BY TMV PROTEIN 
AND ITS ANTISERA 
An antiserum dilution, giving approximately 70% maximum complement fix-
ation with TMV protein, was incubated at 37°C for 15 min with increasing 
concentrations of the four pH 4,5 soluble tryptic peptides, prior to the 
addition of antigen, in compelement fixation assays (4.3.2. 1.9). 
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Fig.s 2.15, 2. 16 and 2. 17 show the ab! llty of peptides 4 (residues 62-
68), 8 (residues 93-112) and 12 (residues 142-158) to inhibit complement 
fixation in this system. The specificity of the inhibition was estab-
llshed by showing that similar molar excesses of the various peptides 
caused no inhibition of complement fixation in a control system consis-
ting of H3 hlstone and anti-H3 serum (Sapieka et~., 1976). 
Fig. 2.18 shows the comparative inhibitory power of the four peptides. 
Peptide 12 demonstrated the most activity with 5,72 n-moles of peptide 
causing 80% inhibition of complement fixation. An equal amount of 
peptide 4 caused 72% inhibition while peptide 8 caused only 21% inhibi-
ti on. Peptide I I (residues 135-141) did not inhibit complement fixa-
tion significantly. 
When the peptides were used to inhibit complement fixation in a system 
comprising TMV protein and anti-TMV protein globulins (4.3. I .3), absor-
bed beforehand with TMV to remove al I the anti-virus activity (4.3. 1.2. I), 
the results were qua I itatively the same as for the whole serum. In 
fig. 2. 19 D it can be seen that I I ,43 n-moles of peptide 12 caused 90% 
inhibition of complement fixation with a cross-absorbed anti-TMV protein 
globulin preparation. Similarly, 22,87 n-moles of peptides 4 and 8 
caused 75% and 47% inhibition of complement fixation, respectively, with 
the same absorbed globulin preparation (fig. 2. 19 C and 0). 
The hapten inhibition caused by peptides 4,8 and 12 with both absorbed 
and whole anti-TMV protein sera points to the existence of a single 
antigenic region corresponding to an antigenic determinant or part the-
reof, in each of these peptides. Peptide I I, which showed no immuno-
logical activity, probably corresponds to a region of the TMV protein 




















0.031 0.125 0.500 2.000 
JIU TMV PROTEIN 
Inhibition of complement fixation in the TMV protein-
anti TMV protein system by tryptic peptide 4 (residues 
62-68). A TMV protein antiserum di luted 1/200 was used. 
Prior to the addition of TMV protein, the antiserum was 
incubated for 15 min at 37°C with the inhibitor. (0) 
no inhibitor, (11)0,29 n-moles of peptide equivalent to 
a 40 molar excess of peptide over TMV protein, ([j)0,57 
n-moles peptide equivalent to an 80 molar excess of pep-
tide over TMV protein, (.6.)2,86 n-moles of peptide equi-
valent to a 400 molar excess over TMV protein, and (~) 
5,72 n-moles of peptide equivalent to an 800 molar excess 
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0.031 0.125 0.500 2.000 
pg TMV PROTEIN 
Inhibition of complement fixation in the TMV protein-anti 
TMV protein system by tryptic peptide 8 (residue 93-112). 
A TMV protein antiserum di luted 1/200 was used. Prior to 
addition of the TMV protein, the antiserum was incubated 
for 15 min at 37°C with the inhibitor. Ce)no inhibitor, 
(())Q,30 n-moles of peptide equivalent to a 40 molar excess 
of peptide over TMV protein, ([])0,60 n-moles of peptide 
equivalent to an 80 molar excess of peptide over TMV protein 
(11)3,00 n-moles of peptide equivalent to a 400 molar excess 
of peptide over TMV protein, and c+)6,74 n-moles of peptide 






















0.031 0.125 0.500 2.000 
pg TMV PROTEIN 
Inhibition of complement fixation in the TMV protein-anti 
TMV protein system by tryptic peptide 12 (residues 142-148). 
A TMV protein antiserum di luted 1;200 was used. Prior to 
the addftion of TMV protef n, the antfserum was fncubated 
for 15 min at 37°c with the inhibitor. <elno inhibitor, 
(())0,29 n-moles of peptide equivalent to a 40 molar excess 
of peptide over TMV protein, <lll0,57 n-moles of peptide 
equivalent to an 80 molar excess of peptide over TMV protein, 
([])2,86 n-moles of peptide equfvalent to a 400 molar excess 
of peptide over TMV protein, and (.6.)5,72 n-moles of peptide 
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•o D D 
1.0 2.0 3.0 4.0 5.0 6.0 
n-MOLES PEPTIDE 
Inhibition of complement fixation in the TMV protein-anti 
TMV protein system by increasing quantities ?f TMV tryptic 
peptides. A TMV protein antiserum di luted /200 was used 
in all tests. (•)tryptic peptide 12, (Q)tryptic peptide 
4, <eltryptic peptide 8, and (0)tryptic peptide II. 




















Fig. 2. 19 
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(A). Enhancement of complement fixation in the TMV protein-
anti TMV protein system by peptide I (residues 1-41). <e)no 
enhancement, (A)0,29 n-moles of peptide per test, equivalent 
to a 40 molar excess of peptide over TMV protein, Cll)0,57 n-
moles of peptide per test, equivalent to an 80 molar excess 
of peptide over TMV protein, (,,.)2,86 n-moles of peptide per 
test, equivalent to a 400 molar excess of peptide over TMV 
protein, and <+)5,72 n-moles of peptide per test equivalent 
to an 800 molar excess of peptide over TMV protein. (8). En-
hancement of complement fixation in the TMV protein-anti TMV 
protein system by peptide I using a different antiserum from 
that in (A) (9)no enhancement, (A)0,72 n-moles of peptide 
per test, equivalent to a 200 molar excess of peptide over TMV 
protein, Cll)I ,43 n-moles of peptide per test, equivalent to a 
400 molar excess of peptide over TMV protein, and ('\")2,86 n-
moles of peptide per test, equivalent to an 800 molar excess 
of peptide over TMV protein. (C). Inhibition of complement 
fixation in the TMV protein-anti TMV protein syst~m by peptides 
I (residues 1-41) and 4 (residues 62-68) using a tMV protein 
antiserum absorbed with TMV. <e)no inhibitor, (A)l 1,43 n-mo-
les of peptide I per test, equivalent to a 100 molar excess of 
peptide over TMV protein, and <11)22,87 n-moles of pepti~e 4 
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per test, equivalent to a 200 molar excess of peptide over 
TMV protein. CD). Inhibition of complement fixation in 
the TMV protein-anti TMV protein system by peptides 8 (res-
idues 93-112) and 12 (residues 142-158) using a TMV protein 
antiserum absorbed with TMV. C9)no inhibitor, (•)22,87 
n-moles of peptide 8 per test, equivalent to a 200 molar 
excess of peptide over TMV protein, and (A.) 11 ,43 n-mo I es of 
peptide 12 per test, equivalent to a 100 molar excess of 
peptide over TMV protein. (Mi I ton and van Regenmortel, 
1979.) 
possible, however, that peptide I I contains too smal I a part of an anti-
genie determinant to react with antibodies. 
Peptide I (residues 1-41) did not inhibit complement fixation in the 
TMV protein-anti TMV protein system, but, on the contrary, enhanced it. 
In fig. 2. 19 A and B, the results obtained with two antisera show that 
increasing amounts of peptide I progressively raised the peak height of 
the complement fixation curve. However, this phenomenon was observed 
only with non-absorbed TMV protein antisera. When the same antiserum 
had been absorbed with TMV, I I ,43 n-mo I es of peptide I caused 96% in-
hibition of complement fixation (fig. 2.19 C). Thus it is expected 
that peptide I contains at least two antigenic regions of which only 
one is antigenic in the free TMV protein subunit. Antibodies specific 
for the other antigenic region were removed by the absorption of the 
serum with TMV so that peptide I could behave as a hapten with the absor-
bed serum. 
Two other TMV protein antisera have been examined in inhibition of com-
plement fixation experiments and the results were not substantially di ff-
erent from those i I lustrated in figs. 2.15 to 2.18. Although the amount 
of inhibition or enhancement caused by an equal molar excess of a partic-
ular peptide varied with each antiserum, the order, relative to each 
other, in which the peptides caused maximal inhibition remained the same. 
2.5.2 INHIBITION STUDIES WITH PEPTIDES IN THE TMV-ANTI TMV AND THE 
TMV PROTEIN-ANTI TMV PROTEIN PRECIPITIN SYSTEMS 
2.5.2. I THE MICRO-PRECIPITIN ASSAY WITH RADIOLABELLED ANTIGENS AS A 
MEANS OF TESTING THE IMMUNOCHEMICAL ACTIVITY OF PEPTIDES 
The advantages of inhibition studies with the precipitin systems con-
sisting of radio label led TMV and TMV protein and their antisera have 
been pointed out in sections 2.3.2 and 2.4.2 respectively. These 
advantages are equally applicable to inhibition studies with peptides. 
In both systems only the specific reaction of the radio label led anti-
gen and its antibodies is measured without having to absorb the anti-
sera. Any inhibition by a peptide would therefore be specific inhi-
bition of the binding of a particular antigenic determinant of the 
system, be it TMV-anti TMV or TMV protein-anti TMV protein. Cross-
reactions between the peptides and contaminating antibodies (due to the 
depolymerization of the virus or aggregation of the protein in the ani-
mal after immunization) cannot be measured. This means that more pep-
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tide would be required for the same amount of inhibition than would be 
the case with an absorbed serum, but, on the other hand, antibodies which 
react with the same determinant in both the virus and the protein subunit 
are not lost. 
The method of antiserum titration is given in section 4.3.4.2.5 and typi-
cal curves of the amount of radio label led antigen in the supernatant of 
the micro-precipitin system are shown in Figs. 2.8 and 2. 10. An expla-
nation of the shape and nature of the curves is given in sections 2.3.2 
and 2.4.2 respectively. 
2.5.2.2 THE EFFECT OF PEPTIDES ON THE PRECIPITIN REACTION OF RADIO-
LABELLED TMV AND ITS SPECIFIC ANTIBODIES 
Increasing concentrations of tryptic peptide I (residues 1-41 ), 4 
(residues 62-68), 8 (residues 93-112), II (residues 135-141) and 12 
(residues 142-158) as we! I as mixtures of these peptides and even a 
whole tryptic digest of the TMV protein were incubated with 0,5 ml of 
five late-course antisera, from different rabbits, prior to the addi-
tion of 0,5 µg of radiolabel led TMV in micro-precipitin assays 
(4.3.4.2.6). The antisera had previously been titrated with radio-
label led TMV (4.3.4.2.5) and the antiserum dilutions giving antibody: 
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antigen proportions in the zone of antigen excess, near the equivalence 
point, had been chosen so that the system would be most sensitive to 
inhibition (2.3.2). In no case, either with the individual, or a com-
bination of peptides, could any significant inhibition of the specific 
radio label led TMV-anti TMV reaction be detected, even when the peptides 
were present in amounts corresponding to 8000 TMV equivalents (2.3.2), 
i.e. a molar ratio of 1,7 x 107:1 of peptide over vims. A 11 of the-
se sera had been used for micro-precipitin assays with radio label led 
TMV which had been successfully inhibited by unlabelled TMV protein at 
pH 6,8 (2.3.3), the same pH at which the peptide inhibition studies were 
carried out. 
Asimilar situation was encountered when attempts were made to inhibit 
the TMV-anti TMV reaction with peptides in the complement fixation sys-
tem ( 2. 5. I . 3) . 
2.5.2.3 THE EFFECT OF PEPTIDES ON THE PRECIPITIN REACTION OF RADIO-
LABELLED TMV PROTEIN AND ITS SPECIFIC ANTIBODIES 
A TMV protein antiserum was titrated with radiolabel led TMV protein 
(4.3.4.2.5) and a dilution was chosen to give antibody:antigen 
II I 
proportions in the zone of antigen excess, near the equivalence point, 
so that the system would be most sensitive to inhibition (2.4.2). In-
creasing amounts of the five tryptic peptides were incubated with 0,5 ml 
of the antiserum dilution prior to the addition of 0,5 ug of radiolabe-
1 led TMV protein in micro-precipitin assays (4.3.4.2.6). Fig. 2.20 
shows the ability of tryptic peptides I (residues 1-41 ), 4 (residues 62-
68), 8 (residues 93-112) and 12 (residues 142-158) to inhibit the speci-
fic reaction between radio label led TMV protein and anti-TMV protein 
antibodies. 
Peptide I demonstrated the most activity with 57,6 n-moles of peptide 
(equivalent to a molar excess of 1600: I over TMV protein) causing 60% 
1nhibit1on of the precipitin reaction. An equal amount of peptide 
12 caused 33% inhibition, while peptides 4 and 8 caused 20% and 18% 
respectively. At the lower peptide concentrations the difference in 
the inhibition caused by peptides 4 and 8 was more evident. Peptide 
I I (residues 135-141) did not inhibit the reaction of anti-TMV protein 
ant1bod1es and the radiolabel led TMV protein significantly. The com-
parative inhibitory power of the four pH 4,5 soluble tryptic peptides 
was the same as was found when these peptides were used to inhibit co-
mplement fixation by TMV protein and its antisera (2.5. I .4). 
The specificity inherent in the micro-precipitin assay system with 
radiolabel led TMV protein (2.4.2) points to each of the active peptides 
containing an antigenic region corresponding to an antigenic dete~i­
nant of the TMV protein subunit, and these results confi~ the conclu-
sions reached from the inhibition of complement fixation experiments 
with a TMV protein antiserum absorbed with TMV (2.5.1 .4). In addi-
tion, the comparatively large inhibition caused by peptide I in this 
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n-MOLES PEPTIDE 
Inhibition of the precipltin reaction of 0,5 µg radio-
label led TMV protein and its specific antibodies by 
increasing amounts of TMV tryptlc peptides. A TMV 
protein antiserum di luted 1/128 was used in al I tests. 
Prior to the addition of the radiolabel led antigen 
the antiserum was incubated for 15 min at 37°C with 
the inhibitors and then left at +4°C for 17 hours. 
(~) tryptic peptide I <residues 1-41), <•) tryptlc 
peptide 12 (residues 142-158), (()) tryptlc peptide 4 
(residues 62-68), <•) tryptlc peptide 8 (residues 
93-112), and <0) tryptic peptide II (residues 135-141>. 
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system points to the conclusion that its second antigenic region is 
recognized by antibodies which can bind this region in both the intact 
virus and the protein subunit, as these antibodies are removed by ab-
sorption with TMV (2.5.1.4 and Fig. 2.19 Band C). 
Two other TMV protein antisera have been examined in micro-precipitin 
assays with peptide inhibitors. The results obtained were not sub-
stantially different from those i I lustrated in Fig. 2.20 although the 
amount of inhibition caused by an equal molar excess of a particular 
peptide varied with each antiserum. 
2.5.3 BINDING STUDIES WITH N-(3H)ACETYL PEPTIDES 
2.5.3. I THE VALUE OF THE DIRECT BINDING ASSAY 
A peptide that contains an antigenic region wi I I be bound by anti-
bodies specific for the corresponding antigenic determinant on the 
intact protein to form soluble antibody-hapten complexes, so long as 
the peptide conformation cah be induced to fit the antibody binding 
site (Atassi, 1977 b). In this system there is no competition be-
tween the peptide and the conformationally intact antigenic determi-
nant, as there is in inhibition experiments, so, low affinity peptide-
antibody binding should be more apparent if the amount of bound pep-
tide can be quantitated. This can be accomplished by attaching a 
radioactive label to the peptide and precipitating the soluble immune 
complexes. 
The double-antibody method for separating the hapten-antibody complexes 
from the free hapten is sensitive, gentle and does not disturb the 
equi I ibrium to any significant extent (Ransom, 1976). It is based on 
the finding that the antigenic sites of an antibody are separate from 
its binding site and, therefore, an antibody molecule can form a complex 
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with its antigen and then itself be complexed to a second antibody spe-
cific for it <Hunter, 1978). 
A particular disadvantage of this method with respect to the tryptic 
peptides of TMV protein, studied in this work, is that peptide I (res-
idues 1-41) already has an acetyl group blocking its N-terminus. It 
therefore cannot be acetylated with tritiated acetic anhydride as the 
four pH 4,5 soluble tryptic peptides of TMV protein can be. 
2.5.3.2 THE LABELLING OF FOUR pH 4,5 SOLUBLE TRYPTIC PEPTIDES WITH 
3H-ACETIC ANHYDRIDE 
Tryptic peptides 4 (residues 62-68), 8 (residues 93-112), 11 (resi-
dues 135-141) and 12 (residues 142-158), as wel I as a synthetic pep-
tide corresponding to residues 134-141 of the TMV strain U2 Ca region 
equivalent to peptide I I in the common strain), were acetylated with 
tritiated acetic anhydride (4.3.3.2) by the method of Benjamini et~., 
( 1965). 
The molar concentrations of the acetylated derivatives of the peptides 
were determined by amino acid analysis (4.2.2) and their specific acti-
vi ties as described in section 4.3.3.1. Typical activities of the 
peptides were: peptide 4 = 1718007 cpm/n-mole; peptide 8 = 149523 
cpm/n-mole; peptide I I 2365957 cpm/n-mole; peptide 12 = 403653 cpm/ 
n-mole; and the synthetic peptide octomer = 1060195 cpm/n-mole (4.3.3.2). 
2.5.3.3 THE BINDING OF N-C 3H)ACETYL PEPTIDES TO ANTIBODIES 
Typical results of the direct binding assays (4.3.3.3) using the glob-
ulin fraction (4.3.1 .3) of TMV and TMV protein antisera are summarized 
in Tables 2.4 and 2.5. In an attempt to determine the contribution of 
TOTAL SPECIFIC of PEPTIDE /0 
GLOBULINS RABBIT cpm/TEST cpm/TESTa BOUND 
anti-TMV protein I 140b 31 0,48 
144b 34 0,55 
II 2 155 71 I , 14 
.... 164 80 I ,29 
II 3 139 22 0,33 
137 20 0,31 
II 4 123 22 0,36 
129 29 0,45 
II 5 237 61 0,4 
anti-TMV protein 
absorbed with TMV 5 250 76 0,5 
anti-TMV 6 196 0 <0,05 
II 7 II I 7 <0,05 
II 8 212 36 0,2 
anti-TMV absorbed 
with TMV protein 8 176 0 <0,05 
aRabbit globulins obtained from unimmunized animals and animals 
immunized with human serum albumin served to establish the degree 
of non-specific binding which was subtracted from the total cpm. 
bResults obtained in duplicate experiments with globulins from 
rabbits 1-4 are presented in order to i I lustrate the reproducib-
i I ity of measurements. 
Table 2.4 Binding of N-<
3H)acetyl tryptic peptide 8 (residues 93-
112) to specific TMV and TMV protein antibodies. 
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virus-specific and protein-specific antibodies to the overal I reacti-
vity of the antisera, the sera were also tested after absorption with 
depolymerized protein or intact formal inized virus (van Regenmortel 
and Lelarge, 1973) as described in section 4.3. 1.2. 
The results obtained with tryptic peptide 8 (residues 93-112) are 
shown in Table 2.4. The amount of label led peptide specifically 
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bound by different TMV protein antisera varied between 0,31 and I ,29% 
of the amount used in the test. Absorbing a particular serum with 
virus did not affect its ability to bind the peptide. On the other 
hand, the prior absorption of a TMV antiserum with TMV protein subunits 
reduced the amount of binding to an insignificant level. Most of the 
anti-virus sera examined showed no significant binding of label led pep-
tide 8. These results suggest that the peptide 8 determinant is func-
tional only in the TMV protein-anti TMV protein system, i.e. that it 
is a cryptotope. 
The specificity of the antibody binding of label led peptide 8 was dem-
onstrated by inhibition wi~h unlabelled peptide 8 (Fig. 2.21 ). Even 
the smal I amount of binding (0,6%) obtained with the antiserum from 
rabbit no. I could be inhibited by increasing concentrations of unlab-
elled peptide 8. This i I lustrates that the low percentage binding 
obtained with certain antisera is nevertheless significant. 
Table 2.5 shows the results of binding assays with the remaining N-( 3H) 
acetyl peptides. The amount of label led peptide bound varied with each 
particular antiserum. By comparing the abi I ity of a single antiserum 
to bind various peptides, it can be seen that peptide 12 (residues 142-









TOTAL SPECIFIC % PEPTIDE 
GLOBULINS RABBIT cpm/TEST cpm/TEST BOUND 
anti-TMV protein 2 2058 1332 I ,8 
" 3 1270 544 0,8 
" 9 2045 1319 I ,8 
" JO 1027 301 0,4 
" 5 1825 . 1099 1,5 
anti-TMV protein 
absorbed with TMV 5 1773 1047 I , 5 
anti-TMV 6 831 105 O, I 
" 8 1274 548 0,8 
anti-TMV absorbed 
with TMV protein 8 747 22 <0,05 
anti-TMV 6 802 167 0, I 
" 8 697 62 >0,05 
anti-TMV absorbed 
wl th TMV protein 8 679 43 <0,05 
anti -U2 protein 13 546 326 0, I 
" 14 470 0 <0,05 
anti-U2 I I 548 45 <0,05 
II 12 503 3 <0,05 
anti-TMV 8 516 17 <0,05 
anti-TMV absorbed 
with TMV protein 8 515 15 <0,05 
anti-TMV protein 10 1015 814 4,8 
" 5 2720 2496 14,7 
anti-TMV protein 
absorbed with TMV 5 1940 1716 I 0, I 
anti-TMV 6 281 81 0,5 
II 8 1185 962 5,7 
anti-TMV absorbed 
with TMV protein 8 532 309 I ,8 
Binding of N-< 3H)acetyl peptides 4 (residues 62-68), 
II <residues 135-141), 12 (residues 142-158) and the 
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n-MOLES UNLABELLED PEPTIDE 8 
Specific inhibition of the antibody binding of N-C 3H> 
acetyl peptide 8 (residues 93-112) by unlabelled peptide 
8. The amount of N-C 3H>acetyl peptide 8 bound by spec-
ific antibodies, expressed as the percentage of 0,042 n-
mole, decreases in the presence of increasing concentra-
tions of unlabelled peptide 8. 
II 8 
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peptide 8 (Tables 2.5 and 2.4). Peptide I I (residues 135-141) and the 
synthetic octomer (residues 134-141) of the U2 strain of TMV showed 
some weak activity only with certain anti-TMV sera and it is difficult 
to ascertain the significance of these low figures. Peptide I I was 
found unable to inhibit the TMV protein-anti TMV protein reaction by 
complement fixation (2.5.1 .4) and micro-precipitin assays (2.5.2.3). 
. 3 
N-( H)acetyl peptide 4, I ike peptide 8, showed more binding with anti-
TMV protein sera than with anti-TMV sera. Absorption of an antl-TMV 
protein serum with virus did not affect the abi I ity of the antibodies 
to bind peptide 4, whereas the absorption of an anti-TMV serum with 
protein subunits reduced the amount of binding to an Insignificant 
I eve I. This indicates that the determinant in peptide 4 probably 
also functions as a cryptotope. 
With pepti~e 12 it was found that both the absorption of a TMV anti-
serum with protein subunits, and the absorption of a TMV protein anti-
serum with virus, caused a decrease in the amount of binding observed. 
However, as the amount of residual binding after cross-absorption was 
sti I I considerable, it appears that peptide 12 is recognized by both 
anti-TMV and anti-TMV protein antibodies. It should be emphasized that 
the binding observed with peptide 12, which ranged from 4,18-14,7% with 
different whole antisera, was at least twice, and at most seven times, 
as great as that of any of the other active peptides. 
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2.6 IMMUNOCHEMICAL STUDIES WITH MUTANT HOMOLOGUES AND A DERIVATIVE 
OF THE ACTIVE TRYPTIC PEPTIDES OF TMV PROTEIN 
2.6.I IMMUNOCHEMICAL STUDIES WITH TRYPTIC PEPTIDES FROM TMV MUTANTS 
2.6.I. I TRYPTIC PEPTIDES FROM TMV MUTANTS AS A MEANS OF LOCATING AMINO 
ACID RESIDUES THAT FORM PART OF ANTIGENIC DETERMINANTS 
In section 2.4. I a strategy was outlined whereby the role of specific 
amino acid residues in the antigenicity of TMV protein could be deter-
mined. The abi I ity of the proteins of six TMV mutants to inhibit the 
precipitin reaction of radiolabel led TMV protein and its specific anti-
bodies was compared with that of unlabelled TMV protein (2.4.3). In 
the second part of the strategy, tryptic peptides containing the amino 
acid exchanges which caused the antigenic behaviour of the mutant pro-
teins to be altered, were compared with the active peptides from wi Id 
type TMV using the same system, viz. inhibition of precipitation be-
tween radiolabel led TMV prot~in and the same TMV protein antisera. Mu-
tant peptides which display inhibitory behaviour not significantly diff-
erent from the wi Id type peptide, even though the whole protein was ser-
ologically distinguishable from TMV protein, would suggest a particular 
amino acid exchange exerts its influence through conformational modula-
tion of the whole protein, although it is not proof that this is the case 
(3.2). On the other hand, a decrease in inhibition relative to the ac-
tive wi Id type peptide indicates that the exchange of a particular resi-
due makes the recognition of the antigenic region in that peptide more 
difficult for the antibodies specific for the corresponding antigenic 
determinant on the TMV protein. Because it is improbable that the con-
formational state of the peptide wi I I approach the native mode of fold-
ing of that region of the protein sequence (Atassi and Singhal, 1970; 
Atassi, 1977 b), especially in the case of the shorter peptides which 
have less than twenty amino acids, it can be assumed that a change in 
the immunochemical behaviour of a mutant peptide implicates that par-
ticular residue in the antigenic region of the peptide. The validity 
of this assumption can be tested by immunochemical studies with over-
lapping synthetic peptides corresponding to the proposed antigenic re-
g i on (At ass i , I 9 7 5 , I 9 7 7 b ) . 
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2.6. 1.2. A COMPARISON OF THE IMMUNOCHEMICAL BEHAVIOUR OF WILD TYPE AND 
TMV MUTANT TRYPTIC PEPTIDES BY PRECIPITIN INHIBITION ASSAYS WITH RADIO-
LABELLED TMV PROTEIN 
The inhibition assays were performed exactly as described in sections 
2.4.2 and 2.4.3 using the same antisera. Figs. 2. I I and 2.22 - 2.25 
i I lustrate the inhibition of the precipitin reaction of radiolabel led 
TMV protein caused by the unlabelled TMV protein and the mutant pro-
teins as wel I as the wi Id type and mutant peptides with the same pooled 
bleedings of antiserum from a single rabbit. 
therefore comparable. 
The results shown are 
Fig. 2.22 shows the inhibition obtained with the I-peptide (residues 1-
41 ), peptide I of Ni 118 <praline in position 20 replaced by leucine) 
and peptide I of Ni 568 (threonine in position 5 replaced by isoleucine). 
No significant difference between the inhibition caused by these three 
peptides is evident, even though Ni 118 protein and Ni 568 protein are 
serologically distinguishable from TMV protein (2.4.3). Asimilar situa-
tion was encountered with TMV peptide 8 (residues 93-112) and Ni 568 pep-
tide 8 (threonine in position 107 replaced by methionine), which also 
gave inhibition curves that were not significantly different (fig. 2.24). 
This is in accord with the findings of Benjamini and co-workers (Young et 
2..!_., 1968; Benjamini et 2..!_., 1969) who defined the antigenic region in 
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n-MOLES PEPTIDE 
Inhibition of the precipitin reaction of 0,5 µg radio-
1 abel led TMV protein and its specific antibodies by 
increasing amounts of tryptic peptide I (residues 1-41) 
from TMV (8), Ni 118 (0) and Ni 568 (..6:.). No signifi-
cant difference in the amount of inhibition caused by 
these peptides was discernable. A 1/128 dilution of a 
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n-MOLES PEPTIDE 
Inhibition of the precipitin reaction of 0,5 µg of radio-
label led TMV protein and its specific antibodies by 
increasing amounts of tryptic peptide 4 (residues 62-68) 
from TMV ( •), 414 ( 0) and Ni 1688 ( .6.). The peptides 
from the two mutant viruses are less successful inhibitors 
of the TMV protein-anti TMV protein reaction than the 
corresponding peptide from the wi Id type virus. A 1/128 
dilution of a TMV protein antiserum was used in al I tests. 
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From these results it must be concluded that the amino acid exchanges 
in the mutant proteins of Ni I 18 and Ni 568 are likely to exert their 
influence on immunochemical behaviour by altering the protein confor-
mation sufficiently to affect the shape of one or more of the protein's 
antigenic determinants, but not sufficiently to affect the other bio-
logical properties of the proteins (3.2). 
The situation with the mutant peptides homologous with peptides 4 and 
12 was found to be completely different. Fig. 2.23 shows that peptide 
4 (residues 62-68) of the mutants 414 and Ni 1688 have a reduced abi-
1 ity to inhibit the TMV protein-anti TMV protein reaction compared with 
wi Id type peptide 4. 57,6 n-moles of peptide 4 from the mutant 414 
(serine in position 65 replaced by glycine) caused only 16% inhibition, 
compared to 38% inhibition by wi Id type peptide 4, while no significant 
inhibitioh was obtained with peptide 4 of the mutant Ni 1688 (praline 
in position 63 replaced by serine). Similarly, 28,8 n-moles of peptide 
12 from the mutants Ni 1688 and Ni 1927 Cproline in position 156 repla-
ced by leucine In both cases) caused 20% inhibition compared to 39% 
inhibition by wi Id type peptide 12 (residues 142-158) (Fig. 2.25). The 
inhibition curves of the two identical mutant peptide homologues of pep-
tide 12 are not significantly different and the "tai loft" seen at the 
highest peptide concentration is probably due to the reduced solubi I ity 
of the mutant peptides causing aggregate formation. 
The result with peptide 4 of the mutant 414 was remarkable in that the 
whole protein was not serologically distinguishable from TMV protein 
(2.4.3). This could be due to a "masking effect" caused by the other 
antigenic determinants on the rest of the TMV protein subunit reacting 

















10 20 30 40 50 
n-MOLES PEPTIDE 
Inhibition of the precipitin reaction of 0,5 µg of radio-
label led TMV protein and its specific antibodies by incr-
easing amounts of peptide 8 (residues 93-1 12) from TMV 
Ce) and Ni 568 (6). No significant difference in the 
amount of inhibition caused by these two peptides was dis-
cernable. A 1/128 dilution of a TMV protein antiserum 
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n-MOLES PEPTIDE 
Inhibition of the precipitin reaction of 0,5 µg of radio-
label led TMV protein and its specific antibodies by increa-
sing amounts of tryptic peptide 12 <residues 142-158) from 
TMV <e), Ni 1927 (0) and Ni 1688 (.0.). The two identical 
peptides from the mutant viruses cause the same amount of 
inhibition which is nevertheless smaller than the inhibition 
caused by the corresponding peptide from the wi Id type virus. 
A 1/128 dilution of a TMV protein antiserum was used in al I 
tests. 
127 
difference in inhibition (about half the inhibition of the wi Id type pep-
tide) caused by the replacement of serine (residue 65) by glycine in a 
single determinant out of five (van Regenmortel and Lelarge, 1973) may 
be beyond the sensitivity of the micro-precipitin inhibition assay (3.2). 
The difference in the abi I ities of Ni 1688 and Ni 1927 protein to in-
hibit the reaction of radiolabel led TMV protein and its antibodies 
(4.2.3) is easily understood in terms of the results with the mutant 
peptidehomologues of peptide 4 and 12. Although these two mutants 
share the amino acid exchange of praline to leucine in position 156, 
it is the replacement of prol ine by serine in position 63 that causes 
the decrease in inhibition by Ni 1688 protein relative to Ni 1927 
p rote i n (Fig. 2. I I B) . 
2.6.2 A COMPARISON OF THE IMMUNOCHEMICAL BEHAVIOUR OF CARBOXYPEPTIDASE 
A TREATED PEPTIDE 12 (BESIDUES 142-157) WITH WILD TYPE PEPTIDE 12 (RESI-
DUES 142-158) BY PRECIPITIN INHIBITION ASSAY WITH RADIOLABELLED TMV 
PROTEIN 
Peptide 12 (residues 142-158) was treated with carboxypeptidase A 
( 4. 1.5 and 2. 1.4 ) in order to remove the C-terminal threonine resi-
due (tab le 2.2). The immunochemical behaviour of this derivative (resi-
dues 142-157) was compared with that of wi Id type peptide 12 using a 
micro-precipitin inhibition assay with radio label led TMV protein and a 
TMV protein antiserum. The antiserum was titrated and the inhibition 
assay was performed as described in section 4.3.4.2. 
Fig. 2.26 shows that the inhibition of the radiolabel led TMV protein-
anti TMV protein reaction caused by the wi Id type peptide 12 and the 
derivative, from which the C-terminal threonine had been removed, was 
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Inhibition of the precipltin reaction of 0,5 µg radio-
label led TMV protein and its specific antibodies by 
Increasing amounts of peptide 12 (residues 142-158) from 
TMV (ft) and a derivative of tryptlc peptide 12 from 
which the C-terminal threonine had been removed (resi-
dues 142-157) (6). No significant difference in the 
amount of Inhibition caused by these two peptides was 
dlscernable. A 1/128 dilution of a TMV protein anti-
serum was used In the tests. 
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to a molar excess of 25-400:1 of peptide over TMV protein. It is, there-
fore, unlikely that the threonine residue in position 158 at the C-termi-
nus of the protein is a part of the cryptotope that is located in peptide 
12. 
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PART 3. DISCUSSION 
3. I EVALUATION OF THE IMMUNOCHEMICAL TECHNIQUES USED TO DETERMINE 
THE ACTIVITIES OF PEPTIDES 
Of the three immunochemical techniques used for demonstrating the 
antigenic activity of TMV peptides, inhibition of the micro-complement 
fixation system (Wasserman and Levine, 1961) (2.5. 1.4) proved to be 
the most sensitive. The molar concentrations of the reactants in the 
-9 complement fixation system were found to average 2xl0 moles/liter, 
a value which compares wel I with the results from other laboratories 
using this technique (Reichlin and Noble, 1977). This sensitivity, 
which means that immunochemical activity can be detected even with 
I 
very smal I amounts of peptide, results from the amplification effect 
which is implicit in the complement fixation system. It is thought 
to result from a smal I number of immune complexes causing the inacti-
vation (fixation) of large numbers of early complement components, so 
preventing their participation in the lysis of sheep erythrocytes. 
When the formation of some of these immune complexes is inhibited by 
a peptide, the early complement proteins, which would normally be un-
available, can be activated by the haemolysin antibodies bound to the 
erythrocytes to cause extensive lysis. The high inhibitions obtained 
with individual peptides (2.5.1.4 - fig. 2.18) must be seen in the 
context of the serum dilution used in the complement fixation assay. 
A quantJtati.ve measure of the proportion of the complement fixing anti-
body population, that reacts with a particular peptide, is the difference 
between the two serum dilutions that cause an equal amount of complement 
fixation in the presence of a fixed quantity of peptide. It was pro-
bably this amplification effect which caused Benjamini and co-workers to 
conclude (Benjamini et~' 1964; Benjamini, 1977) that peptide 8 con-
tained the immunodominant an~igenic determinant of the TMV protein. 
- --- .. -~----~~~ 
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anti gen. Antibodies specific for an antigenic determinant bind the 
corresponding random coi I peptide with less affinity than they would 
the same region of the polypeptide chain in the protein and thus the 
resultant antibody-peptide complexes would dissociate more readily. 
As a result of this, the quantity of peptide bound by antibody, at a 
specific time, may be smal I, even though a considerable amount of bind-
Jng has taken place during the experiment. 
':::i 
Another explanation for the low percentage binding with the N-< 3H)acetyl 
peptides could be framed in terms of the concept of a conformational 
equilibrium of protein fragments in solution (Sachs et~., 1972; Habeeb, 
1977) • However, this hypothesis may not be applicable to al I peptide 
solutions (3.2). 
The value of the direct binding technique lies in the fact that it provi-
ded evidence of activity in peptides that appeared to be inactive in in-
hibition experiments: Antibodies reactive with N-< 3H)acetyl peptide 12 
could only partly be removed from the TMV antisera by absorption with 
TMV protein using this technique (2.5.3.3 - table 2.5). No in h i bi tory 
activity could be detected .with this peptide, though it has a known 
viral determinant (Harris and Knight, 1955; von Sengbusch and Wittmann, 
1965; von Sengbusch, 1965; and van Regsnmortel, 1967), in the TMV-anti 
TMV system with either complement fixation, using TMV protein absorbed 
sera, or the micro-precipitin technique. Direct binding tests may thus 
be of considerable importance for elucidating the nature of antigenic 
determinants in viruses and perhaps other antigens with quaternary 
structure. 
The sensitivity of the direct binding technique is comparable with that 
of microcomplement fixation and the micro-precipitin assay in that the 
molar concentrations of the reactants was of the order of 10-8 
moles/liter. It must be borne in mind, however, that the percentage 
bindings of the individual N-< 3Hlacetyl peptides were smal I. 
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3.2 SUMMARY AND. INTERPRETATION OF THE IMMUNOCHEMICAL RESULTS IN TERMS 
OF THE KNOWN STRUCTURE OF THE TMV PROTEIN SUBUNIT 
A diagrammatic representation of the course of the polypeptide chain of 
the TMV protein subunit (Bloomer et~., 1978), showing the locations 
of five of the tryptic peptides used in this work, is given in fig. 3.1 
and wi 11 be referred to throughout the ensuing discussion. The approx-
imate locations of the residues where amino acid exchanges have occurred 
in the TMV mutants that were used, as wel I as the threonine residue in 
position 158, that was removed from peptide 12 (residues 142-158), are 
also indicated. 
Peptide I (residues 1-41) was remarkable in that it could react with 
antibodies of a TMV protein antiserum to fix complement (2.5. I .4 -
fig. 2.19). This effect was not due to aggregation of the peptide, 
as the same preparation of peptide I was able to inhibit complement 
fixation in the normal manner, when the TMV protein antiserum had first 
been absorbed with TMV to remove antibodies capable of reacting with the 
intact virus. This suggests that peptide I contains two seperate 
antigenic regions: one being a cryptotope (1.2.1), while the other is 
recognized by antibodies capable of binding to the viral capsid. 
In an antiserum raised against TMV protein, antibodies specific for 
cryptotopes, neotopes and determinants common to both virus and depolym-
erized protein subunits can exist ( 1.2.3). If two lgG antibodies, 
peptide 8 










Fig. 3. I : A diagramatic representation of the secondary and tertiary 
structure of the TMV protein subunit in the 20S disk. The 
four approximately para I lel helices are represented as cyl-
inders (based on Bloomer et al., 1978; Argos et al., 1977). 
The regions of the polypeptide chain shown inl)lack repre-
sent the five tryptic peptides used in this study. The 
approximate locations of the amino acid exchanges of the 
mutants are shown as numbered open circles. The portion 
of the protein subunit that is exposed in the viral capsid 
is beneath the dotted Ii nes. · 
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with anti-cryptotope and anti-viral specificities, respecti-vely, were 
to bind to a single peptide, the resultant immune complex would be ca-
pable of fixing complement. Absorption of the antiserum with TMV 
would remove the antibodies capable of reacting with both virus and 
peptide and only the antibodies specific for cryptotopes would remain. 
With respect to the absorbed TMV protein antiserum, peptide I would 
then behave as a monovalent hapten and cause inhibition of complement 
fixation. (Milton and van Regenmortel, 1979.) 
The first 5-6 residues of peptide I have been shown to be located on 
the surface of the protein subunit in the 205 disk <Bloomer et~., 
1978) and this is likely to be the case in the viral helix as wel I 
(Graham and Butler, 1978). This region, therefore, is most likely to 
contain the antigenic site that is recognized by anti-viral antibodies 
as no other part of peptide I is close enough to the viral surface. 
The cryptotope of peptide is likely to be found in the C-terminal 
half of the peptide which is hidden by neighbouring subunits in the 
viral helix (Milton and van Regenmortel, 1979). 
Whether the N-terminal antigenic region of peptide I is a neotope or a 
determinant common to both virus and depolymerized protein subunit, is 
st i I I in doubt. The amount of enhancement of complement fixation 
caused by peptide I with TMV protein antisera <2.5. 1.4 - fig. 2. 19), 
as wel I as the results obtained with the precipitin inhibition experi-
ments with radiolabel led TMV protein, where peptide invariably caused 
inhibition almost twice as great as that of any other single peptide 
(2.5.2.3 - fig. 2.20), suggests that this determinant is common to both 
the intact virus and the depolymerized protein subunit. The results 
obtained in the inhibition of the precipitin reaction with radio label led 
TMV protein (2.5.2) seem to support this conclusion, as antibodies to 
neotopes are not measured by this technique. The high level of inhi-
bition caused by peptide I was taken to represent the involvement of 
antibodies specific for both antigenic regions of the peptide. 
On the basis of ·this argument it was expected that a homologue of 
peptide I from the TMV mutant Ni 568, where the threonine in position 
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5 is replaced by isoleucine, would not react as wei I with antibodies 
specific for the depolymerized protein subunit as the wi Id type peptide. 
However, the mutant peptide was found to inhibit the precipitin react-
ion of radiolabel led TMV protein and its specific antibodies to the 
same extent as the wild type peptide I (2.6.1.2 - fig. 2.22). Unless 
the N-terminal antigenic determinant of peptide is less than five 
amino acids in size, or the replacement of threonine by isoleucine 
does not affect antibody recognition of this site - and both these 
explanations seem unlikely in terms of current knowledge of antigenic 
determinants <Atassi, 1977 b; 1978) - the possibi I ity of the N-termi-
nal region (residues 1-5) of the TMV protein subunit comprising a 
neotope (1.2. I) of the viral caps id, must be considered. 
On the other hand, it is possible that in TMV protein antisera the pro-
portion of antibodies specific for the peptide I cryptotope is very 
large compared to the antibodies specific for the antigenic site in 
the region of residues 1-5. The effect of the replacement of serine 
by isoleucine, in position 5, would then be minimized and may not even 
be distinguishable with cetain antisera using the micro-precipitin 
technique. Further immunochemical studies with the isolated N-terminal 
and C-terminal regions of peptide I are needed to resolve this question. 
In the preliminary experiments, an attempt was made to obtain two pep-
tides (corresponding to the sequences 1-19 and 20-41 respectively) 
which would contain the cryptotope and the viral antigenic determinant 
of peptide I on seperate polypeptide chains. TMV protein and peptide 
I were hydrolysed in 66% (v/v) formic acid solution to cleave the 
aspartyl-proline ~ond between residues 19 and 20 (Baltz and van Regen-
mortel, 1974). Unfortunately, neither of these two peptides was sol-
uble under the conditions of the assay (2. 1.4). 
The bend in the polypeptide chain at the beginning of the LS a-helix 
may be regarded as a likely location for the cryptotope in peptide I, 
especially in view of the reported strong inhibition of the TMV-anti 
TMV precipitin reaction by a peptide corresponding to residues 18-23 
(Anderer, 1963 b). It is not clear how this result can be reconciled 
with the known location of residues 18-23 away from the surface of the 
virus rod (Stubbs et~., 1977; Bloomer et~., 1978). It is possi-
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ble that contamination of the antivirus precipitin system with depolym-
erized viral subunits is responsible for this effect. The prate in of 
the TMV mutant Ni 118, which has a single amino acid exchange, praline 
to leucine in position 20, was found to be distinguishable from the 
wi Id type TMV protein by its reduced ability to inhibit the precipita-
tion of radiolabel led TMV protein by anti-TMV protein antibodies 
(2.4.3 - fig. 2.11). The Ni 118 homologue of peptide I, however, 
caused inhibition that was not significantly different from wild type 
peptide I in the same system (2.6.1.2 - fig. 2.22). This binding can 
be explained if it is assumed that although the amino acid exchange in 
position 20 causes a conformational change in the protein, the same 
exchange does not affect the conformation of the peptide to the same 
extent owing to its random coi I structure. Thus the replacement of 
.. /_,,-, 
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praline by leucine in the protein would exert its influence on the anti-
genicity by modulating the conformation of neighbouring residues that 
are part of an antigenic determinant, in much the same way as suggested 
by von Sengbusch (1965) for the virus-anti virus system. The exact 
location of the cryptotope of peptide I is, however, sti I I to be esta-
b I i shed. 
Tryptic peptide 4 (residues 62-68) was found to inhibit the TMV-anti 
TMV precipitin reaction (Anderer, 1963 b). In addition, amino acid 
exchanges in position 65 and 66 resulted in TMV mutants that are sero-
logically distinguishable from the wi Id type virus (von Sengbusch, 1965; 
van Regenmortel, 1967). The replacement of praline in position 63 by 
serine, however, did not affect serological behaviour Cvon Sengbusch, 
1965). When these results are interpreted in terms of the location of 
this peptide on the surface of the protein subunit in the viral helix, 
it seems likely that the C-terminal part of peptide 4 contains an anti-
genic determinant of the intact virus (I .4.2) . 
In the present work, however, peptide 4 behaved as a cryptotope in al I 
the relevant experiments. Antibodies specific for the antigenic region 
of peptide 4 could not be removed from TMV protein antisera by absorp-
tion with virus, as shown by both inhibition of complement fixation 
(2.5.1.4 - fig. 2.19) and direct binding assays (2.5.3.3 - table 2.5). 
In fact, N-C 3H)acetyl peptide 4 was bound equally wel I by a particular 
TMV protein antiserum before and after it was absorbed with TMV 
(table 2.5). Absorption of a TMV antiserum with TMV protein, on the 
other hand, completely eliminated the antibodies capable of binding 
to N-C 3H)acetyl peptide 4 (table 2.5). Peptide 4 also strongly inhi-
bited the specific precipitin reaction of radiolabel led TMV protein 
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and anti-TMV protein antibodies (2.5.2.3 - fig. 2.20). 
Two possible explanations for the discrepancy between the results with 
peptide 4 reported in this work and the earlier findings (von Sengbusch, 
1965; van Regenmortel, 1967) can be suggested: it is possible that the 
amino acid exchanges in positions 65 and 66 exert their influence through 
some modulation effect on neighbouring residues, or alternatively, that 
the short peptide 4 contains, in addition to the cryptotope, a part of a 
viral antigenic determinant too smal I to be recognized by the correspon-
ding antibodies (Mi I ton and van Regenmortel, 1979). 
An attempt was made to obtain a rough delineation of the peptide 4 cryp-
totope by comparing the activity of the wi Id type peptide 4 with that 
of the tryptic peptide homologues of two mutants(2.6. 1.2 - fig. 2.23). 
The mutants were 414 (serine in position 65 replaced by glycine) and 
Ni 1688 (praline in position 63 and 156 replaced by serine and leucine 
respective I y) . The peptide 4 homologue with serine in position 63 did 
not inhibit the precipitation of radiolabel led TMV protein by its speci-
fie antibodies, while the peptide homologue with glycine in position 65 
showed a greatly reduced inhibition compared to the wi Id type peptide 4. 
This suggests that the peptide 4 cryptotope is located in the N-terminal 
half of the peptide and extends to at least residue 65. Part of the 
cryptotope may be found in the C-terminal region of tryptic peptide 3 
(residues 47-61), but an accurate delineation would require a study with 
overlapping synthetic peptides ( 1.6. I) corresponding to this sequence: 
CVal-Arg)-Phe-Pro-Asp-Ser-(Asp-Phe). In terms of the structure of the 
TMV protein subunit (Bloomer et~., 1978), this sequence is located in 
0 
a projecting loop of the polypeptide chain at the 80 A radius (best i I lu-
strated by comparing fig. 3.1 with the side elevation in fig. 1.4 8). 
Such surface configurations were also found to be associated with anti-
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gen i c sites in the case of myog I obi n (At ass i , 1975; 1977 b). 
The mutant 414 protein is indistinguishable from wi Id type TMV protein 
in its abi I ity to inhibit the precipitation of radiolabel led TMV pro-
tein by its specific antibodies (2.4.3 - fig. 2. I I l. On the other 
hand, the same amino acid exchange at position 65, in the case of the 
peptide, leads to a mutant peptide 4 with decreased inhibitory capacity 
compared to wHd type peptide 4. This implies that residue 65 is loca-
ted within an antigenic determinant. However, if this determinant is 
a cryptotope, as was concluded from the inhibition of complement fixation 
and direct binding studies, the serological distinguishabi lity of amino 
acid exchanges at positions 65 (von Sengbusch, 1965; van Regenmortel, 
1967) and 66 (van Regenmortel, 1967) would mean that they modulate the 
conformation at the sutface of the viral helix. This conformational 
modulation effect, which would occur in the depolymerized protein sub-
unit as wel I, may lead to a smal I change of overal I activity in the mono-
mers, because of the large proportion of the free protein surface that 
contains other protein determinants which are not affected. 
In the case of the amino acid exchange in position 63, the complete loss 
of the inhibitory capacity of the corresponding mutant peptide also 
demonstrates that it is a part of the peptide 4 cryptotope, but because 
of the nature of the exchange, from praline to serine, it is also expec-
ted to lead to a major conformational change in the protein subunit. 
This is i I lustrated by the differing inhibitory power of wi Id type TMV 
protein and Ni 1688 protein in the radiolabelled TMV protein-anti TMV 
protein precipitin system (2.4.3 - fig. 2.11). The difference in the 
behaviour of Ni 1927 protein (proline in position 156 replaced by leu-
clnel and Ni 1688 protein (proline !n position 63 replaced by serine- as 
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wel I as praline in position 156 replaced be leucine) shows that the 
amino acid exchange in position 63 is responsible for the greater 
part of the reduction in the inhibitory capacity of Ni 1688 protein. 
It is not clear why von Sengbusch (1965) failed to find the amino acid 
exchange of praline for serine in position 63 serologically distinguish-
able in the TMV-anti TMV system, especially since a less extreme ex-
change of serine for glycine, only two residues away at position 65, 
was distinguishable. It would be expected that the nature of the 
amino acid exchange in position 63 would affect an adjacent viral anti-
genie determinant, even if residue 63 were not a part of it, especially 
in the quaternary structure of the viral capsid. Also, if the amino 
acid exchange in position 65 caused a conformational modulation of the 
viral subunit surface, the replacement of praline in position 63 should 
do the same. 
The antigenic site in tryptic peptide· 8 (residues 93-112) has been fully 
characterized by Benjamini and co-work~rs (I .4.3; I .5.2; and 1.6.2) and 
found to be a pentapeptide (residues 108-112: Leu-Asp-Ala-Thr-Arg) (Young 
et ~·, 1967). The location of this antigenic determinant in the 
0 
region of the 20 A radius (Bloomer et~., 1978), where it would border 
on the central hole in the viral he! ix (Stubbs et~., 1977), prevents 
it from beJng considered as anything but a cryptotope. It is obvious 
that it cou Id not be anti gen i ca I I y expressed in the intact virus except 
at the extremities of the viral rod (Mi I ton and van Regenmortel, 1979). 
The results obtained in the present work support this conclusion. 
Antibodies specific for peptide 8 could not be removed from antisera 
raised to depolymerized TMV protein by absorption with virus as determi-
ned by both inhibition of complement fixation (2.5. 1.4 - fig. 2. 19) and 
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direct dinding studies (2.5.3.3 - table 2.4). On the other hand, the 
absorption of TMV antisera with protein sununits removed al I the anti-
peptide 8 activity that the antisera possessed (table 2.4). In this 
respect the results are sirni lar to those obtained with peptide 4. 
In view of these findings, it is somewhat surprising that the replace-
rnent of threonine by methionine in position 107 was found to be serolo-
gically distinguishable in the TMV-anti TMV system (von Sengbusch, 1965). 
Similarly, the protein of the TMV mutant Ni 568, which has the same 
amino acid exchange, but in addition has the threonine in position 5 
replaced by isoleucine, was found to inhibit the precipitation of radio-
label led TMV protein far less efficiently than unlabelled wi Id type 
p rote i n ( 2 . 4 • 3 - f i g . 2 . I I A ) . In this case also, neither of the mu-
tant peptide hornologues containing the amino acid exchanges in positions 
5 and 107 were distinguishable from the wi Id type peptides in this sys-
tern, utilizing the same antiserum (2.6.1.2 - fig.s 2.22 and 2.24). In 
view of von Sengbusch's ( 1965) findings with two TMV mutants which have 
the same amino acid replacement at position 107, it is thought likely 
that the exchange of threonine for methionine is responsible for the 
differing serological behaviour of the protein of the mutant Ni 568 
(rather than the amino acid replacement in position 5). The incorpo-
ration of methionine in this region of the protein sequence causes a 
far-reaching conformational modulation of the whole protein subunit, 
affecting antigenic determinants on the viral surface. 
I 
The results obtained with the proteins of the mutants Ni I 18 and Ni 568, 
shuwing them to be serologically distinguishable from the wi Id type TMV 
protein (2.4.3 - fig. 2. I I), have been interpreted in terms of the amino 
acid exchanges in these proteins having a likely conformational effect; 
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rather than a direct involvement in antigenic determinants. In the 
case of Ni I 18 protein, this interpretation is supported by circular 
dichroism data <Budzynski, 1970) which shows conformational differences 
in comparison with wi Id type protein. Peptide homologues from these 
mutant proteins were not distinguishable from the corresponding wi Id 
type peptides (2.6. 1.2 - figs. 2.22 and 2.24) while comparable amino 
acid exchanges in other peptides were detectable (figs. 2.23 and 2.25). 
As these mutants retain their biological properties, the envisaged con-
formational changes must be relatively small. It has been suggested 
(Atassi et S!l·i 1970) that drastic conformational changes are not per-
missible in an evolutionary sense, as they would disrupt the biological 
functions of proteins. However, smal I conformational changes, which 
may not be detected by the rather coarse physical methods now avai I able 
for examining protein conformation, could be tolerated and exert a 
measurable effect on the antigenic reactivity of the protein. On the 
other hand, when certain amino acid exchanges are not distinguishable 
in the protein or a peptide, there is always the possibility that the 
change in a particular amino acid side chain is insufficient to affect 
the immunochemical role of that residue in an antigenic site (I .3. I). 
An alternative multi determinant hypothesis must be considered as wel I 
(White et~., 1978). This suggests that there may be many other anti-
genic determinants, beside those identified so far in proteins such as 
myoglobin and lysozyme, that embrace col lectivefy almost the entire 
surfaces of these proteins and elicit the production of smal I amounts of 
antibodies which are only detectable with very sensitive techniques like 
the micro-complement fixation assay (White et~., 1978). The fact 
that mutant peptide homologues cannot be distinguished from a bivalent 
wi Id type peptide such as peptide I, whereas the corresponding mutant 
---·--·- ----·-- ------· -- -----,- ------~ -------
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The protein of the mutant CP 415, which has the asparagine residue in 
position 140 replaced by lysine, was not distinguishable from wi Id 
type TMV protein when tested for its abi I ity to inhibit the precipita-
ti on of the radio label led TMV protein by its specific antibodies 
(2.4.3 - fig. 2.11 A). This is in accordance with the results of du 
Plessis ahd van Regenmortel ( 1977), who showed that this mutant protein 
could not be distinguished from wi Id type TMV protein in a modified 
. p h age assay ( I . 3 • 3 ) . 
The location of peptide 12 (residues 142-158) at the surface of the pro-
tein subunit which is also exposed in the intact virus, would lead one 
+o expect this region to be antigenical ly very active (Milton and van 
Regenmortel, 1979). The C-terminus of the TMV polypeptide chain has 
been implicated in an antigenic determinant of the virus ever since it 
was found that the serological specificity changes when the threonine 
in position 158 is removed from the subunits of the intact virus by 
carboxypeptidase A. 
/' 
Although antisera raised to the carboxypeptidase 
A treated virus and untreated TMV showed strong mutual cross-reactions, 
cross-absorption of the antisera completely prevented the heterologous 
reaction (Harris and Knight, 1955). Similar studies with the carboxy-
peptidase A treated derivative of the TMV mutant Ni 1927 (praline in 
position 156 replaced by leucine), which has lost the three terminal 
amino acids (Leu-Ala-Thr), showed that this derivative was sti 11 able 
to react with both TMV and Ni 1927 antisera after they had been abscrbed 
with Ni 1927 virus (von Sengbusch and Wittmann, 1965). The existence 
of heterospecific antibodies in TMV antisera (Loor, 1971; van Regenmor-
tel, 1978) was confirmed by the observations that absorption of TMV 
antisera with TMV did not remove the capacity for reaction with the 
mutants Ni 1927, Ni 1688 (von Sengbusch, 1965) and 171 (van Regenmortel, 
1967), which al I have the praline in position 156 replaced by leucine. 
(I. 3. 2.) 
Another explanation for the presence of heterospecific antibodies in 
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TMV antisera, based on the existence of two conformational forms of the 
protein subunit (Vogel, 1973; Vogel and Jaenicke, 1974), was proposed in 
section 1.3.2. It was suggested that the C-terminal region of TMV pro-
tein contains two antigenic sites, a neotope and a cryptotope. The 
neotope is associated with the pH 7,0 conformational form of the pro-
tein subunit, which has the same C-terminal configuration as the 20S 
disk (Vogel, 1973; Vogel and Jaenicke, 1974), and hence the intact 
virus (Graham and Butler, 1978). This antigenic site, which is immuno-
genic only in the virus, is most likely located at the C-terminus of 
the polypeptide chain and involves the threonine residue in position 
158 (Harris and Knight, 1955; von Sengbusch and Wittmann, 1965). The 
cryptotope, on the other hand, exists only by virtue of the configura-
tion of the region comprising residues 151-156 in the pH 8,0 form. 
The present interpretation is based on the assumption that residues 
157 and 158 are not part of the cryptotope. Thus the neotope and the 
cryptotope sites are expected to overlap. 
When intact TMV is injected into an animal, partial dissociation of the 
viral rods may release free protein subunits in the pH 8,0 conformational 
form. This would lead to the formation of antibodies specific for the 
peptide 12 cryptotope. These anti-cryptotope antibodies would not be 
able to bind to the C-terminal configuration of the intact virus because 
of the rigidity resulting from the praline residue in position 156, and 
hence would not be removed from a TMV antiserum by absorption with TMV. 
The replacement of the praline in position 156 by leucine, as in the 
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TMV mutants Ni 1688, Ni 1927 and 171, would lend flexibility to the C-
terminal configuration of the virus (von Sengbusch and Wittmann, 1965) 
and al low some of the anti-cryptotope antibodies to bind to their anti-
genie site. Although the three C-terminal amino acids may sti I I cause 
steric hindrance, it could be less than when the rigid praline is present 
(von Sengbusch and Wittmann, 1965), as the presence of praline al lows no 
flexibility in the configuration of the two terminal residues. It is 
possible that the steric hindrance effect is completely removed by split-
ting off the three terminal amino acids of the mutants (von Sengbusch 
and Wittmann, 1965) to expose the major part of the cryptotope which is 
expected to extend from residues 151-156. 
The existence of a cryptotope in peptide 12 was confirmed by the results 
of inhibition of complement fixation experiments with TMV protein anti-
sera absorbed with TMV (2.5. 1.4 - fig. 2. 19). The removal of virus 
specific antibodies from TMV protein antisera did not lessen the ability 
of peptide 12 to inhibit the remaining specific TMV protein-anti TMV 
protein reaction. Similarly, absorption with the intact virus could not 
remove about 70% of the antibodies in a TMV protein antiserum which reac-
3 ted with N-( H)acetyl peptide 12 in direct binding assays (2.5.3.3 -
tab I e 2. 5). In another experiment, when a TMV antiserum was absorbed 
with TMV protein subunits to remove al I the anti-protein activity, about 
30% of the antibodies reactive with the N-< 3H)acetyl peptide 12 remained 
(2.5.3.3 - table 2.5). These latter antibodies, which could not be 
removed by absorption with TMV protein, are specific for the viral 
capsid and are directed against a neotope. Thus peptide 12 contains a 
neotope in addition to the cryptotope described above. The th re on i ne 
in position 158 is I ikely to be a part of this neotope. 
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Milton and van Regenmortel (1979) suggested that peptide 12 exists, in 
solution, in a mobile configuration and that it can assume the native 
conformation present in the viral capsid. If this is the case, it is 
this conformation which would al low anti-neotope antibodies to combine 
with peptide 12. 
The location of the peptide 12 cryptotope was probed by the use of 
mutant peptide homologues from Ni 1688 and Ni 1927 (prol ine in position 
156 replaced by leucine in both peptides), and a carboxypeptidase A 
treated derivative of peptide 12 (2. 1.4) with the C-terminal threonine 
removed (residues 142-157). The two mutant peptides, which were identi-
cal except for their source, caused the same amount of inhibition of the 
precipitation of radiolabel led TMV protein by its specific antibodies. 
This inhibition was only half that caused by the wi Id type peptide 12 
(2.6.1.2 - fig. 2.25). Ni 1688 protein and Ni 1927 protein were also 
found to be less efficient inhibitors of the precipitin reaction of 
radiolabel led TMV protein than the unlabelled protein of wi Id type TMV 
(2.4.3 - fig. 2. I I). This decrease in the efficiency of inhibition by 
the mutant peptides and proteins, compared to their wi Id type counter-
parts, suggests that the praline residue in position 156 is a part of 
the cryptotope of peptide 12. On the other hand, the replacement of 
praline by leucine does not completely prevent specific antibodies from 
reacting with the cryptotope (in the same way that asimilar replacement 
of praline by serine in position 63 of the mutant peptide 4 homologue of 
Ni 1688 prevents the reaction of specific anti-cryptotope antibodies~-
fig. 2.23). This leads to the assumption that the prol ine residue in 
position 156 is not absolutely essential for antibody binding of the pep-
tide 12 cryptotope. It may wel I be the "boundary" residue of the anti-
genie site. The preliminary result with the peptide 12 derivative from 
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which the C-terminal threonine had been removed (2.1 .4), supports the 
idea that the cryptotope sequence ends at residue 156 and this derivative 
was found to cause the same amount of inhibition of the radiolabel led TMV 
protein precipitin reaction as the wi Id type peptide 12 (2.6.2 - fig. 
2.26). This result has to be viewed with a certain amount of circumspec-
tion since the q~ality of the separation of the undigested peptide 12 
from peptide 12 minus threonine on Sephadex G50(2.1.4 - fig. 2.4) was 
much better than expected from the gel matrix characteristics. However, 
the amino acid analysis of the pooled fractions of the second peak was 
characteristic of a peptide 12 derivative which had lost the C-terminal 
threonine (table 2.2). The observation that the peptide 12 minus 
threonine reacted positively with ninhydrin in a spot test, while peptide 
12 did not (2. 1.4), also favours the view that both peaks do not repre-
sent peptide 12 in different states of aggregation. lmmunochemical 
studies with overlapping synthetic peptides and cross-absorbed antisera 
wi I I be necessary to obtain a more precise definition of the peptide 12 
neotope and cryptotope. 
A finding, which is not exp I icable in terms of the overlapping crypto-
tope-neotope model, is the fact that carboxypeptidase A treated Nf 1927 
virus reacts better with TMV antiserum than both intact TMV and Ni 1927 
(von Sengbusch, 1965).Because of the.absence of the rigid proline residue 
at position 156, it can be argued that intact Ni 1927 virus expresses 
configurations in the C-terminal region that.are necessary for the reac-
tion of antibodies specific for both the neotope and the cryptotope. 
If threonine 158 is a part of the viral antigenic determinant as concl~­
ded by von Sengbusch and Wittmann (1965), carboxypeptidase A treated 
Ni 1927 virus, which has lost the three C-terminal residues, would only 
be able to react with the anti-cryptotope antibodies. It would, there-
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fore, be expected to react less strongly than Ni 1927 with TMV antisera 
in terms of the model described in section I .3.2. If, however, the car-
boxypeptidase derivative of Ni 1927, used by von Sengbusch (1965), had 
not lost these amino acids from al I the subunits in each viral capsid, 
the situation would not be significantly different from that described 
for Ni 1927 virus: The anti-cryptotope antibodies would react with the 
exposed cryptotopes on the subunits lacking the C-terminal residues, 
while the anti-neotope antibodies wou~d combine with the uncleaved Sub-
units in the favourable conformation. Thus the reaction of Ni 1927 
and a partially digested carboxypeptidase treated derivative of this 
mutant with TMV antisera would be expected to be approximately equal. 
In fact, the carboxypeptidase treated Ni 1927 derivative, used by von 
Sengbusch, was only slightly superior to the untreated Ni 1927 virus in 
its precipitin reaction with a TMV antiserum, and both were almost twice 
as active as wi Id type TMV (von Sengbusch, 1965). A test of this model, 
based on the existence of two conformational forms of the protein sub-
unit, would consist in letting Ni 1927 virus and its carboxypeptidase A 
treated derivative react with TMV antiserum after it had been fully ab-
sorbed with TMV protein at pH 8,0. 
In both the inhibition of complement fixation experiments with the TMV 
protein-anti TMV protein system and the inhibition of the precipitin 
reaction with radiolabel led TMV protein, peptide 12 was shown to be anti-
genical ly very active (2.5. 1.4 - figs. 2.17 and 2.18, and 2.5.2.3 - fig. 
2.20). It is not clear why Benjamini et~· (1964) failed to demonstr-
ate activity in this peptide. 
The results of cross-reaction studies with TMV and Ni 1927 protein at 
pH 6,8 and pH 8,0, in the precipitin system with radiolabel led TMV and 
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specific anti-TMV antibodies (2.3.3 - fig. 2.9), were especially sur-
prising in view of the lack of activity displayed by al I five tryptic 
peptides in both inhibition of complement fixation (2.5. 1.3) and inhi-
bition of micro-precipitin (2.5.2.2) assays performed with the same 
antibodies. On the other hand, both TMV protein at pH 6,8 and pH 8,0 
as wel I as Ni 1927 protein at pH 8,0 were able to cause complete inhi-
bition of the·specific TMV-anti TMV reaction (fig. 2.9). The simplest 
exp I anati on of this phenomenon is that sma I I amounts of TMV and Ni 1927 
protein aggregates, 20S and larger, are present in sufficient quantity 
to react with al I the TMV specific antibodies. The pH dependance of 
the inhibitioh could be ascribed to the greater ease of aggregate form-
ation at lower pH, except in the case of Ni 1927 protein at pH 6,8 
which is far less efficient an inhibitor of the TMV-anti TMV reaction 
than the same protein at pH 8,0 (fig. 2.9). This would imply that the 
aggregation behaviour of Ni 1927 protein is the reverse of w i Id type TMV 
protein. Also, analytical ultracentrifugation of identically treated 
TMV protein solutions at the same pH (4.2.4), and with up to double the 
concentrations used in the assays, did not show any sign of the con-
vective disturbances, seen on the base I ine of the sch I ieren pattern 
(Schachman, 1959), associated with trace amounts of the higher aggregates 
(Or. A. Polson - personal communication). 
Assuming, for the moment, that subunit aggregation is not entirely res-
ponsible for the complete inhibition of the TMV-anti TMV reaction obser-
ved with the TMV and Ni 1927 protein so I ut ions, a tentative hypothesis, 
based on the mobi I ity of the polypeptide chain in cowpea chlorotic mottle 
virus, is suggested. It was found by fluorescence studies with pyri-
doxal-51-phosphate label led protein subunits and caps ids of cowpea chlo-
rotic mottle virus, that the mobility of the polypeptide chain in the 
free subunit was greater than in the intact capsid (KrUse et~., 1978). 
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If asimilar situation exists with TMV and its subunit, it would be 
expected that the quaternary structure of the caps id imposes a far more 
rigid conformation on the constituent subunits than is found in the de-
polymerized TMV protein. Continuing this line of reasoning, peptides 
would have the least structure, approaching the random coi I state, de-
pending on their size. It has been shown that peptides resulting from 
the cleavage of myoglobin at praline and arginine residues have an impro-
ved immunochemical reactivity when their helical content increased 
(Atassi, 1977 b). If this is a general phenomenon, it is suggested that 
antibodies specific for a "continuous site" (Atassi, 1978) conformational 
determinant (Sela et~., 1967) of the viral capsid may be able to react 
with the same, less rigidly structured sequence in the depolymerized pro-
tein subunit (even if this region is no longer immunogenic in the absence 
of the quaternary structure), but with a low binding affinity. This 
means that a very large molar ratio of subunits to virus specific anti-
bodies would be required for substantial binding. A proportionately 
larger molar excess of a random coi I peptide, containing the same se-
quence, would be required to achieve an equivalent binding with this type 
of antibody. On the other hand, antibodies raised to the virus wi 11 
bind a neotope having the same sequence with high affinity because of the 
conformation induced by the quaternary structure of the viral helix. 
Then, theoretically, the molar ratio of a single species of neotope to 
antibody wi I I be 2:1, assuming monogamous bivalent binding of the virus 
and ignoring the steric hindrance between antibody molecules. 
The results obtained by Sachs et .9..!_. (1972) imply that a conformation 
identical to the native conformation of staphylococcal nuclease is re-
quired before peptides could be bound by antibodies specific for a con-
formational determinant of the protein. However, the specificity of 
the antibodies used in these experiments is in doubt. Habeeb ( 1977) 
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has argued that the method of Sachs and co-workers for isolating con-
formation specific antibodies is likely to give rise to an antibody 
population capable of cross-reacting with both native nuclease and the 
disordered form of the determinant. Nevertheless, a conformational 
equi I ibrium may not be a feature of al I peptides in solution, and con-
formation specific antibodies may sti I I react in a reversible manner 
with random coi t peptides. In the case of a conformational equilibrium, 
the difficulty would be to detect the low affinity reaction with the 
disordered peptide in the presence of peptide in the native conformation-
al form, as the specific antibodies would bind in an irreversible manner 
to the latter form of the peptide. 
In any case, the hypothesis, based on the reaction of virus conforma-
tion specific antibodies with equivalent less structured sequences in 
protein subunits and peptides, should not be seen as a contradiction 
of the concept of the conformational cryptotope or the neotope (van 
Regenmortel, 1966; van Regenmortel and Le large, 1973), as these would 
relate to the. immunogenicity of a pa~icular region of the polypeptide 
chain when it is associated with a defined conformational form. In a 
more relaxed configuration the same sequence would not necessarily 
elicit the formation of antibodies with the same specificity, or even 
elicit the formation of antibodies at al I. In fact it may react poorly 
with antibodies which bind its quaternary conformational form with a 
high affinity. Regions of the protein sequence which cause the forma-
tion of antibodies with the same specificity in both the subunit and 
the quaternary structure, wouJd be involved in those cross-reactions 
that can be detected at equivalence proportions. 
This hypothesis, although it would explain the complete inhibition with 
TMV protein and the inactivity of the peptides in the TMV-anti TMV system 
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at the molar excesses that were used, is unsatisfactory in that it is 
difficult to devise experimental situations to test its postulates. 
Studies, siml lar to those done by KrUse et~· (1978) on cowpea chlo-
rotic mottle virus, could be carried out to assess the freedom of 
mobility of the polypeptide chains of the subunits in the various 
aggregates of TMV. Another approach would be to release antibodies 
specific for neotopes from TMV rods and use these in direct binding 
studies with radiolabel led N-bromosuccinimide (NBS) treated TMV pro-
tein COhno et~·, 1972; du Plessis and van Regenmortel, 1977) and 
peptides I and 12. NBS treatment, which only modifies the tyrosine 
residue at position 139 (Ohno et~., 1972) is not I ikely to affect 
the sequences of the TMV protein associated with the neotopes in pep-
tides I and 12. The configuration of the peptides could be stabi Ii-
zed by attaching them to carrier molecules. 
To return to the cross-reaction studies with radiolabel led TMV and un-
labelled TMV protein (2.3.3 - Fig. 2.9), an alternative interpretation 
to that of aggregation of the protein subunits, can be formulated in 
terms of the two conformational forms of the A-protein (Vogel, 1973; 
Vogel and Jaenicke, 1974) to explain the difference in the inhibitory 
efficiency of TMV protein at pH 6,8 and pH 8,0. If the peptide 12 
cryptotope is exposed by the C-terminal configuration at pH 8,0, but 
not by the virus-like configuration at pH 7,0, antibodies, specific 
for the cryptotope (present in the TMV antiserum as a result of par-
tial TMV dissociation after injection into the animal) would bind to 
the pH 8,0 protein subunits and in so doing would sterical ly hinder 
any reaction of anti-viral antibodies with the C-terminus of the poly-
peptide chain. In this way less protein subunits would be avai I able 
to inhibit the TMV-anti TMV reaction and greater molar excesses of TMV 
protein would be required for inhibition (the amount of anti-cryptotope 
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antibodies remaining the same). At pH 6,8, however, the virus-I ike C-
terminal configuration of the subunits would cause the peptide 12 cryp-
totope to be sterical ly hindered from reacting with its specific anti-
bodies, and moreover, the C-terminal region would be conformationally 
more suited to react with the anti-viral antibodies specific for this 
region, The net result would be that a smaller molar excess of the 
subunits at pH 6,8 would be required, than at pH 8/J, to achieve an 
equivalent amount of inhibition of the lMV-anti TMV reaction. This 
was in fact observed. The similarity of the slopes of the two TMV 
protein inhibition curves at pH 6,8 and 8,0, can be accounted for by 
assuming that the same anti-viral antibody population is reacting with 
the same sequences of the protein subunits in both conformational 
states to cause inhibition of the TMV-anti TMV reaction. 
Ni 1927 protein is a less efficient inhibitor of the TMV-anti TMV 
reaction than TMV protein (2.3.3 - Fig. 2.9), as would be expected 
from the location of the amino acid exchange in the C-terminal region. 
What is not understood is the reversal of the inhibitory behaviour of 
this protein, at pH 6,8 and pH 8,0, compared to TMV protein. This 
would imply either that its aggregation behaviour (at least from pH 
7,0 - 8,0) is the opposite of that of wi Id type TMV protein, or that 
the two conformational forms of the A-protein in Ni 1927 are the reverse 
of those of TMV protein, depending on the explanation that has been acc-
epted for the behaviour of TMV protein in these experiments. 
The resuJts that Anderer (1963 b) obtained by inhibition studies with 
peptides in the TMV-anti TMV precipitin system have been discussed in 
section 1.4.2. Two of the most active peptides, corresponding to re-
sidues 18-23 and 123-134 respectively, are located too far from the 
surface of the protein subunit in the viral helix to be avai I able to 
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antibodies (Stubbs et~., 1977; Bloomer et ..9..L·, 1978). A third 
active peptide, tryptic peptide 4 (residues 62-68), was found to be-
have I ike a cryptotope in the present work (2.5.1.4 - Fig. 2. 19 and 
2.5.3.3 - table 2.5). Anderer (1963 b) also found tryptic peptide 
12 (residues 142 - 158) to be active, and this peptide was shown in 
the present work to contain a neotope and a cryptotope (2.5.3.3 -
table 2.5). ·in contrast to Anderer's results, none of the five 
tryptic peptides (including peptides 4 and 12), showed any ability to 
inhibit the TMV-anti TMV reaction with either the micro-precipitin or 
complement fixation techniques, even though molar ratios of peptide 
to virus, far in excess of those used by Anderer, were used (2.5. I .3 
and 2.5.2.2). Since three of the so cal led "active" peptides, of 
Anderer, seem to owe their inhibitory properties to non-specific eff-
ects, it is possible that al I the other inhibitions obtained with pep-
tide 12 and C-terminal octa- and hexapeptides are also non-specific 
in nature. The experiments showing that antibodies specific for hexa-, 
penta-, tetra- and tripeptides, corresponding to the C-terminal sequence 
of the TMV polypeptide chain bind to TMV particles (Anderer, 1963 a; 
Anderer and Schlumberger, 1965), only demonstrate that this region is on 
the surface of the subunit in the viral helix. The low level of anti-
bodies specific for the C-terminal hexapeptide, that is found in TMV 
anti sera (Anderer, 1963 a; Anderer and Sch I umberger, 1965; Anderer et 
.9_!_., 1971; and Anderer and StrBbel, 1972) al lows one to predict that 
the use of this peptide to inhibit the reaction between the conforma-
tional C-terminal determinant of the virus and its specific antibodies 
is I ikely to prove difficult. 
It is not suggested that antibodies specific for neotopes cannot bind 
to peptides that contain the sequence corresponding to the neotope .. 
On the contrary, it has been shown by direct binding studies with a 
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protein-absorbed TMV antiserum that peptide 12 reacts with specific anti-
viral antibodies (2.5.3.3 - table 2.5). It is thought, however, that 
the binding of random coi I peptides by antibodies which recognize the con-
formation rather than only the specific sequence of an antigenic deter-
minant (Sela et~., 1967) is by nature weak and.transitory. In a pep-
tide inhibition assay with any type of indicator immune system involving 
. 
multivalent viruses, it is likely that the practically irreversible 
(Hardie and van Regenrrortel, 1975) reaction between high affinity anti-
bodies and virus wi I I be favoured compared to the dissociating antibody-
peptide interaction. This could lead to a situation where al I the anti-
bodies that are capable of reacting with the virus in a monogamous bi-
valent fashion (van Regenmortel and Hardie, 1976) would appear, within 
a very short time, to be unable to react with the peptide. The result 
would be that active peptides would seem to have no inhibitory capacity. 
Of course the probability for the antibody-virus reaction to occur can 
be decreased by increasing the molar ratio of peptide to virus, but there 
Is a limit to the concentration of peptide solutions that can be uti I ized. 
If this argument holds, techniques that rely on competitive inhibition 
are unsuitable for peptide studies with quaternary proteins such as TMV. 
Assays which measure the actual binding reaction between the antibody 
and the peptide (such as direct binding of radiolabel led peptides, equi-
librium dialysis and affinity chromatography for example) would be ex-
pected to be more reliable for determining the amino acid sequences 
associated with conformational antigenic determinants. 
In conclusion, two antigenic determinants have been detected in peptide 
I (residues 1-41), a cryptotope and a viral antigenic determinant. 
Peptides 4 (residues 62-68) and 8 (residues 93-112) contain cryptotopes 
in the region of residues 63-65 and 108-112, respectively. Peptide 12 
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(residues 142-158) contains both a cryptotope and a neotope which are 
likely to be located in the C-terminal region, residue 156 being assoc-
iated with the cryptotope of peptide 12, and r~sldue 158 with the neo-
tope. No antigenic activity could be demonstrated in peptide I I (res-
t dues I 35-1 41 ) . 
3.3 TMV AS A' MODEL FOR THE STUDY OF ANTIGENICITY IN QUATERNARY PRO-
TEIN STRUCTURES 
It Is commonly accepted that antibody molecules have discrete binding 
sites (Poljak, 1975) and it 'is I ikely that antigenic determinants should 
aiso be associated with discrete regions of a protein's primary structure 
(Crumpton, 1974) as was found by Atassi and co-workers CAtassi, 1975; 1977 b; 
1978; Atassl and Habeeb, 1977). Such a discrete antigenic determinant 
has at least two attributes associated with It: an ordered arrangement 
of amino acid residues and a specific conformation. It i s d i ff i cu It 
to assess which of these attributes is more important to the irrmuno-
genicity and the antibody binding in the case of any particular anti-
genic determinant, but it is clear that both attributes are involved. 
The "continuous site" (Atassi, 1978) determinants of myoglobin i I lus-
trate the importance of the amino acid sequence to some antigenic sites 
(Atassi, 1975; 1977 b), while in lysozyme spatially adjacent surface 
res I dues, which are not necessa ri I y in direct peptide bond Ii nkage, form 
"discon:f-inuous site" (Atassl, 1978) determinants which rely on the surface 
conformation of the protein for their integrity (Atassi and Habeeb, 1977; 
Atassl, 1978). 
It Is quite conceivable that the physical methods now available for exam-
ining protein conformation, especially In solution, are not capable of 
determining the subtle changes In conformation that may accompany a. change 
In antigenicity <Atassi et~ •• 1970), but a strategy of approaches Cl. I), 
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that can detennlne the amino acid composition and order in antigenic 
detenninants, ls avai fable CAtassl, 1975; 1977 a; 1977 b). Once the 
antigenic detenninants of various proteins have been defined and mapped, 
the results of conformational studies can be Interpreted more east fy. 
In quaternary protein structures a new class of conformational determi-
nants, comprising portions of separate polypeptide chains from differ-
ent subunits that are adjacent in space ("discontinuous site" determi-
nants- Atassi, 1978) becane possible (Crumpton, 1974), as wel I as new 
detenninants resulting from confonnational change in the individual sub-
units that comprise the quaternary structure. These neotopes Cvan 
Regenmortel, 1966) may be recognized on the basis that homologous antl-
sera contain specific antibodies against the quaternary structure which 
do not arise in antlsera raised to the dissociated subunits. 
Although no evidence has been found to show that TMV has conformational 
determinants arising from the juxtapositioning of protein subunits in 
the viral capsld, neotopes associated with the quaternary structure of 
the virus have been demonstrated. It has been shown that antibodies 
specific for these neotopes are able to react with peptides free in 
solution (fig. 2.19 and table 2.5). This imp I ies that these confor-
mational determinants of TMV may be amenable to Atassi 's strategy Cl. I) 
and that the amino acid sequences, of which these detenninants are com-
posed, can be determined. This information, along with the structural 
data arising from X-ray crystallography of the protein subunit and the 
virus, would shed I ight on the nature of neotopes in TMV and hence quat-
ernary antigenicity in general. 
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Part 4. MATERIALS AND METHODS 
4. I THE PREPARAT I ON OF ANT I GENS AND PEPT I DES 
4.1. I SOURCES AND PROPAGATION OF VIRUS 
The type strain and the fol lowing mutants of TMV were uti I ized in this 
work: TMV vulgare and the n-bromosuccinimide mutant 414 were supplied 
by Prof. M. H. V •. va~ Regenmorte I of the Department of Mi crob i o I ogy, 
University of Cape Town (van Regenmortel, 1967); the spontaneous mu-
tant CP 415 and the nitrous acid mutants Ni 118, Ni 568, Ni 1688 and 
Ni 1927 were obtained from Prof. H.G. Wittmann of the Max Planck Insti-
tute for Molecular Genetics, Berl in (Hennig and Wittmann, 1972). 
The viruses were propagated in Nicotiana tabacum cultivar soulouk at 
25°C in fully control led growth chamber conditions. Infected leaves 
were harvested five days after innoculation. 
4.1 .2 EXTRACTION OF VIRUS FROM INFECTED LEAVES 
The method of von Wechmar and van Regenmortel (1970) was used for the 
extraction and purification of TMV strains and mutants from the leaves 
of infected plants. 
Leaf material, mixed in a weight_ to volume ratio of 2:1 with a buffer 
comprised of equal volumes of 0,05M sodium phosphate buffer and O,OIM 
E D TA ·cethylene-diamine-tetra-acetic acid), adjusted to a final pH 
of 9,5 with I ,OM NaOH, was homogenized and strained through cheese-
cloth. The pH of this filtrate, which had dropped to pH 5-6,was im-
mediately adjusted to pH 7,5 with I ,OM NaOH before centrifugation at 
16000 g for 10 minutes. Powdered activated charcoal and Celite, each 
to a concentration of 5 g/100 ml of the filtrate, were stirred with the 
supernatant for 30 seconds and the slurry was filtered by suction 
through Whatman No. I filter paper, covered with a 0,5 cm layer of 
damp Celite, to remove contaminating plant material. 
The virus in this second filtrate was precipitated by the addition 
of MW 6000 polyethylene glycol and NaCl, each to a final concentra-
tion of 4,0 g/~00 ml of the second fi itrate, and pelleted by centri-
fugation at 16000 g for 10 minutes. The virus pellets were resus-
pended in 0,05M sodium phosphate buffer pH 7,5. 
If necessary, further clarification of the virus solution could be 
achieved by a second precipitation with polyethylene glycol and NaCl 
fol lowed by differential centrifugation. 
4.1.3 PREPARATION OF VIRUS PROTEIN 
4. I .3. I THE COLD ACETIC ACID METHOD 
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The basis of the cold acetic acid method of Fraenkel-Conrat (1957) for . 
the preparation of TMV protein is the dissociation of TMV in a 66% 
( v/v) so I uti on of g I aci a I acetic acid' in water. 
TMV, resuspended In cold disti I led water to a concentration of approx-
imately 10 mg/ml, was mixed with two volumes of glacial acetic acid at 
17°C. The mixture was kept in chipped ice with occasional stirring 
for 30 minutes, or unti I the opalescence of the solution had cleared 
and strings of precipita~ed RNA were seen. After centrifugation at 
12000 g for 10 min, to pellet the RNA, the supernatant was immediately 
decanted and dialysed against disti I led water at+4°C, changing the water 
every day, unti I the protein had precipitated at its isoelectric point 
in the dialysis bags. 
mately pH 5. 
The pH of the cold dist! I led water was approxi-
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The precipitated protein was separated from the supernatant by centrifu-
gation at 12000 g for 10 min and resuspended in disti I led water. A drop 
or two of l,OM ammonia solution was used to aid dissolution and to raise 
the pH to 8,0. The protein solution was centrifuged at 150000 g for one 
hour, to remove undegraded virus and denatured protein, and lyophi I ized. 
4. I . 3. 2 THE ETHANOLAM I NE - DEAE METHOD 
This method, wh 1 ch was deve I oped by Durham ( 1972), i nvo Ives the di sso-
ci ati on of the virus at high pH fol lowed by the removal of the RNA by 
filtration through an ion-exchange resin. 
A solution of 10 mg TMV/ml was dialysed against 0, IM ethanol amine 
pHll,O,. at+4°C, until the opalescence had completely cleared. After 
a further 2-3 hours of dialysis against 0,012M TRIS (Tris(hydroxy-
methyl )-amino-methane) HCI buffer pH 8,3, the solution containing dis-
sociated protein and RNA was centrifuged at 150000 g for one hour to 
remove any undegraded virus sti 11 present. The supernatant was then 
applied to a column of Whatman DE-52 diethylaminoethane eel lulose con-
sisting of ml bed volume for every 50 mg of original virus, equl Ii-
brated with 0,12M TRIS-HCI buffer pH 8,3. The column was eluted with 
the same buffer and fractions, pooled on the basis of the elution pro-
file (fig. 2.1 , page 62), were dialysed against disti I led water for 
3-4 days with frequent changes of water before they were lyophi I ized. 
If a particular preparation of virus, or a particular mutant could not 
be disrupted by the ethanolamine buffer, O,IM NaOH was substituted for 
it to good effect. 
4.1.4 THE GENERATION AND PURIFICATION OF THE TRYPTIC PEPTIDES OF 
TMV PROTEIN 
4. 1.4.1 TRYPTIC DIGESTION OF TMV AND TMV MUTANT PROTEINS 
Tryptic digestion was done by a modification of the method described 
by Benjami ni et ~· ( 1964). 
The trypsin used was a twice-recrystalized preparation manufactured 
by Mi les-Seravac(code 36-555 batch 1455). The TMV proteins, 100 mg 
in 20 ml water, were digested with 2 mg of trypsin at 37°c while the 
pH was maintained at 8,0 with l,OM ammonia solution by means of a pH 
stat (Radiometer TTT 60 titrator). After an hour of digestion an 
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additional 2 mg of trypsin was added (fig. 4. I) and, after a further 
hour, peptide I (residues I - 41) was separated from the other pep-
tides in the digest by precipitation· at pH 4,5 (Funatsu et~., 1964), 
using 2,0M acetic acid, and centrifugation at 48000 g for 15 minutes. 
The soluble peptides were lyophi Ii zed and stored at -20°c. 
4. I .4.2 PURIFICATION OF THE I-PEPTIDE (RESIDUES 1-41) 
Fol lowing its separation from the tryptic digest, the I-peptide was 
purified by three repeated isoelectric precipitations at pH 4,5 (using 
2,0M acetic acid and I ,OM ammonia solution) and dialysis against fre-
quent changes of dlsti I led water (in eel lophane tubing boiled for 10 
minutes ·to reduce the pore size) for at least 7 days. After this per-
iod, the I-peptide had reprecipltated due to the low pH of the water 
containing dlssolved co2. This precipitate was pelleted by centrifu-
gat I on at 48000 g for 15 minutes, red I sso I ved v.i i th a few drops of I ,OM 
ammonia solution, and centrifuged again at the same speed to remove any 
insoluble material present. 
and stored at -20°c. 
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Tryptic digestion of 410,0 mg of TMV protein. Time of 
digestion Is plotted against the volume of I ,OM ammonia 
solution required to maintain the pH at 8,0. 8,2 mg of 
twice recrystalized trypsin was added initially and after 
60 minutes. The temperature was maintained at 37°C 
throughout the di ges ti on. 
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4.·f .4.3 FRACTIONATION OF THE pH 4,5 SOLUBLE TRYPTIC PEPTIDES 
4. 1.4.3. I PREPARATIVE ION-EXCHANGE CHROMATOGRAPHY OF THE pH 4,5 
SOLUBLE TRYPTIC PEPTIDES 
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AGl-X2 resin (Bio-Rad Laboratories, Richmond, California) was activated 
by sequential washing of every 200 ml of packed resin with 3,0 litre of 
disti I led water, 0,5 I itre of I ,OM HCI, 3,0 I itre of disti I led water, 1,0 
litre of 0,5M NaOH and 2,0 I itre of disti I led water at 60°c. The activat-
ed resin was resuspended in a 1% (v/v) pyridine, 1% (v/v) collidine 
buffer, adjusted to pH 8,4 with glacial acetic acid, 1,0 litre for every 
200 ml of packed resin. The "fines" were removed by suction. 
A 150x0,9 cm jacketed coiumn was packed with the activated resin and 
equilibrated with the pH 8,4 buffer. The column was maintained at a 
0 temperature of 37 C and run at a presure of 10-20 bar to assure a flow 
rate of 40 ml/hr. 
Samples of 100-200 mg of the pH 4,5 soluble portion of the tryptic di-
gest were dissolved in 5,0 ml of the pH 8,4 buffer by raising the pH 
of the solution to 10,0 with 0,5M NaOH. The samples were applied to 
the column and eluted with two different pH gradients. 
The first, recommended by Funatsu (1964), was formed by a 9-chamber 
Autograde (Technicon Chromatography Corp.) and consisted of the follow-
ing vo I umes of buffers ( vo I ume percentages) in sequence: ( I) 250 m I I% 
pyridine, 1% col lidine pH 8,2; (2) 360 ml 1% pyridine, 1% col lidine pH 
7,3; (3) 240 ml 0,02M acetic acid; (4) 120 ml 0,2M acetic acid; (5) 120 
ml 0,35M acetic acid; (6) 120 ml 0,5M acetic acid; (7) 240 ml 0,65M 
acetic acid; (8) 120 ml l,7M acetic acid; and (9) 120 ml 5,0M acetic 
acid. 
,, I .' 
The pH of the pyridine-col Ii dine buffers was adjusted with glacial 
acetic acid. 0,1 ml of each 3,3 ml fraction, that was collected, 
was quantitated by the Fol in-Lowry reaction (Campbel I et 2.J..., 1970) 
and the extinction at 700 nm was plotted against the fraction number 
(fig. 2.2). A characteristic elution prof! le CFunatsu, 1964) was 
obtained. The peaks corresponding to peptides 8 (residues 93-112) 
and 10 (residues 123-134) had a smal I amount of precipitate in the 
corresponding fractions. 
The second pH gradient was Identical to that described by Wittmann 
( 1965). Fonned w I th two ml xi ng f I asks, it consisted of the fo 11 ow-
l 
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ing volumes of buffers (volume percentages) in sequence: (I)~ 125 ml 
1% pyridine, 1% collldine pH 8,4; (2) 125 ml 2% pyridine, 1% colli-
dine pH 7,5; (3) 600 ml 1% pyridine, 1% plcoline, 1% lutidine pH 7,2; 
(4) 600 ml 1% pyridine, 1% pi col ine, 1% lutldine pH 6,0; (5) 600 ml 
2% pyridine, 2% picoline, 2% lutidine pH 5,0; (6) 600 ml 3% pyridine, 
3% picoline, 3% lutidine pH 4,0; (7) 150 ml 2,0M acetic acid. The 
pH of the pyridine-col Ii dine and pyridine-pi col ine-lutidine buffers 
was adjusted with glacial acetic acid. 0,2 ml of each 4,0 ml frac-
tion,that was collected, was subjected to alkaline hydrolysis in 2,5M 
NaOH at I 10°c and reacted with ninhydrln reagent (Benson and Patterson, 
1971 ). The extinction at 570 nm was plotted against the fraction num-
ber (fig .. 2.3), and the characteristic elution profile was obtained 
(Wittmann, 1965). 
In both cases the fractions comprising each peak, corresponding to a par-
ticular peptide, were pooled, evaporated to dryness and redissolved In 
a smal I volume of disti I led water preparatory to peptide mapping (4.2.1 ). 
. ~ . 
4. I .4.3.2 PREPARATIVE HIGH VOLTAGE ELECTROPHORESIS OF THE pH 4,5 
SOLUBLE TRYPTIC PEPTIDES 
Whatman 3 Chroma paper (35x40 cm) was washed, by descending chroma-
tography, with 250 ml 50% Cv/v) glacial acetic acid and water, 250 ml 
2,0M ammonia solution and 1,0 I Jitre disti I led water, and dried. A light 
penci I line w~s drawn at the centre across the breadth of each sheet. 
Preparatory to electrophoresis the paper was dampened with the electro-
phoretlc buffer, which contained 200 ml acetone, 80 ml pyridine and 
720 ml water. The pH of the buffer was adjusted to 6.4 by the addi-
tlon of glacial acetic acid. 25 mg of the lyophi Ii zed pH 4,5 soluble 
tryptic digest of virus protein was dissolved in 600 µI of dlsti I led 
water (a micro-drop of 25% (w/v) ammonia solution (Merck) was added If 
there was difficulty with solubi lization) and applied along the pencl I 
line in the centre of the damp paper. The digest was electrophoresed 
at approximately 1000 V and 45 mA in a Hormuth-Vetter pherograph (model 
64) for 5 hours at+4°C, using wicks. After this the paper was dried 
and two strips, with a breadth of 3 cm, were cut from the long edges 
of the paper and dried. The strips were stained with 0,2% Cw/v) nln-
hydrin in ethanol containing 5% (v/v) collidine, and with Ehrlichs re-
agent~ 10% (w/v) p-dimethylaminobenzaldehyde in 20% Cv/v) concentrated 
HCl-acetone (Jepson, 1963) - t~ locate the positions of the peptides 
(fig. 4.2). Vertical bands corresponding to individual peptides were 
cut from the unstained portion of the dried paper.· 
The peptides were extracted from these bands of paper by subjecting 8 
cm lengths of each band to ascending chromatography with the pH 6,4 
buffer, fol lowed by low speed centrifugation (2360 g for 15 min) of 
the wet paper wrapped in aluminium fol I and suspended In a centrifuge 
.. 
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Fig. 4.2 Separation of the pH 4,5 soluble tryptic peptides of TMV 
protein by high-voltage paper electrophoresis. A tryp-
tic digest of TMV protein (25 mg) was applied across the 
middle of a 35x40 cm sheet of Whatman 3 Chroma paper, at 
the position marked 0. After 5 hours electrophoresis 
(1000 v;45 mA) at pH 6;4 the paper was dried and two 3 cm 
strips were cut off along the edges. The strips were 
stained with ninhydrin and Erlichs reagent. Numbers refer 
to the tryptic peptides. Staining colour of peptides 8, 
4, 9 & 2, 3 and 5 was purple; peptide 11 : yellow; peptide 
7: grey. Peptide 12 stained only with Erl ichs reagent 
(10% (w/v) p-dimethylaminobenzaldehyde in 20% Cv/v) concen-
. t rated HC I -acetone ) . 
: ' I 
j ' 
170 
tube. The resultant peptide solutions were evaporated to dryness 
in a vacuum dessicator using P2o5 and NaOH pellets. In some instan-
ces, if the degree of purity of a peptide was lns~fficient, the pep-
tide was submitted to electrophoresis a second time. The peptides 
were dissolved in disti I led water, again evaporated to dryness and 
finally disso~ved in a smal I volume of dlsti I led water. 
The purity and yield of each peptide was determined by amino acid 
analysis (4.2.2). 
4. 1.5 DIGESTION OF TRYPTIC PEPTIDE 12 WITH CARBOXYPEPTIDASE A 
Carboxypeptldase digestion was done by a modification of a method 
described by Ambler (1972). 
Carboxypeptidase A (Mannheim Boehringer) was prepared by washing 
10 µI of a 25 mg/ml suspension of the crystals three times with dis-
ti I led water at+4°Cby centrifugation at 3896 g for 10 minutes, and 
then completely drying the crystals in a vacuum. The dried crystals 
were dissolved in 40 µI I ,OM CNH 4>Hco3 and the solution was made up 
to 250 µI with N-ethylmorpholine buffer pH 8,1 (1,15 ml N-ethylmorpho-
line, I ,50 ml of a 10% Cv/v) aqueous solution of glacial acetic acid 
and 48,0 ml water, adjusted to pH 8,1 with the 10% Cv/v) glacial ace-
tic acid solution). 
Approximately 2,6 mg of purified peptide 12 (residues 142-158) 
(4. 1.4.3.2) was dried in a vacuum and dissolved in I ,3 ml of N-ethyl-
morpholine buffer pH 8,1. 5 µI of the prepared solution of carboxy-
peptidase A was added to the peptide solution and the mixture was k~pt 
at 37°C for two hours with continuous stirring. Thereafter it 
was stored overnight at +4°c. 
The carboxypeptidase A digest (1,3 ml) was applied to a 65xl ,6 cm 
column of Sephadex G50 fine equilibrated with disti I led water. The 
column was run with disti I led water and a flow rate of 30 ml/hr was 
maintained. I ,5 ml fractions were collected and monitored for 
their absorbance at 210 nm and 280 nm using a disti I led water blank 
(fig. 2.4). 20 µI of every second fraction was spotted onto What-
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man 3 Chroma paper, dried, and sprayed with 0,2% (w/v) ninhydrin in 
ethanol containing 5% (v/v) col Ii dine to test for colour development. 
The fractions under each peak of the elution prof! le were pooled, 
dried and redissolved in 21 5 ml of O,IM Tris(hydroxymethyl )aminometh-
ane - 0,15 M NaCl buffer pH 7,4 (4.3.2.1.2). 0,5 ml of each sample 
of the pooled fractions was dried, hydrolysed with 6,0M HCI and sub-
mitted for amino acid analysis (4.2.2). 
4. 1.6 THE GENERATION OF THE FORMIC ACID PEPTIDES OF TMV PROTEIN 
4.1.6. I CLEAVAGE OF THE ASP-PRO PEPTIDE BONDS OF TMV PROTEIN AND 
THE I-PEPTIDE (RESIDUES 1-41) BY THE FORMIC ACID METHOD OF MIKI AND 
KNIGHT (1965) 
10 mg/ml aqueous solutions of TMV protein and the I-peptide (residues 
1-41) were made 66,6% with concentrated formic acid (98-100%> and were 
incubated at 37°C for 20 hours in closed containers. The formic acid 
was then removed by evaporation in a vacuum dessicator containing NaOH 
pellets and P2o5• 
The dried samples were resuspended in disti I led water and in both 
cases an insoluble precipitate was formed. After centrifugation 
at 60000 g for 30 minutes the supernatants were tested for the pre-
sence of proteinaceous material by the ninhydrin reaction after 
alkaline hydrolysis for 2 hours in 2,5M NaOH at I 10°c (Benson and 
Patterson, 1971 ). Only the supernatant of the sample containing 
degraded TMV protein showed colour development in excess of the 
background. 
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Portions of the whole digest, the washed precipitate and the super-
natant of the degraded TMV protein were lyophi I ized and used for SDS-
polyacrylamide gel electrophoresis (4. 1.6.3). 
4. 1.6.2 SEPHADEX G50 EXCLUSION CHROMATOGRAPHY OF THE FORMIC ACID 
PEPTIDES OF TMV PROTEIN IN A SOLUTION OF 50% CV/V) GLACIAL ACETIC 
ACID IN WATER 
The formic acid digest of TMV protein was evaporated to dryness 
(in a vacuum desslcator containing NaOH pellets and P2o5> and re-
dissolved In a solution of 50% (v/v) glacial acetic acid in water 
so that the final concentration was 10 mg/ml. 5,0 ml of this sol-
ution was applied to a 80xl,6 cm column of Sephadex G50 fine equi Ii-
brated and run with a solution of 50% (v/v) glacial acetic acid In 
water. The flow rate was maintained at 30-40 ml/hr and 3,0 ml frac-
tions were collected and monitored for their absorbance at 280 nm 
against a solution of 50% (v/v) glacial acetic acid in water as the 
blank (fig. 2.5). 
The fractions were pooled according to the peaks of the elution patt-
ern, dried and resuspended in water before lyophi lization and SDS-
polyacrylamide gel electrophoresis (4.1 .6.3). 
4. 1.6.3 SOS - POLYACRYLAMIDE GEL ELECTROPHORESIS OF THE FORMIC ACID 
PEPTIDES OF TMV PROTEIN 
This was done according to the method of Weber and Osborn (1975), 
using 15% (w/v) acrylamide gels containing I ,0% Cw/v) sodium dodecyl 
sulphate (SOS). 
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14,625 g of acrylamlde and 0,375 g of methylene bisacrylamide were 
dissolved in each 100 ml volume of 1,0% Cw/v) SOS O,IM sodium phos-
phate buffer pH7,0. The solution was degassed in ice before 1,0 ml 
of fresh 10,0% Cw/v) ammonium persulphate solution and 100 µI N,N,N,N-
tetramethylethylene-di amine CTEMED) were added. This solution was 
immediately pipetted into glass tubes (IOx0,5 cm) so that they were 
fi I led to within 1,0 cm of the top of each tube. The tubes had been 
previously sealed with Parafilm (American Can Co.) at one end. Water 
was carefully layered over the gels and approximately 45 min was al low-
ed for polymerization at room temperature. The Parafi Im was removed 
and the gels were pre-electrophoresed in a Shandon disc. gel electro-
phores ls apparatus using 1,0% Cw/v) SOS O,IM sodium phosphate buffer 
pH 7,0 In the trays, at 2,0 mA per tube for 2-3 hrs unti I the voltage 
remained constant. 
After pre-electrophoresis the tray buffer was changed and 10 µI of 
each sampre was applied to the gels. 
The samples consisting of 4,0 mg of each of three marker proteins: TMV 
protein (17500 daltons), lysozyme <14000 daltons) and insulin (6000 dal-
tons), as wel I as 4,0 mg of the lyophi If zed formic acid TMV protein dig-
est, its precipitate and its supernatant, were dissolved in 1,0 ml of 
the 1,0% (w/v) SOS O,IM sodium phosphate buffer pH 7,0 containing 50 µI 
2-rnercaptoethano I. The samples were incubated at I00°c for two 
minutes and one drop of 0,05% Cw/v) bromophenol blue and one drop of 
glycerol were added before application of the samples to the gels. 
The samples were electrophoresed at 6,6 mA per tube unti I the band 
of bromophenol blue had moved more than 3/4 of the way down the gel. 
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The gels were removed from the tubes, by forcing buffer between the 
gel and the glass with a syringe, and stained with a 0,25% (w/v) sol-
ution of Coomassie blue in methanol, glacial acetic acid and water 
(9:2:9) for an hour at 35°c. Destaining was accomplished by incuba-
ting the gels at 35°C in a solution of methanol, glacial acetic acid 
and water (9:2:9) unti I the bands were clear. The gels were stored 
In a 7% (v/v) solution of glacial acetic acid In water in stoppered 
tubes. 
The pooled fractions from the Sephadex G50 column were electrophor-
esed in the same manner, using the same marker proteins. 
4.2 CHARACTERIZATION OF TMV PROTEIN 1 THE PROTEINS OF THE TMV MUTANTS 
AND THEIR PEPTIDES 
4.2. I PEPTIDE MAPPING OF THE pH 4,5 SOLUBLE TRYPTIC PEPTIDES 
A 40x35 cm sheet of Whatman 3 Chroma paper was prepared for electropho-
resis by.marking the origin in penci I in the middle of the length of 
the sheet and 5 cm from the edge, and by soaking the paper in electro-
phoretic buffer, which contained 200 ml acetone, 80 ml pyridine and 
720 ml water. The pH of the buffer was adjusted to 6;4 by the addition 
of glacial acetic acid. 
I mg of the pH 4,5 soluble tryptlc digest (4.1.4.1) was dissolved in 
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10 µI of water (a micro-drop of 25% (w/v) ammonia solution (Merck) 
was added if there was difficulty with solubi lization) and applied 
with a Hami I ton syringe to the origin of the damp paper. The digest 
was electrophoresed at approximately 1000 V and 45 mA in a Hormuth-
Vetter Pherograph (model 64) for 2,5 hrs at +4°c, using wicks, and 
dried by evaporation at room temperature. 
Subsequently, the dried paper was subjected to ascending chromatogra-
phy with a pyridine:iso-amylalcohol :water as the phase, which was 
prepared by mixing the constituents in the ratio 5:4:4. A Shandon 
500 Chromotank was used for the chromatography. 
The paper was then thoroughly dried by evaporation and the different 
peptide spots were developed by staining with the fol lowing reagents: 
(I) 0,2% Cw/v) ninhydrin in ethanol containing 5% Cv/v) col Ii dine; 
(2) Ehrlichs reagent - 10% (w/v) p-dimethylaminobenzaldehyde in ace-
tone (Merck "pro-analysi") containing 20% (v/v) concentrated CD=l .19 
g/ml) HCI (Jepson, 1963); or (3) 0,02% (w/v) phenanthrenequi none in 
ethanol mixed with an equal volume of 10% Cw/v) NaOH in a solution of 
60% Cv/v) ethanol in water (Yamada and ltano, 1966). The ninhydrin 
reagent stains al I the pH 4,5 soluble tryptic peptides of TMV protein, 
except peptide 12 (residues 142-158), and imparts a distinctive yellow 
colour to peptide I I (residues 135-141) and a grey colour to peptide 7 
(residues 91-92). The two tryptophan containing peptides, peptide 3 
(residues 47-61) and peptide 12 (residues 142-158) are stained with the 
Ehrlichs reagent, while the phenanthrenequinone method causes al I the 
peptides except peptide 4 (residues 62-68) and 12 (residues 142-158) 
which do noi contain arginine, to fluoresce in ultraviolet light with a 
wavelength of 266 nm. 
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4.2.2 AMINO ACID ANALYSIS 
Dried samples of proteins Cl ,O mg) and peptides (0,5 ml of each pep-
tide solution was evaporated) for amino acid analysis were dissolved 
in 500 µI of twice disti I led, constant boi I ing, HCI, containing 2 
drops of thioglycollc acid, and hydrolysed for 20 hrs at I05°C in 
sealed tubes flushed with nitrogen and evacuated to 0,02 mm Hg (Hare, 
1975). Mr. J. de A. Rodrigues, of the Department of Biochemistry of 
the University of Cape Town, assisted in the identification of the 
free amino acids on a Beckman Amino Acid Analyser model 119. An in-
ternal standard of norleucine was used with the neutral and acidic am-
ino acids while a-amino S-guanidinopropionic acid CAGP) was used with 
the basic amino acids, and quantitation was done by means of A/D con-
verters between the 440 and 570 mµ channels of the analyser and a 
Hewlett Packard computer (Laboratory Data System 3352B). 
No corrections were made for hydrolytic losses or incomplete cleavage. 
4.2.3 SDS-POLYACRYLAMIDE GEL ELECTROPHORESIS OF TMV PROTEIN AND THE 
TRYPTIC I-PEPTIDES FROM TMV, Ni I 18 AND Ni 568. 
Samples (ranging from 5-50µ1) of solutions of TMV protein and the tryp-
tic I-peptides from TMV, Ni 118 and Ni 568, were electrophoresed in SDS-
polyacrylamide slab gels containing 18% (w/v) acrylamide according to 
the met~od of Thomas and Kornberg (1975), which is a modification of the 
method of Laemml i ( 1970). The electrophoresis was performed by Miss S. 
L.U. Schwager of the Department of Biochemistry of the University of 
Cape Town. The gels were stained in a 0,1% Cw/v) solution of Coomassie 
bri I Ii ant blue in methanol :acetic acid:water (5:1 :5), and destained by 
diffusion at 37°C in 5% (w/v) methanol mixed with 7,5% (v/v) glacial ace-
tic acid in water. The resu I ts were recorded as densitometer traces 
(Vitatron T L D 100 densitometer) using a 615 nm filter. 
4.2.4 ULTRACENTRIFUGAL ANALYSIS OF TMV PROTEIN 
The sedimentation coefficient (S) of TMV protein preparations was 
determined by sedimentation velocity experiments in a Beckman model 
E analytical ultracentrifuge (Chervenka, 1969). An AnD rotor with 
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a standard 12 mm single sector centrepiece was used. The samples 
were centrifuged at 40000 r.p.m. and 56000 r.p.m. and photographs were 
taken at various intervals with the sch I ieren optical system. The 
logarithm of the distance of the peak from the axis of rotation at 
various time intervals was plotted against time and the S value was 
calculated from the resulting graph. 
4.3 
4.3. I 
4. 3. I • I 
IMMUNOCHEMICAL METHODS 
ANTI SERA 
PREPARATION OF ANTISERA 
Rabbits were immunized by a series of intramuscular injections consis-
ting of 2,0-4,0 mg immunogen in 1,0 ml sterile water (TMV protein), or 
0,05M sodium phosphate buffer pH 7,5 (TMV), mixed with 1,0 ml of Freunds 
incomplete adjuvant, at intervals of 2-3 weeks. The immunogens were: 
TMV, formalinized TMV, TMV protein, formalinized TMV protein, bovine 
serum albumin, human serum albumin and H3 histone. The formalinized 
virus and virus protein were prepared by dialysis against 0,2-0,5% for-
maldehyde (final concentration w/v) solutions (van Regenmortel and Le-
large, 1973). Antiserum was collected from the animals at various inter-
vals over a period of several months by bleeding from the ear vein fol lo-
wed by clotting of the blood at room temperature and extraction of the 
serum by centrifugation at 12000 g for 10 min. Normal rabbit serum from 
unimmunized animals was collected in the same manner. Often a number of 
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subsequent bleedings from .. t"he same an-imal: were pooled. 
Goat anti-rabbit serum was prepared by immunizing a goat with 4,0 mg 
of rabbit lgG (prepared by the method of Reif (1969) in I ,0 ml sterile 
0,15M NaCl mixed with I ,0 ml of Incomplete Freu~ds adjuvant, Injected 
I ntramuscu I ar ly. Injections of immunogen were repeated weekly, as 
were the bleedings from the jugular vein. The serum was extracted 
from the blood by the same method that was used for the rabbit anti-
sera. Every two subsequent bleedings were pooled. 
Al I antlsera were prepared under the supervision of Dr. M.B. von Wech-
mar of the Department of Microbiology of the University of Cape Town 
0 and subsequently stored at -20 C. 
4.3. 1.2 CROSS-ABSORPTION OF SERA 
4.3. 1.2. I ABSORPTION OF TMV PROTEIN ANTISERA WITH TMV 
The virus specific antibodies were absorbed from TMV protein antisera 
by the incubation of the sera with formalinized TMV, which dissociat-
es less than the untreated virus (van Regenmortel and Lelarge, 1973). 
Antisera intended for absorption with TMV were titered by a tube pre-
clpltin test with TMV as the antigen, to ascertain optimal proportions 
for the· reaction of the TMV specific antibodies in the serum with the 
intact virus. The amount of TMV required to absorb a specific volume 
of serum was calculated,and formallnized TMV in excess of this amount 
was mixed with the serum and incubated at 37°c for 2 hrs before being 
left at +4°C overnight. The TMV-antibody precipitate was removed by 
centrifugation at 17400 g for 15 min and the supernatant, which con-
tained the TMV protein specific antibodies, was centrifuged at 167500 g 
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for I hr to remove any remaining unprecipitated virus. 
This procedure was repeated unti I the TMV protein antlsera were shown 
to be free of TMV specific antibodies by tube preclpitln and Ouchter-
lony tests. The sera were concentrated to their orig~nal volume by 
evaporation and stored at -20°c. 
4.3. 1.2.2 ABSORPTION OF TMV ANTISERA WITH TMV PROTEIN 
0 Lyophl Ii zed TMV protein wa5 dissolved in dlsti I led water at +4 C and 
di luted with an equal volume of pH 8,0 borate buffered saline (pre-
pared by dissolving 78,lg NaCl, 70,0g H3Bo3 and 50,5g Na2B4o7. IOH2o 
in 2,0 litre dist! I led water and adju5tlng the pH of a five-fold di lu-
tion of this solution to 8,0 with l,OM HCI). Thi5 solution was cen-
trlfuged at 167500 g for I hr, to remove protein aggregates, and 
spectrophotometrical ly quantitated using an extinction coefficien~ of 
0 1% E 282 nm= 1,27 (Fraenkel-Conrat, 1957). 
TMV antisera, intended for absorption with TMV protein, were adjusted 
to pH 8,0 with 0,IM NaOH and were titred by a tube precipitin test 
with TMV protein as the antigen, to ascertain optimal proportions for 
the reaction of the TMV protein specific antibodies in the serum with 
the disaggregated protein. The amount of TMV protein required to ab-
sorb a specific volume of serum was calculated, and an exactly equlva-
lent volume of the pH 8,0,TMV protein solution was mixed with the serum 
and Incubated overnight at +4°C. The TMV protein-antibody precipitate 
was removed by centrifugation at 17400 g for 10 min and the supernatant, 
which contained the TMV specific antibodies, was kept. 
This procedure was repeated unti I the TMV antisera were shown to be 
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free of TMV protein specific antibodies by tube precipitin and Ouch-
ter I ony tests. The resultant di luted antiserum supernatant was 
adjusted to pH 5,0 with O,IM HCI to encourage the formation of RNA-
free he Ii ces of any unp reci pi tated TMV protel n remaining in the serum, 
and left for 2 days at room temperature. After centrifugation of 
the serum at 167500 g for I hr it was adjusted back to pH 7,5 with 
0,IM NaOH, and' concentrated to its original volume by evaporation. 
The absence of free TMV protein in the absorbed sera was demonstrated 
by tube precipitin and Ouchterlony tests with a good anti-TMY protein 
serum. 0 Absorbed sera were stored at -20 C. 
4.3. 1.3 THE ISOLATION OF THE GLOBULIN FRACTION FROM WHOLE SERA 
Anti-TMY and anti-TMV protein globulins were prepared from whole and 
absorbed immune sera by precipitation In 50% (w/v) saturated ammonium 
sulphate by the method advocated by Campbel I et~· (1970). 
Each serum was mixed with an equal volume of 4,0M (NH4 >2so4, that was 
added dropwise with a burette, so that an insoluble precipitate was 
formed. The pH of the suspension was adjusted to pH 7,4 with 2,0M 
NaOH and left stirring for 30 min at room temperature before centri-
fugation at maximum revolutions (1000 g) in a Roto-Uni bench top cen-
tri fuge for 30 min. The supernatant was discarded and the precipi-
tate was dissolved in 0,15M NaCl made O,OOIM with phosphate buffer and 
pH adjusted to 7,4 with I ,OM NaOH. This crude globulin preparation 
was precipitated two more times In the same manner, to purify it. The 
final solution of globulins in pH 7,4 saline was exhaustively dialysed 
against repeated changes of borate buffered saline pH 8,0 (4.3.1.2.2) 
unti I no more sulphate ions could be detected in the dialysate, outside 
the membrane, with barium chloride. After dialysis the globulin prep-
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aration was centrifuged at 27000 g for 60 min and the volume of the 
supernatant was adjusted to that of the original whole serum. 
The concentration of the globulin preparations was determined spec-
trophotometrical ly using an extinction coefficient of E ~a~%~m = I ,43 
as a compromise for that suggested by Little and Elsen (1968) on the 
advice of Dr. J.D. Young (personal communication). 
preparations were stored at -20°c. 
4.3.2 COMPLEMENT FIXATION ASSAYS 
The globulin 
The microcomplement fixation method of Levine (Wasserman and Levine, 
1961; Levine and van Vunakis, 1968) was used with minor modifications 
as described below. 
4.3.2.1 EXPERIMENTAL PROCEDURE 
4.3.2. I.I EQUIPMENT 
Sorval I glass centrifuge tubes with the dimensions 120xl7 mm were 
employed as reaction tubes and adaptors were used to fit the tubes 
into the swinging-buckets of the Sorval I HS-4 rotor. Al I low speed 
centrifugation was carried out in a refrigerated Sorval I RC2-8 cen-
trifuge. 
Pipetting was done with serological pipettes or Cornwal I type, 2 ml 
and 5 ml, automatic pipetting outfits (Becton, Dickinson and Co.). 
The complement fixation assays were incubated in a large thermoregu-
lated waterbath (Labotec Pty. Ltd.) and in a cold room regulated to 
0 +4 c. 
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Al I optical density detenninations were made with a Pye Unlearn 
SP 1700 digital read-out spectrophotometer. 
4.3.2.1.2 DILUENTS 
A stock solution of TRIS-NaCl buffer was prepared by dissolving 81,6g 
NaCl and 12,lg TrisChydroxymethyl )aminomethane in approximately 800 
ml of disti I led water. A further 6,6 ml of concentrated HCI was 
added, the solution was mixed, and 33,0 ml of 0,15M MgS04 and l~,O ml 
of O,IM Cac1 2 were added to the solution. The pH was adjusted to 7,4 
with concentrated HCI and the volume was made up to I ,0 litre. Ten-
fold dilutions of this stock buffer were made, adjusted to pH 7,4 and 
used in the assays. Both stock buffer and the di luted TRIS-NaCl 
0 buffer were stored at +4 C. 
A separate 0,1% Cw/v) solution of ovalbumin in TRIS-NaCl diluent was 
0 also prepared and stored at +4 C. No preservatives, such as sodium 
azide,were used in the buffers or sera, as these compounds have an 
adverse effect on sheep erythrocytes. 
4.3.2. 1.3 SHEEP ERYTHROCYTES 
Blood taken from sheep was mixed with an equal volume of Alsevers 
0 solution and stored at +4 C for a week before use so that the erythro-
cytes were uniformly susceptible to immune haemolysis (Levine and van 
Vunakis, 1968). It was found that sheep erythrocytes remained stable 
at this temperature for at least a month. 
A 5% suspension of sheep erythrocytes was prepared from the whole 
blood immediately preparatory to its use In an assay: The blood was 
washed three times in the TRIS-NaCl diluent at 500 g for 10 min, or 
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untl I the supernatant was colourless. A 1120 dilution of packed sheep 
erythrocytes was made in TRIS-NaCl diluent and quantitated by lysing 
1,0 ml of this suspension with 14,0 ml of fresh 0,1% (w/v) Na2co3 sol-
tu ion. The absorbance of the lysed eel Is was read against dlsti I led 
water at a wavelength of 541 nm. The volume of the 1120 suspension 
was adjusted to make it 5% with respect to sheep erythrocytes accord-
ing to the fol lowing formula:-
volume of SRBC 
solution in ml 
1,0 ml of the 5% 
x absorbance at 541 nm 0,680 
volume of diluent to be 
added in ml. 
suspension of sheep erythrocytes lysed in 14,0 ml of 
0,1% (w/v) Na2co3 solution had an absorbance of 0,680 at 541 nm (Levine 
and van Vunakis, 1968). 
4.3.2. I .4 SENSITIZATION OF SHEEP ERYTHROCYTES 
Rabbit haemolytic serum for sheep red eel Is (haemolysin) was obtained 
from Wei I come Reagents Ltd. and was found to have a consistent titre 
of 11100. If, however, the haemolytic antibody is to be titered for 
optimum sensitization of eel Is, the method of Osler et~· (1952) 
should be used. Al I haemolysin was stored at +4°C without preserva-
tives. 
For sensitization of the sheep erythrocytes, an equal volume of a 
11100 dilution of haemolysin in TRIS-NaCl diluent was added slowly 
to the 5% suspension of erythrocytes (4.3.2.I .3) in an Erlenmeyer 
flask with constant swirling of the contents. After incubation at 
37°c for 15 min to al low for maximum sensitization, the resultant 
2,5% suspension of the sensitized erythrocytes was di luted with TRIS-
NaCl diluent to ensure a final concentration of 0,25% sheep erythro-
cytes. This suspension of sensitized erythrocytes was kept on ice 
at o0 c, for a maximum of 8 hrs, unti I it was used. 
4.3.2.1 .5 COMPLEMENT 
Lyophi Ii zed guinea pig serum (Behring lnstltut) was reconstituted 
with the supplied diluent and stored at +4°C. 
The complement was titered by adding I ,0 ml of each of a series of 
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I I I I complement dilutions corresponding to /100, /125, /150, /175, •.• 
I ..•. /400, to 4,0 ml of TRIS-NaCl diluent and I ,0 ml of 0,1% (w/v) 
solution of ovalbumin in diluent in centrifuge tubes, in an ice bath. 
After incubation for 16-18 hrs at +4°C (to mimic the conditions of 
an assay), I ,0 ml of the 0,25% suspension of sensitized sheep eryth-
rocytes (4.3.2.1.4) was added and haemolysis was allowed to proceed 
at 37°c for 60 min. Controls with an excess of complement, as wel I 
as no complement, were included in order to determine the extent of 
complete lysls and the background lysis of the sensitized blood eel Is 
respectively. After incubation the haemolysis reaction was stopped 
by immersing the tubes in an ice bath for 15 min preparatory to cen-
trifugation at 770 g for 10 min. The absorbance of each supernatant 
was read at a wavelength of 413 nm against distil led water, and this 
value was plotted against the complement dilution as i I lustrated in 
fig. 4.3. The titre of the complement was taken as the highest di lu-
tion of complement that gave complete lysis. 
Complement should be re-titrated at least every seven days as Its 
activity decays in solution. 
4.3.2.1 .6 ANTI SERA 
Antisera specific for the various antigens (4.3.2.1 .7) used in the 
complement fixation assays were raised in rabbits (4.3. I. I). Each 
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Titration of reconstituted lyophi Ii zed guinea pig cample-
ment for complement fixation tests. Increasing dilutions 
of complement were used to lyse a constant number of sheep 
erythrocytes sensitized with rabbit haemolysin with a titre 
of 1/100. The titre of the compl~ment is 1/175. (4.3. I. I) 
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ment proteins before being diluted with TRIS-NaCl diluent to the 
desired extent for the particular complement fixation assay. 
The titre of an antiserum was taken to be that dilution of the serum 
which gave 75% fixation at the peak of the complement fixation curve 
(Champion et 3!!_., 1974). Dilutions of antiserum were chosen with 
the Intention of bracketing the titre so that the complement fixation 
curves ranged from approximately 20-80% fixation, but the most suit-
able dilutions had to be determined by trial and error for each anti-
serum. 
4.3.2.1 .7 ANTIGENS 
The antigens used In complement fixation assays were prepared differ-
ently. 
Prior to each assay, TMV was centrifuged at 87500 g for 20 min in a 
swinging-bucket rotor to select for long virus rods and to remove any 
dissociated protein. It was then resuspended in TRIS-NaCl diluent 
and the concentration of the solution was determined from Its extinc-
tion at 260 nm. A correction for I ight-scattering was made by using 
the formula of Rayleigh and the fol lowing extinction coefficient: 
3204 




E 260nm(corrected) 310 
(Hendry, 1977) 
Lyophl I I zed TMV protein was dissolved in cold dist! I led water (+4°C>, 
di luted with double strength TRIS-NaCl diluent and centrifuged at 
167500 g for I hr immediately before use, to remove protein aggregates. 
The concentration of protein In the supernatant was determined from its 
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extinction at 282 nm with the extinction coefficient of EO,I% 
282 nm = I ,27 
( Fraenke I-Con rat, 1957). 
Salt-free, lyophi llzed H3 hlstone was obtained from Mr. D.R. Absolom 
of the Department of Microbiology, University of Cape Town. It was 
dissolved in TRIS-NaCl diluent to make a stock solution of known con-
centration. 
The range of antigen concentrations required to achieve maximum fixa-
tion of complement was found to vary with different antisera and was 
selected by trial and error. 
4.3.2. 1.8 THE COMPLEMENT FIXATION ASSAY 
Each complement fixation assay was usually performed with a range of 
antiserum dilutions which bracketed the serum titre. A series of 
centrifuge tubes was set aside for each antiserum dilution. 
To each series of centrifuge tubes, in an ice bath, was added in or-
der, 1,0 ml di luted antiserum, 1,0 ml 0,1% (w/v) solution of oval-
bumin in diluent, 2,0 ml of TRIS-NaCl diluent, I ,O ml di luted comp-
lement, previously titred (4.3.2.1.5) and 1,0 ml antigen solution, 
serially di luted in twofold steps.· Simi ltaneously, the fol lowing 
controls were prepared to assist the interpretation and quantitation 
of the assay: (I) tubes containing each antiserum dilution and 
complement, but no antigen, to test for anticomplementary activity by 
the serum; (2) a tube containing the highest concentration of antigen 
used in the assay and complement, but no antibody, to test for comple-
ment binding or destruction by the antigen; (3) two tubes, one with a 
single aliquot of complement and the other with double the amount, to. 
Summary of complement fixation assay. 
A ) Prep a rat i on : 
I) TRIS-NaCl diluent 
2) 0,1% (w/v) ovalbumin in TRIS-NaCl diluent 
3) titrate complement {if necessary) 
4) Ab di I utions 
5) Ag di I ut i ons 






1,0 m I 
I ,O m I 
Controls 
Ab Ag 100% lysls 
Ab di I uti on I ,O ml - -
O, I% ova I b. I ,O ml 1,0 ml I ,0 ml 
TRIS-NaCl di I uent 3,0 ml 3,0 ml 3,0+ml} 4,0 ml 
C' dilution 
Ag di I uti on 
I ,0 ml 1,0 ml 2,0+ml} 1,0 ml 
- I ,0 ml -













I ,O ml sensitized SRBC to al I tests and controls 
I hr at 37°C 
C) Resu I ts: 
15 min at o0 c (Ice bath) 
770 g for 10 min 
Read at A413 nm 
<A413 100% lysis - A413 bkgd.*) - <A413test - A413bkgd.*) %CF=100x·---------------.,-,,----,-:=-::r-:---:------,.-----:--,--:---::~-------------
<* bkgd. = background) 
Plot %CF vs Ag cone. 
(A413100% lysis - A413 bkgd.*) 
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determine the extent of total lysis; and (4) two tubes containing 
only diluent and ovalbumin solution, to determine the background lysis 
of the sheep erythrocytes. The total volume contained in each tube 
of the assay, as wel I as the controls, was 6,0 ml. 
The contents of each tube were mixed and left to incubate at +4°C for 
16-18 hrs while antigen binding and complement fixation occurred. 
Thereafter, 1,0 ml of a 2,5% suspension of sensitized sheep erythro-
cytes (4.3.2.1 .4) was added to each tube and haemolysis was al lowed to 
proceed for 60 min in a 37°c waterbath. After immersion in an ice 
bath for 15 min to stop the haemolytic reaction, the tubes were centri-
fuged at 770 g for 10 min and the absorbance of the supernatants was 
read at a wavelength of 413 nm. 
The results, expressed as the percentage of complement fixed by the 
anti body-anti gen comp I exes, were ca I cu I ated as to 11 ows: 
(A413nmtotal lysis-A413 nmbkgd.*)-CA413nmtest-A413nmbkgd.*) %CF = x 100 
(A413nmtota I lys i s-A413nmbkgd. *) 
C* bkgd. = background) 
The percentage complement fixed was plotted against the antigen con-
centration in µg/ml to give the characteristic complement fixation 
curve (figures 2. 13 and 2. 14). 
4.3.2. I .9 INHIBITION AND ENHANCEMENT OF COMPLEMENT FIXATION BY PEPTIDES 
The antiserum dilution was carefully chosen, so that the complement fixa-
tion curve formed a peak at approximately 75% fixation (the titre of the 
serum)~ for inhibition studies, while a peak of approximately 30% fixation 
was preferable for studies with peptides known to enhance complement fix-
at Ion. 
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1,0 ml of di luted antiserum was pipetted Into each centrifuge tube 
in the assay and to this was added I ,0 ml of the appropriate con-
centratlon of peptide dissolved in 0,1% (w/v) solution of ovalbumin 
in di I uent. Identical peptide dilutions were added to each tube 
of a series comprising a complement fixation curve, and Increasingly 
di luted peptide solutions were added to each subsequent series of 
tubes. The antiserum-peptide mixtures were incubated at 37°c for 
15 min In a waterbath. After cooling in an ice bath the normal 
procedure for complement fixation (4.3.2. 1.8) was continued, except 
that. an additional control was prepared with peptide and complement 
only, to ensure that the peptide did not behave in a pro- or anti-
complementary fashion. Normal complement fixation assays with the 
same antiserum dilution were performed in trfpllcate, simultaneously 
with the inhibition or enhancement assay, for the purpose of comparl-
son. 
The percentage inhibition of complement fixation caused by each concen-
tration of peptide was calculated from the degree by which the peak of 
the normal complement fixation curve was depressed in the presence of 
the peptide. The fol lowing formula was used: 
% Inhibition of = 100 -( % fixation t"d x IOO) 
I t f . ti pep 1 e comp emen 1 xa on % f i·xati on 
norma I 
Percentage inhibition of complement fixation was plotted against the 
amount of peptide inhibitor (fig. 2.18). 
In the case of a peptide enhancing the complement fixation,caused by 
the antigen and antibody, no attempt was made to calculate the extent 
of that enhancement. 
4.3.3 BINDING ASSAYS WITH N-C 3H)ACETYL PEPTIDES 
4.3.3. I DETERMINATION OF RADIOACTIVITY 
Radioactivity was determined using a Packard Trl-Carb model 3385 
liquid scinti I lation counter. Samples, made up to 1,0 ml with 
disti I led water or buffer, were counted in standard plastic scin-
ti I lation vials (Packard) using 10,0 ml of lnsta-Gel scinti I lation 
cocktai I (Packard). 
Counts per minute (cpm)-were either used without correc-i·ion, or were 
converted to disintegrations per minute (dpm) using Packard standard 
quenched samples. The quench correction curves were stored in a· 
Wang 700 bench top computer program, which was written by Mr. E. Lee 
of the Department of Biochemistry, University of Cape Town. 
4.3.3.2 LABELLING OF PEPTIDES WITH 3H-ACETIC ANHYDRIDE 
Tritiated acetic anhydride with a specific activity of approximately 
4 Ci/m-mole was obtained from The Radiochemical Centre, Amersham, and 
used to label the four pH 4,5 soluble tryptic peptides of TMV protein 
utilized in this work. They were, peptide 4 (residues 62-68), pep-
tide 8 (residues 93-112), peptide 11 (residues 135-141) and peptide 
12 (residues (142-158). A synthetic peptide corresponding to resi-
dues 134-141 of the protein of the U2 strain of TMV was prepared by 
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Dr. J .D. Young of the Space Sciences Laboratory of the University of 
California by the solid phase peptide synthesis method (Merrifield and 
Stewart, 1965),and it also was label led with tritiated acetic anhydride. 
The method described by Benjamini et~· (1965) was used to acetylate 
the peptides. 
500 n-moles of peptide in aqueous solution were pipetted into the 
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titration vessel and buffered with 100 µI of a 0,5 M sodium phosphate 
buffer pH 7,5. The volume of the peptide solution was increased to 
1,0 ml with disti I led water so that a smal I electrode from a pH meter 
could be immersed in it. The pH of the peptide solution was adjusted 
to 7,5 with O,IM NaOH while stirring continued. 
The tritiated acetic anhydride was dissolved in 1,0 ml of benzene (add-
ed to the frozen tritiated acetic anhydride in its vial) and this was 
added to the peptide solution at the rate of 100 µI every five minutes 
with constant stirring. The pH was maintained at 7,5 by the dropwlse 
addition of O,IM NaOH. After al I the tritiated acetic anhydride sol-
ution had been added, the peptide solution was left stirring at room 
temperature for an hour, then the pH was again adjusted to 7,5. The 
acetylated peptide solution was sealed and left at +4°C for 16-18 hrs 
before the benzene was evaporated off the solution. 
The N-C 3H)acetyl peptide was separated from the unreacted acetate in 
the solution by exclusion chromatography using a 40x2,6 cm column of 
Sephadex G25 medium equilibrated with a solution of 50% (v/v) glacial 
acetic acid in water. The column was run with the same solution and 
a flow rate of 30 ml/hr was maintained while 2,0 ml fractions of the 
eluarrt were collected. 5 µI of .each fraction, I ,0 ml of dist! I led 
water and 10,0 ml of lnsta-Gel scintillation cocktai I (Packard) were 
mixed in plastic sclntl I lation vials and counted in a Packard Tri-
Carb model 3385 liquid scinti I lation counter for 0,1 min ((4.3.3.1). 
Counts per 0,1 min were plotted against the fraction number to obtain 
the elution prof! le (fig. 4.4). The first peak in the elution profile 
was pooled and evaporated to dryness ,in a vacuum dessicator in the pre-
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Fig. 4.4 The separation of N-< 3H> acetyl tryptic peptide 4 (residues 
62-68) from unreacted (3H) acetate by exclusion chromato-
graphy on a 40x2,6 cm Sephadex G25 column equi I ibrated and 
run with a solution of 50% (v/v) glacial acetic acid in 
water. The flow rate was maintained at 30 ml/hr and 2,0 ml 
·fractions were collected. The radioactivity in 5 µf of 
each sample was determined and plotted against the fraction 
number. The bars (I) indicate the fractions that were pooled. 
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was di sea rded. The purified, dried N-C3H> acetyl peptide was dissol-
ved in disti I led water to a calculated concentration of 100 n-moles/ml 
and a portion of this solution was submitted for amino acid analysis 
after the peptide had been hydrolysed (4.2.2). 
4.3.3.3 EXPERIMENTAL PROCEDURE 
The method, here described, is a modification of the Farr technique 
(Farr, 1958) which was used by Benjamini et tl· (1965) in their work 
with tryptic peptide 8 (residues 93-112>. Instead of precipitating 
the immune complexes with 50% (w/v) saturated (NH 4>2so4, a double-
antibody system (Coombs et tl·, 1945) was used. 
4.3.3.3. I EQUIPMENT 
Falcon clear plastic tubes with the dimensions 75xl0 mm were employed 
as reaction tubes and adaptors were used to fit the tubes into the 
swinging-buckets of a Sorval I HS-4 rotor. Centrifugation was carried 
out in a refrigetated Sorval I RC2-B centrifuge. 
Pipetting was done with microliter Finnpipettes using Finntlps of the 
app rop ri ate s I zes. Radioactivity determinations were carried out on 
a Packard Tri-Carb model 3385 I iquid scinti I lation counter (4.3.3. I). 
4.3.3.3.2 DILUENTS 
A stock solution of borate buffered saline was prepared by dissolving 
78,lg of NaCl, 70,0g of H3Bo3 and 50,5g of Na2s4o7.10H20 in disti I led 
water and adjusting the vo I ume of the so I ut ion to I ,0 I i tre. Five-
fold dilutions of thl°s stock buffer were made, adjusted to pH 7,5 with 
l,OM HCI and used to di lute the globulin preparations. Both the stock 
buffer and the di luted borate buffered saline were stored at +4°C. 
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A separate 1,0% (w/v) solution of ovalbumin in borate buffered saline 
0 pH 7,5, was also prepared and stored at +4 C. This was used to di lute 
3 the N-( H)acetyl peptide solutions. 
4.3.3.3.3 SPECIFIC RABBIT GLOBULINS 
Globulin preparations (4.3.1 .3) of cross-absorbed (4.3. 1.2) and whole 
rabbit antisera (4.3.1 .I) were made and di luted to a final concentra-
tion of 5,0 mg/ml with borate buffered saline pH 7,5, for use in the 
direct binding assays. The di luted globulin preparai·ions were stored 
at+ 4°C with sodium azide 0,04% (w/v) as a preservative. 
4.3.3.3.4 GOAT-ANTI RABBIT GLOBULINS 
A globulin preparation (4.3.1 .3) of a goat antiserum specific for rab-
bit lgG (4.3.I .I) was adjusted to serum strength with borate buffered 
saline pH 7,5, and titrated against increasing concentrations of rabbit 
fgG (prepared by the method of Reif (1969) by tube precipitin test to 
find the proportions of goat and rabbit antibodies, which gave complete 
p rec i pi tat ion. This was found to occur with 500 µI of goat-anti rabbit 
globulins and 0,05 mg of rabbit lgG. 
The goat-anti rabbit globulins were stored at +4°c with sodium azide 0,04% 
(w/v) as a.preservative. 
4.3.3.3.5 N-< 3H)ACETYL PEPTIDES 
The concentrations of the N-C 3H>acetyl peptide preparations (4.3.3.2) 
were calculated from the amino acid analyses (4.2.2) of the peptides 
and adjusted to a final concentration of 0,042 n-moles/100 µI with a 
1% (w/v) solution of ovalbumin in borate buffered saline pH 7,5. The 
label led peptide solutions were stored at -20°c. 
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4.3.3.3.6 THE DIRECT BINDING ASSAY 
The binding assay consisted of mixing 0,05 mg (100 µI of a 0,5 mg/ml 
solution) of specific globulins with 0,042 n-moles (100 µI) of N-< 3H> 
acetyl peptide and incubating the mixture for 15 min at room tempera-
tu re. Thereafter 500 µI of goat-anti rabbit globulins (4.3.3.3.4) 
were added and the mixture incubated for 17 hrs at +4°C. The preci-
p I tates were cent'ri fuged at 7000 g for I hr and the supernatants were 
discarded. The inner sides of each tube were wiped dry with a tissue, 
with out disturbing the precipitate. The precipitates were dissolved 
in 1,0 ml l,OM NaOH and 0,5 ml of the resuspended precipitate was tra-
nsferred to counting vials, where a further 0,5 ml of 2,0M HCI and 
10,0 ml lnsta-Gel scinti I lat ion cocktai I (Packard) were added. The 
vials were counted twice on a Packard Trl-Carb model 3385 I iquid scin-
ti I latlon counter (4.3.3.1). 
The extent of non-specific binding was determined by using globulins 
obtained from unimmunized rabbits and from rabbits Immunized with 
human serum albumin. The specific binding was calculated by subtrac-
ting the average count of two non-specific binding tests from the 
binding observed with specific globulins: 
% peptide av. cpm/test - av. cpm/non-specific control 100 
specifically=< >x---
bound specific activity ·of peptide in cpm/n-mole 0,042 
The background cpm resulting from N-C 3H>acetyl peptide sticking to the 
walls of the tubes was determined by omitting the globulins from a set 
of controls, and then treating them identically to the rest of the assay. 
4.3.3.3.7 INHIBITION OF THE SPECIFIC BINDING OF THE N-C 3H)ACETYL 
PEPTIDES BY UNLABELLED PEPTIDES 
The direct binding assay was done as described in section 4.3.3.3.6, 
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except that increasing concentrations of the same, but unlabelled, 
peptide were incubated for 15 min at room temperature with a constant 
amount of specific globulins C0,05 mg) before 0,042 n-moles of the 
N-C 3H>acetyl peptide was added to each test. Controls containing no 
inhibitor were carried out simi ltaneously with the assay, in addition 
to the non-specific binding and background controls. 
4.3.4 MICRO-PRECIPITIN ASSAYS WITH RADIOLABELLED ANTIGENS 
4.3.4. I PREPARATION OF RADIOLABELLED TMV AND TMV PROTEIN 
4.3.4.1. I INCORPORATION OF 3H-NUCLEOSIDES INTO TMV 
Tritiated nucleosides were incorporated into TMV in infected plants by 
the same basic method used by Singer (1971) to incorporate tritated 
amino acids into TMV protein. 
Young plants at the 3-4 leaf stage of development were infected with 
TMV by rubbing onto their leaves a mixture of an 8,0 mg/ml solution of 
TMV and celite. This was washed off and the plants were left for 2-4 
days while the infection became systemic (Hirai and Wildman, 1967). 
The stems of the plants were then cut off at soi I level and immersed 
in a smal I volume of a solution of the tritiated nucleosides unti I it 
had been completely imbibed. The rad I oacti ve materi a I was "washed" 
into the plants by further smal I aliquots of water, and then the plants 
were floated on Knopps solution Cl ,Og CaCN03>2, 0,25g KH 2Po4, 0,25g MgS04 
an.d 0, 12g KCI dissolved in 1,0 I itre disti I led water) with constant I igh-
ting for a further 2-3 days, or unti I signs of wi I ting became ev~dent. 
The tritiated nucleosides that were used were [5,6- 3H] uridine and 
[2,5 1 ,8-3HJ adenosine, chosen for their high specific activities (~50 
Ci/m-mole) and obtained from The Radiochemical Centre, Amersham. These 
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tritiated nucleosides were used singly, and mixed, so that I ,0 mCi 
of the radioactive material was distributed amongst eight plants. 
The radioactive solutions were di luted with disti I led water. 
The radlolabel led TMV was extracted from the plant material by the same 
method as von Wechmar and van Regenmortel (1970). In some prepara-
tions polyethylene glycol was used to concentrate the virus, while in 
others the virus was concentrated by centrifugation at 65000 g for 
I hr after filtration through activated charcoal and celite (4.1.2). 
The purity and concentration of the radio label led TMV preparations 
were assessed by ultraviolet spectrophotometry (2. I. I) and the specific 
activity was determined using a Packard Tri-Carb model 3385 liquid scin-
ti I lation counter (4.3.3. I). 
The radiolabel led virus, suspended in O,lM Tris(hydroxymethyl )amino-
0 methane-0,i5M NaCl buffer pH 6,8 (4.3.4.2.2), was stored at +4 C. 
4.3.4. 1.2 INCORPORATION OF 3H-AMINO ACIDS INTO TMV PROTEIN 
The method of Singer (1971) was used to incorporate the fol lowing tri-
tiated amino acids into TMV protein in infected plants: 
L-[2,3-3HJ alanine, L-[4,5(n)-3HJ isoleucine, L-[4,5-3HJ leucine, 
L-[3-3HJ -serine and L-[3,4Cn>-3HJ valine. These radiolabel led amino 
acids, which were obtained fr91TI the The Radiochemical Centre, Amersham, 
were chosen for their high specific activities (10-40 mCi/m-mole). They 
were di luted with disti I led water so that 2,5 mCi of radioactive material 
was distributed amongst ten infected plants. The plants were selected, 
Infected with TMV,and prepared to imbibe the solution of the radioactive 
amino acids in the manner described in section 4.3.4. I. I. 
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TMV was extracted from the plant material by the method of von Wechmar 
and van Regenmortel (1970), using polyethylene glycol to concentrate 
the virus (4. 1.2). The radiolabel led TMV protein was prepared from 
the virus by the ethanolamine-DEAE method (Durham, 1972) as described 
in section 4.1.3.2, except that it was stored at +4°C in aqueous solu-
tion and not lyophi Ii zed. 
The purity and concentration of the radio label led TMV protein prepara-
tions were assesed by ultraviolet spectrophotometry (2. 1.2) and the 
specific activity was determined using a Packard Tri-Carb model 3385 
liquid scintillation counter (4.3.3.1). 
4.3;4.2 EXPERIMENTAL PROCEDURE 
4.3.4.2. I EQUIPMENT 
Standard glass Wasserman tubes, with the dimensions 75xl I mm, were 
employed as reaction tubes and adaptors were used to fit the tubes 
into the swinging-buckets of a Sorval I HS-4 rotor. Centrifugation 
was carried out in a refrigerated Sorval I RC2-B centrifuge. 
Pipetting was done with serological pipettes, Drummond Microdispen-
sers and Finnpipettes (using Finntips of the appropriate sizes). Rad-
ioactivity determinations were carried out on a Packard Tri-Carb 
model 3385 liquid scinti I lation counter (4.3.3. I). 
4.3.4.2.2 DILUENTS 
O,IM Trls(hydroxymethyl )aminomethane-0,15M NaCl buffers were prepared 
by the tenfold dilution of the TRIS-NaCl stock solution used in the 
complement fixation system (4.3.2. 1.2). The pH of the buffers was ad-
justed to 6,8, 7,4 or 8,0 with I ,OM HCI or l,OM NaOH, as required for 
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a particular assay. 
Separate solutions of 1,0% (w/v) ovalbumin in the TRIS-NaCl buffer were 
also adjusted to pH 6,8, 7,4 or 8,0 with I ,OM NaOH as required. 
All the·buffers were stored at +4°C until use. 
4.3.4.2.3 ANTISERA 
Antisera specific for TMV and TMV protein were raised in rabbits 
(4.3.1.1). Before use, the antisera were di luted with a solution of 
1,0% Cw/v) ovalbumin in TRIS-NaCl buffer, which was adjusted to the 
pH at which the assay was to be performed. 
4.3.4.2.4 RADIOLABELLED ANTIGENS 
Radiolabel led TMV and TMV protein were prepared as described in sec-
tions 4.3.4. I. I and 4.3.4. I .2. 
Prior to each assay, the radio label led TMV was centrifuged at 87500 g 
for 20 min in a swinging-bucket rotor to select for intact virus rods 
and to remove any dissociated protein. It was then resuspended in the 
TRIS-NaCl buffer pH 6,8 and the concentration of the solution was det-
ermined from its extinction at 260 nm. A correction for ltght scatter-
ing was· made by using the formula of Rayleigh and the fol lowing extinc-
tion coefficient: 
3204 
A260nm (corrected)= A260nm - (A320nm x ) 
2604 
( Hen d ry , I 9 77 ) 
E0,1% = 3,0 
260 nm (corrected) 
The solution of radiolabel led TMV was ~djusted to a final concentration 
of 25,0 µg/ml with TRIS-NaCl buffer pH 6.8. 
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The radiolabel led TMV protein solution, on the other hand, was di l-
uted with double strength TRIS-NaCl buffer pH 7,4 at +4°C, and cen-
trl fuged at 167500 g for I hr immediately before use to remove pro-
tein aggregates. The concentration of the protein in the superna-
tant was detennined from 
coefficient of E~ai%nm -
its extinction at 282 nm with an extinction 
1,27 CFraenkel-Conrat, 1957). The solution 
of radio label led TMV protein was adjusted to a final concentration of 
25,0 µg/ml with TRIS-NaCl buffer pH 7,4, for use in the assays. 
4.3.4.2.5 TITRATION OF THE ANTISERA WITH THE RADIOLABELLED ANTIGENS 
0,5 ml of each of a series of twofold dilutions of antiserum were 
added to I ,O ml of TRIS-NaCl buffer Cat the desired pH) in Wassennan 
tubes. To this was added 0,5 µg (20 µI) of the appropriate radio-
label led antigen and the mixture was Incubated for 17 hrs at +4°C. 
The precipitates were centrifuged at 3079 g for 10 min and I ,0 ml of 
the supernatant was mixed with 10,0 ml of lnsta-Gel scinti I lation 
cocktai I (Packard) in plastic counting vials (Packard). The radio-
activity in the vials was determined (4.3.3. I) and disintegrations 
per minute (dpm) were plotted against the reciprocal of the antiserum 
dilution. From this curve an antiserum dilution, which gave anti-
body:antigen proportions in the zone of antigen excess, near the equi-
valence point,was chosen for the inhibition studies (Fig.s 2.8 and 
2. 10). 
Five minimum binding controls, containing the radiolabel led antigen, 
but with a solution of 1,0% Cw/v) ovalbumin In TRIS-NaCl buffer re-
placing the antiserum, were included with each titration. 
In the case. of radlolabel led TMV protein, the initial mixing of 
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antigen and antiserum was carried out at +4°C to discourage protein 
aggregation (Klug and Durham, 1971). 
4.3.4.2.6 INHIBITION OF THE PRECIPITIN REACTION OF RADIOLABELLED 
TMV AND TMV PROTEIN WITH SPECIFIC ANTISERA 
The inhibition assays, with different inhibitors, were performed 
under various pH conditions. The inhibition of the radiolabel led 
TMV-anti TMV reaction by unlabelled virus protein was carried out 
at pH 6,8 and pH 8,0, whl le inhibition experiments with peptides in 
this system were done at pH 6,8. The inhibition of the radiolabel I-
ed TMV protein-anti TMV protein reaction by unlabelled virus protein 
and peptides was carried out at pH 7,4. Increasing amounts of the 
Inhibitors were di luted with TRIS-NaCl buffers at the appropriate pH 
for the assay, prior to their use. 
The antiserum was titrated (4.3.4.2.5) at the same pH as the inhibi-
tlon assay was to be done, and the antiserum dilution providing the 
antibody:antlgen proportions most suitable for inhibition studies was 
chosen. The serum was di luted with a solution of I ,0% (w/v) oval bu-
min in TRIS-NaCl buffer at the appropriate pH. 
The inhibition assay consisted of mixing 0,5 ml of the di luted anti-
serum in a solution of I ,0% (w/v) ovalbumin in TRIS-NaCl buffer with 
1,0 ml aliquots of Increasingly concentrated solutions of the inhibi-
tor in TRIS-NaCl buffer at the appropriate pH. The mixture was incu-
bated for 15 min at 37°c then left at +4°c for 17 hrs. 0,5 µg (20 µI) 
of the radlolabel led antigen was added and the mixture was incubated 
0 for a further 17 hrs at +4 C. The precipitates were centrifuged at 
3079 g for 10 min and I ,0 ml of the supernatant was mixed with 10,0 ml 
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of lnsta-Gel scinti I latlon cocktal I (Packard) In plastic counting 
vials (Packard). The radioactivity In the vials was determined 
(4.3.3.1) and disintegrations per minute Cdpm) were calculated. 
When radiolabel led TMV protein was the antigen, it was added to the 
mixture of antiserum and inhibitor at +4°C to discourage the forma-
tlon of protein aggregates (Klug and Durham, 1971 ). 
The fol lowing controls were included with each assay: Five tubes 
containing the radio label led antigen, but with a solution of I ,0% 
Cw/v) ovalbumin In TRIS-NaCl buffer and TRIS-NaCl buffer substitu-
ted for the antiserum and inhibitor respectively. These provided 
the average minimum binding control. Five tubes containing anti-
serum and radiolabel led antigen, but no Inhibitor, provided the 
average maximum binding control. All the controls were carried 
out at the same pH as the assay. 
The average dpm in the minimum binding controls corresponds to 100% 
Inhibition, and the average dpm in the maximum binding controls, to 
0% inhibition. The percentage inhibition caused by each concentra-
ti on of Inhibitor is therefore calculated as fol lows: 
% Inhibition = ( test dpm - max ·binding av. dpm d ) x 100 min binding av. dpm - max binding av. pm 
The percentage inhibition was plotted against inhibitor concentration 
to give the inhibition curve. 
Controls containing only 0,5 µg of the radio label led antigen were 
carried out simultane~usly with the assay as a check on the amount 
of the radio label led antigen added to each test. 
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